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The accurate segregation of chromosomes during mitosis is essential for the survival and development
of all eukaryotes, and this process requires the attachment of mitotic spindle microtubules to the
kinetochore, which is assembled on the chromosomal centromere. Defections in centromere or
kinetochore function can lead to the loss of genetic material during cell division, which can result in
development defects or disease. Therefore, elucidating how the centromere is stably and accurately
propagated across cell and organismal generations is crucial to our understanding of how genetic
information is accurately inherited. Centromere location is specified epigenetically by the histone H3
variant termed centromere protein A (CENP-A). CENP-A molecules at the centromere are known to
possess a remarkably stability, exhibiting almost no detectable turnover. This stability is crucial for
maintenance of centromere identity, but the molecular basis for this stability is unclear. Additionally, new
CENP-A molecules must be assembled onto centromeric chromatin at every cell cycle, or else this
epigenetic mark will be diluted and inevitably lost over time. The process of CENP-A assembly is
exquisitely regulated, but is poorly understood. In this thesis, we identified the role of an essential
centromeric protein, CENP-C, in not only binding to CENP-A nucleosomes, but also reshaping and
stabilizing it at centromeres. We then pinpoint the mechanism by which CENP-C stabilizes CENP-A
nucleosomes through a critical arginine anchor, which drives the structural transition of the CENP-A
nucleosome. We then assemble a core centromeric nucleosome complex (CCNC) containing the CENP-A
nucleosome bound to the nucleosome-binding domains of both CENP-C and another centromeric protein,
CENP-N, and provide the first biophysical insight into how both proteins collaborate to rigidify CENP-A
nucleosomes in vitro. Additionally, using gene-editing and rapid protein degradation approaches, we
demonstrate that CENP-C and CENP-N are both crucial in the maintenance of CENP-A nucleosomes in
cells. And finally, we report the landscape of Cdk regulation on the CENP-A-specific chaperone, HJURP,
which provide insight into the mechanism of nascent CENP-A assembly. Taken together, these findings
advance our understanding in how centromere location is specified and maintained to ensure faithful
inheritance of genetic information across cell divisions.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Biochemistry & Molecular Biophysics

First Advisor
Ben E. Black

Subject Categories
Biochemistry | Biology | Biophysics

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2829

CENP-A AND FRIENDS: A COLLABORATIVE MODEL FOR THE
EPIGENETIC TRANSMISSION OF CENTROMERE IDENTITY
Lucie Y. Guo
A DISSERTATION
In
Biochemistry and Biophysics
Presented to the Faculties of the University of Pennsylvania
In Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2018

_____________________________________________________
Ben E. Black, Ph.D.
Associate Professor of Biochemistry and Biophysics
Supervisor of Dissertation

_____________________________________________________
Kim A. Sharp, Ph.D.
Associate Professor of Biochemistry and Biophysics
Graduate Group Chairperson
Dissertation committee:
Jim Shorter, Ph.D. Associate Professor of Biochemistry and Biophysics
Benjamin Garcia, Ph.D. Presidential Professor of Biochemistry and Biophysics
Roger A. Greenberg, M.D., Ph.D. Associate Professor of Cancer Biology
Shelley L. Berger, Ph.D. Daniel S. Och University Professor
Andrew J. Andrews, Ph.D. Assistant Professor, Fox Chase Cancer Center

TABLE OF CONTENTS
ACKNOWLEDGEMENTS ............................................................................................................. vi
ABSTRACT ..................................................................................................................................... viii
LIST OF FIGURES ............................................................................................................................ x
LIST OF TABLES .............................................................................................................................. x
CHAPTER 1: THE EPIGENETIC BASIS FOR CENTROMERE IDENTITY .................. 1
1.1. Introduction ............................................................................................................................ 1
1.2. Chromosomes and centromeres .................................................................................. 3
1.3. CENP-A as the epigenetic marker of centromere location ............................. 5
1.4. Structural features of CENP-A nucleosomes .......................................................... 7
1.5. Recognition of CENP-A nucleosomes by centromere proteins ................. 11
1.5.1 CENP-C ................................................................................................................................... 11
1.5.1.1 CENP-C as the platform for kinetochore assembly ........................................... 11
1.5.1.2 Nucleosome recognition by CENP-C ....................................................................... 12
1.5.2 The CENP-L/N subcomplex ........................................................................................... 14
1.5.2.1 Nucleosome recognition by CENP-N ...................................................................... 14
1.5.2.2 Cell-cycle dependence of CENP-N recruitment .................................................. 15
1.5.3 The CENP-T/W/S/X and CENP-H/I/K/M subcomplexes .................................. 16
1.5.4 CENP-B ................................................................................................................................... 17
1.6. Propagation of centromere location ....................................................................... 18
1.6.1 The machinery for depositing CENP-A ...................................................................... 19
1.6.2 Regulation of CENP-A assembly ................................................................................... 21
1.7. Summary ................................................................................................................................ 25
CHAPTER 2: CENP-C RESHAPES AND STABILIZES CENP-A NUCLEOSOMES AT
THE CENTROMERE .................................................................................................................... 26
2.1. Abstract .................................................................................................................................. 26
2.2. Introduction ......................................................................................................................... 26
2.3. Results ..................................................................................................................................... 27
2.3.1 CENP-C binding alters the shape of the CENP-A nucleosome .......................... 27
2.3.2 CENP-C binding rigidifies secondary structure at the interior of the CENP-A
nucleosome ..................................................................................................................................... 28
2.3.3 CENP-C alters nucleosome terminal DNA ................................................................ 38
2.3.4 CENP-C stabilizes CENP-A at centromeres .............................................................. 40
ii

2.4. Discussion ............................................................................................................................. 47
2.5. Methods .................................................................................................................................. 48
2.5.1. FRET experiments (by Samantha Falk) ................................................................... 48
2.5.2. HXMS...................................................................................................................................... 53
2.5.3. MNase digestions (by Nikolina Sekulic)................................................................... 54
2.5.4. SANS (by Nikolina Sekulic) ........................................................................................... 54
2.5.5. SNAP labeling experiments and cell fusions (by Evan Smoak and Samantha
Falk) ................................................................................................................................................... 55
2.5.6. PAGFP experiments (by Evan Smoak) ...................................................................... 58
2.5.7. Cell lethality assay ............................................................................................................ 59
2.5.8. Immunoblotting................................................................................................................. 60
CHAPTER 3: CENTROMERES ARE MAINTAINED BY FASTENING CENP-A TO DNA
AND DIRECTING AN ARGININE ANCHOR-DEPENDENT NUCLEOSOME
TRANSITION .................................................................................................................................. 61
3.1. Abstract .................................................................................................................................. 61
3.2. Introduction ......................................................................................................................... 62
3.3. Results ..................................................................................................................................... 65
3.3.1 CENP-CCD confers stability to CENP-A nucleosomes ............................................ 65
3.3.2 The arginine anchor of CENP-CCD stabilizes CENP-A ........................................ 70
3.3.3 CENP-NNT fastens CENP-A to nucleosomal DNA .................................................... 77
3.3.4 The Core Centromeric Nucleosome Complex (CCNC) ......................................... 87
3.3.5 CENP-A nucleosome stability requires both CENP-C and CENP-N................. 95
3.4. Discussion ............................................................................................................................. 98
3.5. Methods ................................................................................................................................ 102
3.5.1. Generation of cell lines ................................................................................................. 102
3.5.2. Cell culture......................................................................................................................... 103
3.5.3. Immunoblotting............................................................................................................... 104
3.5.4. SNAP labeling experiments ......................................................................................... 104
3.5.5. Immunofluorescence and microscopy ................................................................... 104
3.5.6. Recombinant protein purification ............................................................................ 105
3.5.7. Assembly of NCPs and complexes ............................................................................ 106
3.5.8. Binding assays (with Praveen Kumar Allu) .......................................................... 107
3.5.9. HXMS.................................................................................................................................... 108
3.5.10. HXMS data analysis ..................................................................................................... 109
3.5.10. Hydroxyl radical footprinting (by Praveen Kumar Allu) .............................. 110
iii

3.5.11. Sucrose gradient sedimentation (by Praveen Kumar Allu) ......................... 110
CHAPTER 4: IDENTIFICATION OF CDK-DEPENDENT HJURP
PHOSPHOSITES.......................................................................................................................... 111
4.1. Abstract ................................................................................................................................ 111
4.2. Introduction ....................................................................................................................... 112
4.3. Results ................................................................................................................................... 112
4.3.1 Identification of Cdk-dependent phosphorylation sites on the CENP-A
chromatin assembly complex by quantitative phosphoproteomics ....................... 112
4.4. Discussion ........................................................................................................................... 119
4.5. Methods ................................................................................................................................ 120
4.5.1. SILAC and affinity purification of prenucleosomal HJURP/CENP-A/H4 complex
............................................................................................................................................................ 120
4.5.2. Mass spectrometry and data analysis ..................................................................... 120
CHAPTER 5: CONCLUSION .................................................................................................... 122
5.1. Summary .............................................................................................................................. 122
5.2. Future directions for Chapters 2 and 3 ............................................................... 123
5.2.1. Toward a structure for the CCNC.............................................................................. 123
5.2.2. Structure-function studies of CENP-N .................................................................... 124
5.2.3. Toward biophysical elucidation of a larger CCNC .............................................. 125
5.2.4. Cell cycle dependence of the roles of CENP-C and CENP-N in stabilizing the
CENP-A nucleosome .................................................................................................................. 125
5.2.5 Single molecule FRET analyses of the CCNC ......................................................... 126
5.3. Future directions for Chapter 4 ............................................................................... 127
5.4. Final thoughts ................................................................................................................... 128
APPENDIX A: PROTOCOLS FOR CHAPTERS 2 AND 3 .............................................. 129
A1. Gene-editing of DLD-1 cells by CRISPR/Cas ....................................................... 129
A1a. Extracting genomic DNA ............................................................................................... 129
A1b. Designing gRNAs for CRISPR ....................................................................................... 130
A1c. Designing repair templates for CRISPR .................................................................... 134
A1d. Transfection and selection for clones ....................................................................... 137
A2. Pulse-chase SNAP experiments to assess CENP-A maintenance ............. 139
A3. Purification of CENP-NNT-His ...................................................................................... 146
A4. Reconstitution of CENP-A nucleosomes and assembly of the Core
Centromeric Nucleosome Complex (CCNC) ................................................................ 149
A5. HXMS of nucleosome and complexes .................................................................... 152

iv

A5a. Making buffers for HXMS reactions ........................................................................... 152
A5b. Set up HXMS reactions.................................................................................................... 154
A5c. Crosslinking pepsin to POROS resin .......................................................................... 156
A5d. Setting up and calibrating the Orbitrap ................................................................... 159
A5e. Running ND samples for generating peptide pool ............................................... 161
A5f. Protein sequences ............................................................................................................. 162
A5g. Generating exclusion list and final peptide pool .................................................. 163
A5h. Running the deuterated timecourse samples........................................................ 167
A5i. Analysis of deuterated samples by ExMS ................................................................. 168
APPENDIX B: PROTOCOLS FOR CHAPTER 4 ............................................................... 171
B1. SILAC experiments .......................................................................................................... 171
B1a. Making media for SILAC ................................................................................................. 171
B2b. Growing HeLaS3 spinner cells in SILAC media ..................................................... 174
APPENDIX C: LIST OF PLASMIDS ...................................................................................... 176
APPENDIX D: LIST OF OLIGOS ............................................................................................ 178

v

ACKNOWLEDGEMENTS
I owe the following people (and many others) unwavering gratitude for their
support during my PhD years:
First and foremost, to my advisor, Ben Black, who has been an incredible mentor
and role model. Thank you for teaching me to think critically and rigorously, for
continually pushing me beyond what I assume to be my limits, and always holding
my work to the highest standards. Thank you for having invested so much time and
energy into my scientific training. These years of working in your lab have
undoubtedly been the most challenging, stimulating, and intellectually rewarding
years of my life, and it has completely transformed me— not only into a better
scientist, but also as a more diligent, resilient, and confident person. Your
enthusiasm about science is infectious, and these years of working in your lab have
surely persuaded me to try to continue making biomedical research a central part of
my career down the road.
To the past and current members of the Black lab who I've had the privilege of
working with: Glennis Logsdon, Samantha Falk, Nikolina Sekulic, Tanya
Panchenko, Morgan Gerace, Jennine Dawicki McKenna, Evan Smoak, Levani
Zandarashvili, Praveen Kumar Allu, Hollis De Laney, Emily Bassett, Jamie
DeNizio, Arunika Das, Hollis De Laney, Evan Selzer, Krystal Haislop, Kelly
Karch. You all are some of the smartest, kindest, most hard-working people I have
ever met. I feel so grateful to have been part of a team with people who are just as
passionate about the science as I have been. And a special thank-you to Nikolina,
Samantha, Tanya, and Kevan— for having all the time you invested in training me
when I first joined the lab. Also, to Glennis, who has been one of my best friends
both in lab and in life. And to Kevan and Morgan, who have been amazing baymates.
Thank you to my outside collaborators for the project outlined in Chapter 3: Kara
McKinley at the Iain Cheeseman lab (MIT), Dani Fachinetti (Institut Curie), Don
Cleveland (UCSD).
Thank you to my collaborators for the project outlined in Chapter 4: Xing-Jun Cao
at the Ben Garcia lab, and Ana Stankovic from the Lars Jansen lab (Instituto
Gulbenkian).
Thank you to my thesis committee: Jim Shorter, Ben Garcia, Roger Greenberg,
and Shelley Berger (as well as formerly Walter Englander and Mitch Weiss).
Thank you so much for all your time and your valuable scientific feedback. Thank

vi

you to Andy Andrews for kindly agreeing to read my thesis and attend my thesis
defense.
Thank you to the Walter Englander lab for all your help with HXMS: Leland
Mayne, Zhong-yuan Kan, Wenbing Hu, Scott Ye. My HXMS experiments would
have been impossible without your guidance.
Thank you to other labs in the Penn community who have always given me valuable
feedback during my research presentations: ChromoClub (Mike Lampson and
Katya Grishchuk labs), the Crystal Talks community (Ronen Marmorstein lab and
other labs), the GFBB group (Ben Garcia, Huaying Fan, Roberto Bonasio labs).
Thank you for all the guidance you’ve given me over the years.
Thank you to the BMB Graduate Group (Kim Sharp, Kate Ferguson, Rahul Kohli,
Ruth Keris, Kelli McKenna), and well as the Penn Medical Scientist Training
Program (Skip Brass, Maggie Krall, Maureen Kirsch, David Bittner). Thank you
for having provided me with such a supportive community in which to train as
scientist.
Lastly— thank you to my family—my mom, dad, and my Irene, for your unwavering
encouragement during all my many years of school. Thank you to my son Aiden, for
having been such an easy-going and pleasant baby so far… otherwise it would have
been a lot harder to get work done in lab! And thank you to my husband Ryan,
without whom none of this would have been possible.

vii

ABSTRACT
CENP-A AND FRIENDS: A COLLABORATIVE MODEL FOR THE
EPIGENETIC TRANSMISSION OF CENTROMERE IDENTITY
Lucie Guo
Ben Black

The accurate segregation of chromosomes during mitosis is essential for the
survival and development of all eukaryotes, and this process requires the
attachment of mitotic spindle microtubules to the kinetochore, which is assembled
on the chromosomal centromere. Defections in centromere or kinetochore function
can lead to the loss of genetic material during cell division, which can result in
development defects or disease. Therefore, elucidating how the centromere is stably
and accurately propagated across cell and organismal generations is crucial to our
understanding of how genetic information is accurately inherited. Centromere
location is specified epigenetically by the histone H3 variant termed centromere
protein A (CENP-A). CENP-A molecules at the centromere are known to possess a
remarkably stability, exhibiting almost no detectable turnover. This stability is
crucial for maintenance of centromere identity, but the molecular basis for this
stability is unclear. Additionally, new CENP-A molecules must be assembled onto
centromeric chromatin at every cell cycle, or else this epigenetic mark will be
diluted and inevitably lost over time. The process of CENP-A assembly is exquisitely
regulated, but is poorly understood. In this thesis, we identified the role of an
essential centromeric protein, CENP-C, in not only binding to CENP-A nucleosomes,
but also reshaping and stabilizing it at centromeres. We then pinpoint the
mechanism by which CENP-C stabilizes CENP-A nucleosomes through a critical
arginine anchor, which drives the structural transition of the CENP-A nucleosome.
We then assemble a core centromeric nucleosome complex (CCNC) containing the
CENP-A nucleosome bound to the nucleosome-binding domains of both CENP-C and
another centromeric protein, CENP-N, and provide the first biophysical insight into
how both proteins collaborate to rigidify CENP-A nucleosomes in vitro. Additionally,
using gene-editing and rapid protein degradation approaches, we demonstrate that
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CENP-C and CENP-N are both crucial in the maintenance of CENP-A nucleosomes in
cells. And finally, we report the landscape of Cdk regulation on the CENP-A-specific
chaperone, HJURP, which provide insight into the mechanism of nascent CENP-A
assembly. Taken together, these findings advance our understanding in how
centromere location is specified and maintained to ensure faithful inheritance of
genetic information across cell divisions.
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CHAPTER 1: THE EPIGENETIC BASIS FOR
CENTROMERE IDENTITY
1.1. INTRODUCTION
All eukaryotes require a highly regulated machinery to faithfully propagate
genetic material during cell division. The centromere is a specialized region on each
chromosome that provides the locus for forming a protein complex known as the
kinetochore. During mitosis, the kinetochore connects chromosomes to spindle
microtubules, which segregate chromosomes between daughter cells (Figure 1).
Maintaining centromere identity is crucial for the survival and well-being of all
organisms. Loss of a single centromere causes loss of that chromosome in one
daughter cell and an extra copy in the other. On the other hand, presence of multiple
functional centromeres on a single chromosome will render that chromosome
vulnerable to breakage by opposing forces of spindle microtubules. Centromere
defects during meiotic divisions cause aneuploidy (defined as gain or loss in
chromosome number) in the gametes, which leads to spontaneous abortion or
developmental defects in the embryo (Hassold and Hunt, 2001). Also, aneuploidy
has been consistently observed in virtually all human cancers (Kops et al., 2005;
Rajagopalan and Lengauer, 2004), and has been proposed to contribute to
carcinogenesis by causing genomic instability (Sheltzer et al., 2011; Solomon et al.,
2011).

1

Figure 1. Schematic of the centromere in cell division.
(Adapted from http://www.nig.ac.jp)
In this chapter, I begin with a historical overview of the centromere and its
epigenetic nature of inheritance. I then hone in on the epigenetic marker of
centromere location, centromere protein A (CENP-A), and summarize its initial
discovery and its unique structural features that play a role in specifying
centromere identity. Then, since CENP-A does not exist in isolation at the
centromere, but rather bound to a host of constitutively associated centromere
proteins, I summarize these "friends of CENP-A" at the centromere, and our current
understanding of their roles in eukaryotic centromere architecture. Lastly, I explain
the key players and regulatory mechanisms ensuring the nascent assembly of CENPA with each new cell divisions. Therefore, with this chapter, I aim to set the
historical context for the two main focuses of my graduate work: elucidating the
contributions from CENP-A's closest binding partners at the centromere, CENP-C
and CENP-N, in endowing CENP-A with its remarkable ability to be stably retained
at existing centromeres without any detectable turnover (Chapters 2 and 3), and
regulation of the CENP-A-specific histone chaperone, HJURP, in the assembly of
nascent CENP-A molecules at the centromere (Chapter 4).
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1.2. CHROMOSOMES AND CENTROMERES
Our understanding of heredity first stems from work by Darwin, whose
seminal 1859 book On the Origin of Species set forth the theory of evolution, which
eventually became the unifying theory for all of the life sciences. But at the time of
its publication, despite its compelling evidence for evolution, one of its major
problems was lack of an underlying mechanism for heredity. During the 18th
century, some scientists, including Dutch microbiologist Antonie van Leeuwenhoek,
were influenced by prior thoughts in preformationism— the idea that living being
exist as miniature versions of themselves prior to their development— and
speculated the existence of a “homunculus” (little man) inside each sperm. Of
course, our understanding of how inherited traits are transmitted from across
generations stems from principles first proposed by Gregor Mendel, whose studies
in peas were published in 1866 as “Experiments in Plant Hybridisation” which
postulated what eventually became known as the Mendelian laws of inheritance,
which included the principles of independent assortment (in which specific traits
operate independently) and independence segregation (in which each pair of alleles
segregate in germ cells and recombine during reproduction). And in 1882, Walther
Flemming, a German anatomist, studied cell division in the fins and gills of
salamanders, and discovered a structure that strongly stained with aniline dyes,
which he named “chromatin”. He saw that during cell division, chromatin separates
into threadlike strings, which were later named “chromosomes” (mean “colored
bodies”)(Figure 2). Then, in the early 1900s, Sutton and Boveri independently
postulated that genetic information is carried by chromosomes. Sutton examined
the Brachystola magna (a grasshopper), and showed that there exist matched pairs
of maternal and paternal chromosomes that separate during meiosis (Sutton, 1902,
1903). Boveri studied sea urchins and showed that proper embryonic development
required the presence of all chromosomes. With that, the work by Sutton and
Boveri, which was collectively called the chromosome theory of inheritance, became
the fundamental unifying theory of genetics, and finally provided the underlying
mechanism for the laws of Mendelian inheritance.
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Figure 2. Drawing of mitosis by Walther Flemming in 1882
(O’Connor and Miko, 2008)
The architecture of chromatin remained elusive for many decades. Some
proposed that each chromosome was a bundle of various strands of DNA wound
around each other, and it wasn’t until 1984 when Schwartz and Cantor separated
intact chromosomal DNA by a pulsed-field gradient gel, that it was shown that each
chromosome is one linear DNA molecule (Schwartz and Cantor, 1984). In 1936, the
site where chromosomes associate with the spindle during cell division was given
the name “centromere” (Darlington, 1936). Centromeres were originally define as
regions of suppressed meiotic recombination (Beadle, 1932), and later recognized
by cytogenetic techniques as the most constricted region of mitotic chromosomes,
often residing within dark-staining heterochromatin by C-banding. The centromere
was first cloned in S. cerevisiae (budding yeast) in 1980 by Clarke and Carbon, who
identified the genes that persistently segregated with the centromere of
chromosome III, and showed these DNA sequences were sufficient to direct
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segregation of exogenous DNA (Clarke and Carbon, 1980). The centromere in
budding yeast contains a small stretch of DNA spanning 125 bp that is sufficient for
directing accurate chromosome segregation and contains three DNA elements:
CDEI, CDEII, and CDEIII that are common to all chromosomes, a feature that is not
present in higher eukaryotes (Bloom and Carbon, 1982; Saunders et al., 1988). Since
budding yeast centromeres are small and possess a single microtubule attachment
per chromosome, which is now known as “point centromeres”. In contrast to the
“point centromere” of the budding yeast, fission yeast and higher eukaryotes
possess “regional centromeres” that span kilo- to mega-bases of highly repetitive
DNA organized into hierarchy arrays of satellite repeats. The notable exception is C.
elegans and other nematodes, as well as some insects and plants, which do not
possess point nor regional centromeres, but rather holocentric centromeres, which
diffusely span the entire length of the chromosome (Guerra et al., 2010; HughesSchrader and Ris, 1941).

1.3. CENP-A AS THE EPIGENETIC MARKER OF CENTROMERE
LOCATION
Even though the budding yeast centromere relies on DNA for specifying its
location, in all other eukaryotic species, there is a growing consensus that the
location of the centromere is specified “epigenetically” by the protein that associate
with centromeric DNA, particularly by centromeric protein A (CENP-A), which is
known as Cse4 in S. cerevisiae (Stoler et al., 1995), HCP-3 in C. elegans (Buchwitz et
al., 1999), Cnp1 in S. pombe (Takahashi et al., 2000), and CID in Drosophila (Henikoff
et al., 2000). The first report of centromeric proteins came from an examination of
serum samples from a patient with scleroderma, with a syndrome consisting of
calcinosis, Raynaud’s phenomenon, esophageal dismotility, sclerodactyly and
telangiectasia (thus “CREST syndrome), who developed anti-centromere proteins as
recognized by immunofluorescence (Earnshaw and Rothfield, 1985). These proteins
were designated as CENP (CENtromere Protein)-A, B, and C, in order of smallest to
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largest molecular weight as they appeared on the gel. And the first glimpse that
centromeres could be specified not by any specific DNA sequences, but rather by the
proteins, came from a study involving patient samples, in which the authors
observed that on the inactive centromere of a dicentric chromosome, while the
centromere DNA structures remained intact (as seen by traditional banding), CENPA, B, and C were all undetectable (Earnshaw and Migeon, 1985). Using sera from
CREST patients, the CENP-A protein was crudely extracted from nuclei of HeLa cells
and shown to elute from a cation exchange column under denaturing conditions at
nearly the identical NaCl concentration as H3 and H4; with these limited data,
Palmer et al. boldly speculated that "CENP-A functions as a centromere-specific core
histone, possibly substituting for H3 or H4” (Palmer et al., 1987). A few years later,
taking advantage of the fact that CENP-A is quantitatively retained in bull
spermatozoa (unlike the canonical histones), Palmer et al. purified CENP-A and
obtained limited sequencing data suggesting that it contained regions of high
similarity to histone H3, and some regions that are dissimilar, which they again
precociously proposed to be “involved in loading CENP-A to centromeric DNA or in
centromere-specific functions of CENP-A”(Palmer et al., 1991). CENP-A was cloned
for the first time in 1994, and it was shown that CENP-A shares ~60% homology
with histone H3, and the expression of epitope-tagged derivative of CENP-A was
sufficient for targeting to centromeres (Sullivan et al., 1994). From these collective
lines of evidence, there emerged the provocative finding that what makes the
centromere unique from the rest of the chromatin is “at the most fundamental level
of chromatin structure, the nucleosome” (Sullivan et al., 1994).
There exist multiple compelling lines of evidence that the presence of
endogenous centromeric repeats is neither necessary nor sufficient for centromere
identity. In S. pombe, plasmids containing minimal centromeric DNA can
stochastically establish functional centromeres, albeit inefficiently, but can be
faithfully propagated if the centromere becomes functional (Steiner and Clarke,
1994). Additionally in S. pombe, if the centromere were conditionally deleted, the
survivors will gain centromeres at other novel chromosomal locations (Ishii et al.,
2008). Indeed, one of most striking pieces of evidence that human centromeres are
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inherited epigenetically came from the discovery of neocentromeres, which is a new
centromere that forms on a normally non-centromeric region of chromatin, usually
following the disruption of the natural centromere. The best-characterized
neocentromere is on a chromosome 10 fragment, called mar del(10), which is
mitotically stable and lacks detectable α-satellite sequences, which are the major
repeat sequences underlying all human natural centromeres (Voullaire et al., 1993).
Additionally, in pseudodicentric chromosomes, which contain two regions with αsatellite sequence (arisen from DNA translocation or duplication), only one of the
two α-satellite regions remains an active centromere. Neocentromeres and active
centromeres of pseudodicenteric chromosomes, despite being dissimilar in their
underlying DNA sequence, maintain their ability to recruit CENP-A (Bassett et al.,
2010; Lo et al., 2001; Voullaire et al., 1993). Furthermore, it has been shown that
artificial targeting of Drosophila CENP-A (a.k.a. CID) fused to LacI to a stably
integrated lac operator is able to generate a ectopic centromere that assembles a
functional kinetochore be stably transmitted for several cell generations, even after
the CID-LacI fusion protein is eliminated (Mendiburo et al., 2011). Novel centromere
formation by artificial targeting proteins has also succeeded in human cells, by
targeting fusion proteins of LacI with CENP-A (Logsdon et al., 2015) or the CENP-Aspecific chaperone, HJURP (Barnhart et al., 2011). Taken together, there is growing
consensus in the field that it is CENP-A nucleosomes, and not the underlying
sequence, that specifies centromere location in higher eukaryotes.

1.4. STRUCTURAL FEATURES OF CENP-A NUCLEOSOMES
CENP-A nucleosomes have distinct structural properties compared to
canonical H3 nucleosomes (summarized in Figure 3). Experiments in hydrogendeuterium exchange coupled to mass spectrometry showed that the centromeretargeting domain (CATD) of CENP-A confers a unique structural rigidity, resulting in
tetramers with H4 that are more conformationally rigid than the H3/H4 tetramer
(Black et al., 2004). And when CENP-A/H4 tetramers are assembled into
nucleosomes, despite the conformational constraints required for nucleosome
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formation, nucleosomes assembled with CENP-A are still conformationally rigid
than nucleosomes assembled with canonical histone H3 (Black et al., 2007a).
Crystal structure of the CENP-A/H4 tetramer revealed that the interface
between the CENP-A molecules on either side of the nucleosome are rotated
compared to the H3-H3 interface, as well as unique patches of hydrophobic residues
on the CENP-A α2 helix and Loop1 (so called “hydrophobic stitches”) that mediate
the conformational rigidity that CENP-A confers to nucleosomes (Sekulic et al.,
2010). Additionally, CENP-A possesses a bulged loop L1 containing side chains that
generate a positive surface charge, in contrast to the negative surface charge at this
location on canonical nucleosomes (Luger et al., 1997; Sekulic and Black, 2012;
Sekulic et al., 2010).
The crystal structure of the CENP-A nucleosome claimed that the CENPA/CENP-A interface to be rotated to a conventional degree, so that the (CENPA/H4)2 tetramer and the nucleosome maintain a shape similar to that of canonical
H3 nucleosomes (Tachiwana et al., 2011). However, since a crystal structure is a
snapshot of the nucleosome shape most conducible to crystallization, it remained a
possibility that the CENP-A nucleosome could sample multiple conformations in
solution, and that as the (CENP-A/H4)2 tetramer is assembled into a nucleosome,
the unique rotation at the CENP-A/CENP-A interface would generate a smaller
radius of curvature of DNA wrapping near the dyad of the nucleosome, as well as
wider spacing of the H2A/H2B heterodimers (Sekulic and Black, 2012). Indeed, insolution FRET studies (which are further described in this thesis) have revealed that
the H2B distances for CENP-A nucleosomes are ~5Å farther apart than expected
from the crystal structure of the CENP-A nucleosome, whereas H2B distances in
canonical nucleosomes are shorter and match the prediction from their crystal
structure (Falk et al., 2015). Specifically, this nucleosome shape change directed by
CENP-A is dominated by lateral passing of the two DNA gyres (Falk et al., 2016).
Additionally, careful overlay of the structures of the (CENP-A/H4)2 tetramer, the
CENP-A nucleosome and the canonical H3 nucleosome reveal that the CENP-A
nucleosome crystal structure has a CENP-A–CENP-A interface that exhibits rotation
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but not compaction, and therefore is an intermediate structure between the (CENPA/H4)2 tetramer and the H3 nucleosome (Falk et al., 2016).
Another important distinguishing feature of CENP-A nucleosomes, which has
emerged from multiple lines of evidence, is the unwrapping of its terminal DNA.
Early reconstitutions of CENP-A and H3 nucleosomes and comparison of their
electrophoretic mobility revealed that CENP-A nucleosomes exhibit unwrapping at
the entry-exit site relative to canonical nucleosomes, which hinders the binding of
the linker histone H1 (Conde e Silva et al., 2007). The αN helix, which would
stabilize DNA interactions at the termini, is seen to be shorter in the crystal
structure of the CENP-A nucleosome compared to that of the H3 nucleosome
(Tachiwana et al., 2011). Hydrogen-deuterium exchange coupled to mass
spectrometry (HXMS) of CENP-A vs. H3 polynucleosomes arrays has revealed that
the αN helix of CENP-A is less protected than that of H3 upon folding of the
nucleosome arrays (Panchenko et al., 2011). Chip-Seq experiments examining
CENP-A at human centromeres and neocentromeres have also revealed that CENP-A
nucleosome possess looser DNA termini than that of conventional H3 nucleosomes
(Hasson et al., 2013). Recent experiments with electron cryomicroscopy (ECM) have
again confirmed that CENP-A nucleosomal ends exhibit a high degree of flexibility,
and that the αN helix of H3 plays a role in stabilizing the termini DNA in the
conventional nucleosome (Roulland et al., 2016).
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Figure 3. Unique physical properties of the mammalian CENP-A-containing
nucleosome.
Distinguished physical properties of CENP-A nucleosome are highlighted in black
circles. Clockwise from the top left, these include transient unwrapping/flexibility of
the final helical turn of DNA at each nucleosome terminus; hydrophobic stitches that
rigidify the CENP-A/H4 interface; a bulged loop L1 that is of opposite charge as on
H3 in the conventional nucleosome; and the unstructured C-terminus that mediates
recognition of CENP-A nucleosomes by CENP-C. Reproduced from (Sekulic and
Black, 2012)
There has been some proposals that CENP-A resides in strange
conformations, such as tetrasomes (Williams et al., 2009), hexasomes (Mizuguchi et
al., 2007), and especially hemisomes with right-handed DNA wrapping (Bui et al.,
2012; Furuyama et al., 2013; Shivaraju et al., 2012). However, the recent growing
consensus in the field is that CENP-A nucleosomes exist as an octamer in vivo with
conventional left-handed DNA wrapping (Bassett et al., 2012; Hasson et al., 2013;
Padeganeh et al., 2013; Sekulic et al., 2010; Tachiwana et al., 2011), similar to the
conventional H3 nucleosome.
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1.5. RECOGNITION OF CENP-A NUCLEOSOMES BY
CENTROMERE PROTEINS
The key function of the centromere is to recruit the kinetochore, which then
mediates the attachment of sister chromatids to spindle microtubules. At the
centromere, CENP-A is bound to a large complex of inner kinetochore proteins
collectively referred to as the constitutive centromere-associated network (CCAN).
To date, the CCAN is a group of 16 proteins that are known to form individually subcomplexes: CENP-C (Carroll et al., 2009; Kato et al., 2013), the CENP-L/N complex
(Carroll et al., 2009; Fang et al., 2015; McKinley et al., 2015), the CENP-H/I/K/M
complex (Basilico et al., 2014; Klare et al., 2015a; McKinley and Cheeseman, 2016),
the CENP-O/P/Q/U/R complex, ,and the CENP-T/W/S/X complex (Nishino et al.,
2012), and there are multivalent interactions between many members of the CCAN.
Additionally, CENP-B is known to specifically bind to mammalian centromeric DNA,
and recent evidence suggest that CENP-B could directly interact with CENP-A
(Fachinetti et al., 2013). Many of these proteins had been identified in the CENP-A
interactome (Foltz et al., 2006; Izuta et al., 2006). In this section, I summarize the
literature on each of the sub-complexes within the CCAN, and the extensive network
of known interactions between these sub-complexes.

1.5.1 CENP-C
1.5.1.1 CENP-C AS THE PLATFORM FOR KINETOCHORE
ASSEMBLY
CENP-C was the first protein to be identified as a component of the human
kinetochore plate (Saitoh et al., 1992). Among members of the CCAN, CENP-C has
emerged as a key “founder” of kinetochore assembly. Human CENP-C is 943 amino
acids in length, and sequence analysis predicts CENP-C to be almost entirely
disordered (Westermann and Schleiffer, 2013), with the exception of a cupin fold at
the C-terminus known to be required for dimerization (Cohen et al., 2008; Sugimoto
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et al., 1997; Trazzi et al., 2009; Westermann and Schleiffer, 2013). CENP-C likely
acts as a linear platform, with distinct modules that attach to downstream
components (summarized in Figure 4). A fragment encompassing a.a. 200-400 on
CENP-C has been shown to interact with CENP-H/K of the CENP-H/I/K/M
subcomplex (Klare et al., 2015a). At its N-terminus, CENP-C contains a binding site
for the Mis12 subcomplex of the KMN network (Przewloka et al., 2011; Screpanti et
al., 2011), thus CENP-C functions as a primary link between the inner and outer
kinetochore. While some studies have proposed two parallel and non-redundant
pathways of kinetochore recruitment driven CENP-C and CENP-T (see “Section 1.5.3
The CENP-T/W/S/X and CENP-H/I/K/M subcomplex”), there is growing evidence
that is actually a single pathway of kinetochore assembly, involving CENP-C as the
founder, with CENP-H/I/K/M and CENP-T/W as followers that are dependent on
CENP-C (Basilico et al., 2014; Carroll et al., 2010; Gascoigne et al., 2011a; Logsdon et
al., 2015; Milks et al., 2009).

Figure 4. Summary of the known functions of each domain of the CENP-C protein at
the outset of the projects described in this thesis.

1.5.1.2 NUCLEOSOME RECOGNITION BY CENP-C
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For binding to the nucleosome, CENP-C contains two putative nucleosomebinding domains: the central domain [CENP-CCD a.a. 426-537](Carroll et al., 2010)
and the CENP-C motif [CENP-CCM a.a. 736-758](Kato et al., 2013), which are
proposed to engage the CENP-A nucleosome through similar histone contact points.
CENP-CCD is conserved in mammals (Kato et al., 2013), was mapped initially as the
primary CENP-A nucleosome contact site, and has high specificity for CENP-A
nucleosomes versus its counterparts with canonical H3 (Carroll et al., 2010). CENPCCM, on the other hand, is conserved from yeast to humans, and represents the only
identified nucleosome-binding domain in species lacking a conserved CENP-CCD
(Kato et al., 2013). There currently exists an NMR model of the CENP-CCD bound to a
canonical nucleosome in which the 6 a.a. C-terminal tail of CENP-A replaces the
corresponding region of histone H3, as well as a crystal structure of CENP-CCM
bound to this nucleosome (Kato et al., 2013). These structural information suggest
that both CENP-C domains could interact with CENP-A nucleosomes in a similar
manner, using multiple contact points, specifically the 6 amino-acid C-terminal tail
(“LEEGLG”) tail of CENP-A, the acidic patch of H2A, and the α2 helix of histone H4
(Kato et al., 2013). Both CENP-CCD and CENP-CCM, across multiple species, possess
hydrophobic residues (WW or YW) that are proposed to interact with the “LEEGLG”
tail, as well as a critical arginine residue (R522 in humans or R742 in Xenopus) that
is proposed to interact with the acidic patch of H2A. This mechanism of nucleosome
recognition by a critical arginine residue is a shared feature of a diverse set of
nucleosome binding proteins studied to date (Armache et al., 2011; Barbera et al.,
2006; Makde et al., 2010; McGinty et al., 2014; Morgan et al., 2016), and has been
called the “arginine anchor” as an emerging paradigm for nucleosome recognition
(Figure 5)(McGinty and Tan, 2016).
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Figure 5. The arginine anchor motif.
Side chains of arginine anchor residues from RCC1, Sir3, PRC1 (Ring1B), LANA, and
CENP-C shown in surface representation with side chains from acid triad of H2A in
stick representation. Nucleosomal DNA shown as sticks. Reproduced from (McGinty
and Tan, 2016)
Prior reports have suggested that either or both of the nucleosome binding
domains of CENP-C could be important for its own localization to centromeres
(Carroll et al., 2010; Kato et al., 2013; Lanini and McKeon, 1995; Milks et al., 2009;
Trazzi et al., 2002; Yang et al., 1996). At the outset of this thesis, it had been unclear
whether one or both of these domains are required for CENP-A nucleosome
recognition.

1.5.2 THE CENP-L/N SUBCOMPLEX
1.5.2.1 NUCLEOSOME RECOGNITION BY CENP-N
Other than CENP-C, the only other member of the CCAN known to directly
bind to CENP-A is the CENP-N subunit of the CENP-L/N subcomplex. CENP-N was
first identified as a “reader” of epigenetic marks in CENP-A-containing chromatin,
reported to directly bind the centromere targeting domain (CATD) of CENP-A, and
also play a role in nascent CENP-A assembly (Carroll et al., 2009). The CATD
provides exposed side-chains within its Loop 1 that are specific to the CENP-A
nucleosome, which was predicted to be the sites for recognition by CENP-N (Sekulic
and Black, 2009), and was shown to be important for the initial recruitment of
CENP-N (Logsdon et al., 2015). Indeed, two residues on the Loop1 of CENP-A (R80
and G81, termed the “RG loop”) was shown to be the key residues for recognizing
CENP-N, since mononucleosomes assembled with CENP-AR80A,G81A no longer binds to
the N-terminal domain of CENP-A (Fang et al., 2015). For CENP-N, its nucleosome14

binding region was narrowed down to its N-terminal domain (a.a. 1-289), while
deletion of its more conserved C-terminal domain (a.a. 290-339) did not affect
nucleosome binding but is required for its partner CENP-L (Carroll et al., 2009). It is
not known which exact CENP-N residues are required for the interaction interface
between CENP-N and the CENP-A nucleosome. Mutation of two residues far apart in
primary sequence (CENP-NR11A and CENP-NR196A) resulted in reduced CENP-A
nucleosome binding, indicating that both residues in CENP-N contribute to
recognition of CENP-A nucleosomes (Carroll et al., 2009). Furthermore, the
recombinant CENP-L/N subcomplex has shown to be capable of directly binding
CENP-C (McKinley et al., 2015; Nagpal et al., 2015), specifically via a.a. 235-509 of
CENP-C (McKinley et al., 2015).
Even though CENP-N and CENP-C are both known to directly bind to CENP-A
nucleosomes, at the outset of the projects described in this thesis, it had not been
clearly shown with recombinant components whether CENP-N and CENP-C can bind
to the same or different CENP-A nucleosomes. It was first proposed that CENP-C and
CENP-N can bind to distinct sites on the same nucleosome, since it was reported that
[35S]methionine-labeled CENP-N could still bind to reconstituted nucleosomes
incubated with CENP-CCD from rabbit reticulocytes, but the band on the native gel
that was indicated to be the complex was not further isolated to confirm that both
binding partners are present (Carroll et al., 2010).

1.5.2.2 CELL-CYCLE DEPENDENCE OF CENP-N RECRUITMENT
It has been proposed that CENP-N recruitment to CENP-A chromatin is cellcycle dependent. The centromeric localization of CENP-N has been shown to be
increased at early S phase, peaking at middle/late S and G2 phase, and decreased
during mitosis and G1 phase (Fang et al., 2015; Hellwig et al., 2011). Furthermore,
recombinant CENP-N(1-289) binds more weakly to CENP-A polynucleosomes in the
presence of MgCl2, suggesting that chromatin compaction prevents CENP-N
recruitment, possibly due to decreased accessibility of the RG loop (Fang et al.,
2015).
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1.5.3 THE CENP-T/W/S/X AND CENP-H/I/K/M
SUBCOMPLEXES
CENP-T/W/S/X and CENP-H/I/K/M are both important heterotetramers
within the CCAN. CENP-T-W and CENP-S-X each possess histone folds, and coassemble to form a CENP-T/W/S/X heterotetramer that resembles a centromeric
nucleosome-like structure, which binds to and induces positive supercoils within
the DNA (Nishino et al., 2012; Takeuchi et al., 2014). CENP-H/I/K/M binds to the
PEST-rich region (a.a. 200-400) of CENP-C (Klare et al., 2015a), and also directly
interacts with CENP-T/W/S/X (Basilico et al., 2014). CENP-M resembles a small
GTPase (structurally and evolutionarily), but cannot perform GTP-binding and
conformational switching (Basilico et al., 2014). CENP-H/I has been reported to play
a role in nascent CENP-A deposition (Okada et al., 2006).
It has been suggested that CENP-C and CENP-T form parallel but nonredundant pathways that recruit the outer kinetochore: targeting CENP-C and
CENP-T independently to an ectopic chromosome locus revealed that CENP-C
interacts with KNL1 and the Mis12 complex, whereas CENP-T directly interacts with
Ndc80 (which in turn promotes recruitment of KNL1/Mis12), suggesting that these
two pathways are not duplications, but rather distinct mechanisms (Rago et al.,
2015). These two pathways have been reported to be susceptible to distinct modes
of regulation, with Aurora B promoting KMN recruitment to CENP-C and Cdk
promoting KMN recruitment to CENP-T (Rago et al., 2015). Furthermore, the
targeting of CENP-T or CENP-C to ectopic chromosomal loci can result in CENP-Aindependent kinetochore assembly (Gascoigne et al., 2011a; Hori et al., 2013).
However, this model of CENP-T/W as a founder of an independent axis of
kinetochore assembly has been called to question by various lines of evidence.
Recruitment of CENP-T to ectopic centromeres during initial centromere
establishment has been shown to require CENP-C, CENP-N, as well as the N-terminal
tail of CENP-A (Logsdon et al., 2015). Furthermore, A point mutant affecting the
interaction between CENP-M and CENP-I prevents kinetochore recruitment of the
CENP-T/W complex (Basilico et al., 2014).
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1.5.4 CENP-B
CENP-B is known to bind specifically to a 17bp DNA sequence known as the
“CENP-B” box (Masumoto et al., 1989). CENP-B knockout mice are viable and
largely developmentally and reproductively normal, with a few phenotypic defects:
CENP-B-null mice have normal weight at birth, but subsequently lag behind.
Additionally, the testes of CENP-null mice have significantly decreased weight and
sperm content (Hudson et al., 1998; Perez-Castro et al., 1998). This is in stark
contrast to the essential protein members of the CCAN, and is still perplexing to this
field. However, CENP-B could play a role in centromere formation, since the de novo
formation of human artificial chromosomes requires presence of a-satellite DNA
containing CENP-B boxes (Okada et al., 2007), but paradoxically, human
neocentromeres can exist in the absence of CENP-B (Voullaire et al., 1993), and the
human Y chromosome does not contain CENP-B boxes (Masumoto et al., 1989).
Nonetheless, the presence of CENP-B has been reported to help protect against
chromosome missegregation: chromosomes without CENP-B (i.e., neocentromeres,
the Y chromosome) are shown to mis-segregate at greater frequency (Fachinetti et
al., 2015), and this dependence on CENP-B is heightened upon artificially reduced
CENP-C levels at the centromere (Fachinetti et al., 2015). So perhaps, the functions
of CENP-B have been made largely redundant by the multitude of players at the
mammalian centromere.
Nonetheless, there is growing evidence that the presence of CENP-B on the
CENP-B boxes can influence nearby nucleosomes. The crystal structure of the
complex of CENP-B bound to DNA showed that the DNA-binding domain of CENP-B
induces a 60° kink in the CENP-B box DNA (Tanaka et al., 2001) and induces
translational positioning of nucleosomes (Tanaka et al., 2005; Yoda et al., 1998).
Recently, ChiP-seq analyses of CENP-A-containing particles from human
centromeres on a-sat DNA and naturally occurring neocentromeres has suggested
that CENP-B plays a role in CENP-A-nucleosome phasing, and suggests that CENP-B
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binding to the CENP-B box promotes asymmetric unwrapping of CENP-Anucleosome terminal DNA (Hasson et al., 2013). Also, CENP-B may directly interact
with CENP-A via the amino-terminal tail of CENP-A (Fachinetti et al., 2015).

1.6. PROPAGATION OF CENTROMERE LOCATION
Maintenance of genomic integrity requires accurate propagation of
centromere number and position with each cell cycle. Failure to accurately
propagate the centromere would cause the chromosome to be unable to attach to
the mitotic spindle, leading to catastrophic consequences for cell division.
Therefore, the machinery to ensure accurate inheritance of the epigenetic
centromere marker, CENP-A, is of utmost importance for preserving genomic
stability across cell and organismal generations.
Central to the accurate propagation of CENP-A is the extraordinary stability
of the CENP-A molecule, which does not exchange upon assembly into a centromere
(further explained in Chapter 2 and 3 of this thesis)(Bodor et al., 2013; Falk et al.,
2015). Indeed, this stability has been measured out through the entire fertile
lifespan of female mice (>1 year): the pool of CENP-A nucleosomes assembled
before birth in the mouse oocyte is stably transmitted to embryos (Smoak et al.,
2016). The CENP-A nucleosome itself contains multiple unique physical features
(see “Section 1.4. Structural features of CENP-A nucleosomes”) that likely contribute
to its extraordinary stability. In addition to the “intrinsic” features of CENP-A
nucleosomes, there are “extrinsic” factors, specifically its binding partners at the
centromere, that play a key role in ensuring the stability of the CENP-A nucleosome.
Chapters 2 and 3 describe in detail our efforts to attribute key roles to CENP-C and
CENP-N in maintaining centromere identity.
Beyond the stable maintenance of existing CENP-A molecules at the
centromere, the deposition of newly synthesized CENP-A molecules into
centromeric chromatin, which occurs once in each cell cycle, is a crucial event for
the propagation of centromere location. This chapter summarizes the machinery
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responsible for depositing CENP-A, as well as the intricate regulatory mechanisms
to ensure accurate deposition.

1.6.1 THE MACHINERY FOR DEPOSITING CENP-A
Whereas canonical H3.1-containing nucleosomes is assembled by chromatin
assembly factor-1 (CAF-1), CENP-A assembly uses a CENP-A-selective histone
chaperone, the Holliday junction recognition protein (HJURP), which was first
identified from isolation of the soluble, yet-to-be loaded pool of CENP-A/H4 (the
“prenucleosomal pool”); HJURP directly interacts with CENP/H4 in the prenucleosomal pool, and deposits CENP-A/H4 into centromeric nucleosomes in a cell
cycle-dependent manner (Dunleavy et al., 2009; Foltz et al., 2009). HJURP is
sufficient for assembling CENP-A nucleosomes onto plasmid DNA in vitro (Barnhart
et al., 2011). HJURP is related to the yeast centromeric protein Scm3, which
assembles Cse4 (the yeast CENP-A homologue) into centromeric chromatin
(Camahort et al., 2007; Cho and Harrison, 2011; Mizuguchi et al., 2007; Stoler et al.,
2007). A stretch of approximately 80 amino acids at the N-terminus of HJURP, a
region that shares the most homology with the yeast Scm3 protein, is necessary and
sufficient for binding CENP-A, and is called the CENP-A binding domain (CBD)
(Shuaib et al., 2010). Specifically, HJURP interacts with the CENP-A targeting domain
(Foltz et al., 2009). A crystal structure of HJURP CBD with CENP-A/H4 revealed that
the C-terminal β-sheet domain of HJURP CBD caps the DNA-binding region of CENPA/H4 and prevents it from spontaneous association with DNA (Hu et al., 2011).
Furthermore, while the surface-exposed residues within the CATD determine
specificity for HJURP recognition, and upon binding to HJURP, the contact points
adjacent to the CATD serve to transmit stability throughout the histone fold
domains of CENP-A and H4, suggesting that HJURP not only acts to shield CENPA/H4 from nonspecific aggregation with nucleic acids prior to deposition, but also
stabilizes the folded state of CENP-A/H4 (Bassett et al., 2012). Upon CENP-A
assembly, HJURP forms an octameric CENP-A nucleosome from individual CENPA/H4 heterodimers, and it has been reported that HJURP exists as a homodimer
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through its C-terminal domain in the soluble prenucleosomal complex, as well as at
chromatin as new CENP-A is assembled, thus providing a mechanism for how the
assembly machinery assembles an octameric CENP-A nucleosome (Zasadzińska et
al., 2013).
In addition to the CENP-A chaperone, HJURP, deposition of CENP-A in
vertebrates requires Mis18 proteins. Whereas S. pombe has one Mis18 protein,
vertebrates have two Mis18 paralogues, Mis18α and Mis18β, and additionally,
humans possess the Mis18 binding protein (called Mis18BP1, also KNL2), which is
required for recruiting Mis18 to centromeres (Fujita et al., 2007; Maddox et al.,
2007). Mis18 has been suggested to alter histone modifications and the methylation
status of centromeric chromatin to “prime” the centromere for CENP-A recruitment
(Fujita et al., 2007; Kim et al., 2012). Mis18 is known to be required for the
recruitment of HJURP to centromeres for CENP-A assembly (Moree et al., 2011;
Perpelescu et al., 2015). Specifically, the Mis18α and β form a heterotetramer
through their C-terminal coiled-coil domains, and these domains interact with
HJURP directly to recruit it to centromeres; as HJURP binds, it disrupts the Mis18α-β
heterotetramer and removes Mis18α from centromeres, which likely removes
Mis18 from centromeres (Nardi et al., 2016). Therefore, Mis18 and HJURP work in a
concerted fashion to assemble CENP-A at the centromere (summarized in Figure 6).
In order for centromere location to be accurately propagated from one cell
division to the next, assembly of new CENP-A nucleosomes must occur at locations
of existing CENP-A nucleosomes on the chromatin. It has been reported that Mis18
plays a direct role in specifying the location of nascent CENP-A assembly, by directly
associating with the critical member of the CCAN, CENP-C (Dambacher et al., 2012;
Moree et al., 2011). Specifically, the Mis18 complex contains two CENP-C binding
domains, one on Mis18β and one on Mis18BP1, which are combinatorially required
to generate robust centromeric localization of the Mis18 complex (Stellfox et al.,
2016).
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Figure 6. Summary of the players in the assembly of nascent CENP-A nucleosomes
at the centromere.
HJURP exist as a dimer with the CENP-A/H4 heterotetramer in the “prenucleosomal
complex”, and the Mis18 complex recruits HJURP to centromeres and also directly
binds to CENP-C.

1.6.2 REGULATION OF CENP-A ASSEMBLY
Unlike canonical H3.1, whose assembly is coupled to DNA replication in S
phase, replication of centromeric chromatin is uncoupled from centromeric DNA
replication, and in metazoans is restricted to mitosis/early G1 phase (Jansen et al.,
2007; Shelby et al., 2000) (Summarized in Figure 7). CENP-A assembly depends on
passage through mitosis (Jansen et al., 2007). This cell-cycle coupled assembly of
CENP-A is regulated by cyclin-dependent kinase (Cdk) activity: inhibiting Cdk1/2 in
any phase of the cell cycle is sufficient to induce precocious CENP-A assembly (Silva
et al., 2012). Specifically, CENP-A assembly machinery is present and poised for
CENP-A assembly prior to mitosis, but sequestered away from centromeric
chromatin until mitotic exit, and only allowed to assemble CENP-A upon decline of
Cdk1/2 activity in telophase/G1 phase (Silva et al., 2012). The targets of Cdk
regulation within the CENP-A assembly machinery includes the Mis18 complex,
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since upon mutating all 24 of the putative Cdk consensus sites with Mis18BP1,
Mis18BP1 is targeted prematurely to centromeres (Silva et al., 2012). However,
CENP-A is not assembled prematurely with this Mis18BP1 mutant, indicating that
there are likely additional targets of Cdk regulation among the CENP-A assembly
machinery. Indeed, it has been reported that three putative Cdk consensus sites
within the centromere-targeting domain of HJURP are susceptible to Cdk regulation
(Müller et al., 2014; Wang et al., 2014), and mutation of all three sites to alanine
results in premature CENP-A assembly, but only in a minority of cells (Müller et al.,
2014). Therefore, it is likely that the full set of Cdk targets on the CENP-A assembly
machinery has not been uncovered, and Chapter 4 of this thesis centers on using a
quantitative phosphoproteomics approach to comprehensive map the landscape of
Cdk regulation on the CENP-A-specific chaperone, HJURP.

Figure 7. Model of CENP-A-containing chromatin throughout the cell cycle.
Centromeric CENP-A levels fluctuate with the cell cycle. Prior to S phase, CENP-A is
fully loaded at the centromere, but upon replication, the number of CENP-A
molecules present on each daughter strand are reduced to half per centromere,
since no new CENP-A is added. During G2, new CENP-A is synthesized and
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assembles in a soluble prenucleosomal complex with its binding partner H4 and its
chaperone HJURP, but is not loaded onto centromeres until G1. Therefore, cells
progress with half-loaded centromeres through mitosis, until late
anaphase/telophase when CENP-A is deposited by HJURP to restore CENP-A levels.
Reproduced from (Falk and Black, 2012)
In addition to temporal regulation by Cdk1/2, initiation of CENP-A assembly
has also been shown to depend on polo-like kinase 1 (Plk1), which acts as a
licensing kinase to bind to and phosphorylate Mis18, and thereby promotes its
centromeric localization (McKinley and Cheeseman, 2014). Plk1 activity is required
for CENP-A assembly, more specifically for the localization of Mis18 to G1
centromeres (McKinley and Cheeseman, 2014). Therefore, regulation of CENP-A
assembly by Cdk1/2 and Plk1 constitute a two-step paradigm.
Although it has been convincingly shown by multiple lines of evidence that
CENP-A assembly is temporally restricted to the telophase/G1 phase of the cell
cycle, it is still unclear why such regulation is necessary—in other words, what (if
any) consequences there are for the cell if CENP-A assembly were to be forced to
occur outside of telophase/G1. Even though one report claimed that CENP-A
assembly could be forced to occur precociously, in G2 (Müller et al., 2014), it offered
no insight into the mitotic consequences for those cells. Another report
constitutively tethered the Mis18α subunit to the centromere by fusing it to the Cterminal domain of CENP-C, thereby bypassing both the Cdk regulation of the Mis18
complex and Plk1 licensing, and found that this resulted in severe mitotic defects,
including misaligned chromosomes and multipolar spindles (McKinley and
Cheeseman, 2014). However, it is unclear whether the severe mitotic defects could
be derived from another outcome of the constitutive centromeric presence of the
CENP-C-Mis18α fusion protein.
Since new CENP-A nucleosomes are not deposited until telophase/G1,
centromeric chromatin could contain “gaps” after DNA replication has occurred, but
before the full complement of CENP-A nucleosomes are re-acquired at the next
telophase/G1. It has been proposed with evidence from stretched chromatin fibers
and labeled H3.3 that H3.3 could be deposited in those "gaps", thus acting as a
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"placeholder" after the dilution of CENP-A in S phase (Dunleavy et al., 2011). Indeed,
there exists a crystal structure of a heterotypic nucleosome, containing one copy of
CENP-A and one copy of H3.3, which still maintains CENP-C binding on only the
CENP-A side of the nucleosome (Arimura et al., 2014). It is still unclear whether the
loss of CENP-C from one side of the CENP-A/H3.3 heterotypic nucleosome could be
relevant for S phase, and furthermore, it is unknown how H3.3 could be evicted
from centromeric chromatin upon deposition of CENP-A in the next telophase/G1
phase.
Furthermore, CENP-A assembly is not only temporally restricted by the
aforementioned mechanisms, but could also be susceptible to mechanisms of spatial
restriction. The typical human centromere contains ~400 molecules of CENP-A,
which is only ~4% of all centromeric nucleosomes (Bodor et al., 2014). Even this
low concentration of centromeric CENP-A at physiologic centromeres is likely to be
in excess of what is necessary for chromosome segregation, since cells with as little
as 1% of endogenous CENP-A levels can still partially recruit kinetochore proteins
and direct chromosome segregation, and disruption of kinetochore nucleation
requires almost complete loss of CENP-A (Fachinetti et al., 2013). Therefore, the
CENP-A nucleosomes present at the centromere is likely an ample pool, of which
only a subset is required to nucleate centromere and kinetochore complexes (Bodor
et al., 2014). There are likely regulatory mechanisms in place to limit the total
protein level of CENP-A, since exogenous CENP-A expression in human cells often
leads to downregulation of endogenous CENP-A (Falk et al., 2015; Jansen et al.,
2007). A massive overexpression of CENP-A can result in ectopic deposition of
CENP-A into chromosome arms (Falk et al., 2015; Gascoigne et al., 2011a; Van
Hooser et al., 2001), possibly through a DAXX-mediated mechanism (Lacoste et al.,
2014). Additionally, overexpression of HJURP in DT40 chicken cells results in
centromere expansion surround natural centromeres, and ectopic HJURP
localization onto artificial centromeres also results in centromere expansion
(Perpelescu et al., 2015). Therefore, there may exist mechanisms to tightly tune the
total protein levels of CENP-A and its chaperone, HJURP, to prevent ectopic CENP-A
deposition to non-centromeric regions of chromatin.
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1.7. SUMMARY
Kinetochores are assembled upon chromatin defined by the presence of
CENP-A-containing nucleosomes, which are the epigenetic hallmark of centromere
location. Understanding the mechanism by which CENP-A specifies centromere
identity is paramount to the accurate propagation of genetic material over cell and
organisms generations. Much has been learned since centromeres were first
isolated in budding yeast in 1980, but there are crucial gaps in our understanding of
the centromere. For example, although it is known that CENP-A molecules are
remarkably stable, a characteristic that is critical for the stable transmission of
centromere location, it is unknown how such stability is achieved. Chapter 2 focuses
on the role of CENP-C, an essential centromeric protein and binding partner of
CENP-A, in ensuring centromere stability by modulating physical properties of the
CENP-A nucleosome. Chapter 3 builds upon the insights from Chapter 3, and focuses
on our efforts in building a core centromeric nucleosome complex (CCNC) and
uncovering its biophysical properties, and through doing so, unveils a definitive
model for the stability of centromeric CENP-A nucleosome.
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CHAPTER 2: CENP-C RESHAPES AND STABILIZES
CENP-A NUCLEOSOMES AT THE CENTROMERE
Chapter 2 is based on the following publication:
Falk, S.J.*, Guo, L.Y.*, Sekulic, N.*, Smoak, E.M.*, Mani, T., Logsdon, G.A., Gupta,
K., Jansen, L.E.T., Van Duyne, G.D., Vinogradov, S.A., Lampson, M.A., and Black,
B.E. (2015). CENP-C reshapes and stabilizes CENP-A nucleosomes at the
centromere. Science 348, 699–704.
*Co-first authors

2.1. ABSTRACT
Inheritance of each chromosome depends upon its centromere. A histone H3
variant, centromere protein A (CENP-A), is essential for epigenetically marking
centromere location.We find that CENP-A is quantitatively retained at the
centromere upon which it is initially assembled. CENP-C binds to CENP-A
nucleosomes and is a prime candidate to stabilize centromeric chromatin. Using
purified components, we find that CENP-C reshapes the octameric histone core of
CENP-A nucleosomes, rigidifies both surface and internal nucleosome structure, and
modulates terminal DNA to match the loose wrap that is found on native CENP-A
nucleosomes at functional human centromeres. Thus, CENP-C affects nucleosome
shape and dynamics in a manner analogous to allosteric regulation of enzymes.
CENP-C depletion leads to rapid removal of CENP-A from centromeres, indicating
their collaboration in maintaining centromere identity.

2.2. INTRODUCTION
Centromeres direct chromosome inheritance at cell division, and
nucleosomes containing a histone H3 variant, centromere protein A (CENP-A), are
central to current models of an epigenetic program for specifying centromere
location (Black and Cleveland, 2011). The centromere inheritance model in
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metazoans suggests that the high local concentration of preexisting CENP-A
nucleosomes at the centromere guides the assembly of nascent CENP-A, which
occurs once per cell cycle after mitotic exit. This model predicts that after initial
assembly into centromeric chromatin, CENP-A must be stably retained at that
centromere; otherwise, centromere identity would be lost before the next
opportunity for new loading in the next cell cycle. Here, we use biochemical
reconstitution to measure the shape and physical properties of CENP-A
nucleosomes with and without its close binding partner, CENP-C, and combine these
studies with functional tests that reveal the mechanisms underlying the high
stability of centromeric chromatin.

2.3. RESULTS
2.3.1 CENP-C BINDING ALTERS THE SHAPE OF THE CENP-A
NUCLEOSOME
CENP-C recognizes CENP-A nucleosomes via a region termed its central
domain (amino acids 426 to 537; CENP-CCD)(Carroll et al., 2010; Kato et al., 2013).
We first considered how CENP-CCD may affect the overall shape of the CENP-A–
containing nucleosome using an intranucleosomal fluorescence resonance energy
transfer (FRET)–based approach. We designed an experiment to measure FRET
efficiency, ΦFRET, between two fluorophores on defined positions on the H2B
subunits of CENP-A nucleosomes in the absence or presence of CENP-CCD and then
used these measurements to calculate intranucleosomal distances (Figure 8, and
Fig. S1 in Falk et al., 2015). The H2B distances for CENP-A nucleosomes in the
absence of CENP-CCD are ~5 Å farther apart than expected from their crystal
structure (PDB ID 3AN2)(Tachiwana et al., 2011), indicating that CENP-A–
containing nucleosomes in solution prefer a histone octamer configuration not
captured in the crystal structure. It is likely that CENP-A nucleosomes sample both
conformations in solution, with crystal contacts stabilizing the form that was
reported (Tachiwana et al., 2011). In contrast to CENP-A nucleosomes, conventional
27

nucleosomes have smaller H2B distances in solution (Figure 8) that are consistent
with their crystal structure (Luger et al., 1997). Separation of H2A/H2B dimers from
each other is consistent with a nucleosome model based on rotation of the CENPA/CENP-A′ interface in (CENP-A/H4)2 heterotetramers (Sekulic et al., 2010). Upon
binding of CENP-CCD, with the known stoichiometry of two CENP-CCD molecules per
nucleosome (Kato et al., 2013), the H2A/H2B distances shorten to ones that are
nearly identical to those in conventional nucleosomes (Figure 8). The differences
we observed between H3 nucleosomes, CENP-A nucleosomes, and CENP-A
nucleosomes in a complex with CENP-CCD are found using either the human αsatellite DNA sequence that corresponds to the most heavily occupied site at
centromeres (Hasson et al., 2013) or the completely synthetic “601” nucleosome
positioning sequence (Lowary and Widom, 1998) (Figure 8).

Figure 8. CENP-A nucleosomes have a conventional shape only upon CENP-CCD
binding.
Calculated FRET efficiencies (ΦFRET) and distances between donor and acceptor
fluorophores on H2B S123C for the indicated nucleosomes on either α-satellite or
Widom 601 DNA. Data are shown as the mean ± SEM of three independent
nucleosome reconstitutions.

2.3.2 CENP-C BINDING RIGIDIFIES SECONDARY STRUCTURE AT
THE INTERIOR OF THE CENP-A NUCLEOSOME
The shape change that we measure within the nucleosome upon CENP-CCD binding
most likely occurs through rotation at the four-helix bundles between histone dimer
pairs within the octameric core, with interhistone contacts being stabilized or
destabilized depending on the preference for rotational state. We tested this
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prediction using hydrogen/deuterium exchange-mass spectrometry (HXMS). Strong
protection of CENP-A nucleosomes (Figure 9,
Figure 10D, and Figure 11) is conferred by CENP-CCD binding on peptides
spanning helices that are predicted (Kato et al., 2013) to contact it (i.e., the α3 helix
and C-terminal residues of CENP-A, the α2 helices of both H4 and H2A, and regions
of H2A encompassing its acidic patch residues). In addition to the surface changes
induced by CENP-CCD, there are internal changes to the nucleosome that we
measure by HX (Figure 9A,B, and movie S1 in Falk et al., 2015) that are consistent
with the change in nucleosome shape that we observed by FRET (Figure 8). The
separation of H2A/H2B dimers in CENP-A nucleosomes lacking CENP-CCD (Figure
8) is predicted to weaken an internal, intermolecular β sheet that serves as the
physical connection between the H2A subunit on one face of the nucleosome and the
H4 subunit on the opposite face. When CENP-CCD binds to the CENP-A nucleosome,
peptides spanning the corresponding β-sheet residues of both H2A and H4 exhibit
extra protection from HX by 1 to 2 deuterons, where the same level of HX takes 5 to
10 times as long to occur than in CENP-A nucleosomes lacking CENP-CCD (Figure 9,
Figure 12, Figure 13)
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Figure 9. CENP-CCD rigidifies CENP-A nucleosomes.
(A) HXMS of all histone subunits of the CENP-A nucleosome from a single time point
(104 s; see all time points in
Figure 10). Each horizontal bar represents an individual peptide, and peptides are
placed beneath schematics of secondary structural elements. (B) Regions showing
substantial protection from HX mapped onto the structure of the CENP-A
nucleosome (PDB ID 3AN2). (C and D) Comparison of representative peptides
spanning the β-sheet region in histone H4 and histone H2A over the time course.
The maximum number of deuterons possible to measure by HXMS for each peptide
is shown by the dotted line. (E) The internal H4/H2A interface mapped (see Figure
12) onto the canonical nucleosome crystal structure (PDB ID 1KX5).

30

Figure 10. CENP-CCD binding induces additional protection from HX at multiple
regions within the CENP-A nucleosome.
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(A,B) Experimental scheme for HXMS. HXMS is an approach that measures the
exchange of
amide protons along the polypeptide backbone of the histones with deuterons from
heavy water (D2O) in the exchange buffer (Englander, 2006). Amide protons
engaged in hydrogen bonds inside α-helices and the interior of β-sheets are
protected from HX, exchanging only upon transient unfolding of structure, and thus
this technique detects stabilization/destabilization of these structures. (C) CENP-A
nucleosome alone and in complex with CENP-CCD as assessed by native gel stained
with ethidium bromide (i) or Coomassie Blue (ii). Bands from native gel were
excised and assessed by SDS-PAGE (iii). (D) Regions of CENP-A nucleosomes where
CENP-CCD binding leads to additional protection from HX. The level of protection
added by the presence of CENP-CCD is determined by subtracting the level of HX of
the CENP-A nucleosome alone from that of CENP-A nucleosomes bound by CENPCCD. Each horizontal bar represents an individual peptide, placed beneath
schematics of secondary structural elements of the CENP-A nucleosome. Peptides
that exhibit additional protection from HX upon CENP-CCD binding are colored in
blue, with shading according to the legend. It is notable that prior to nucleosome
assembly, CENPA/H4 is protected from HX by HJURP (Bassett et al., 2012), and after
chromatin assembly CENP-A/H4, as well as the nucleosome subunit, H2A, is
protected from HX by CENP-CCD (this study). HJURP is thought to protect CENPA/H4 during the long cell cycle window between when CENP-A is expressed in late
S-phase (Shelby et al., 2000) to when it is assembled at centromeres in the
subsequent G1 (Jansen et al., 2007). Our studies strongly suggest that CENP-C is
important for stabilizing CENP-A nucleosomes at the centromere to maintain
centromere identity.
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Figure 11. Regions on the surface of the nucleosome that exhibit additional
protection from HX upon CENP-CCD binding.
(A) CENP-A 130-140, (B) H4 52-60, and (C) H2A 63-93, mapped in black onto the
structure of the CENP-A nucleosome (PDB 3AN2). Horizontal blocks represent
peptides from CENP-A containing nucleosomes, placed beneath schematics showing
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locations of α-helices and β-sheets of each histone. Multiple charge states were
detected for a subset of peptides, each represented by its own block. Representative
peptides from these regions exhibiting protection or from flanking regions
exhibiting no extra protection are plotted as the number of deuterons exchanged at
each time point. The maximum number of deuterons for each peptide possible to
measure by HXMS is shown by the dotted line. Residues highlighted in yellow are
those that exhibited methyl chemical shift perturbation in the NMR model of H31132LEEGLG nucleosome bound to CENP-CCD (Kato et al., 2013). The glutamate
residues in pink on H2A are acidic patch residues. Note that PDB 3AN2 does not
contain CENP-A residues 136-140, thus only 130-135 are colored.

Figure 12. Mapping HX protection in the interior of the nucleosome when CENP-CCD
binds to the surface of CENP-A nucleosomes.
(A) All peptides encompassing the β-sheet interface between H4 and H2A (the 104 s
time point is shown) from which the minimal regions that exhibit protection is
deduced to be H4 92-100 and H2A 99-108 based on partially overlapping peptide
HX data. Note that protection of H2A residues encompassing the β-sheet can be
distinguished from those of surface contacts (i.e., acidic patch residues marked with
asterisks). Underlined residues contain the backbone amide hydrogens that engage
in hydrogen bonding within the β-sheet. The first two residues of each peptide and
prolines are boxed in dashed black lines because exchange of the first two backbone
amide protons cannot be measured (42) and prolines lack amide protons. (B) These
minimal regions are colored in black in the nucleosome structure (PDB 1KX5) and
are shown in various orientations. The H2A/H4 β-sheet is buried in the interior of
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the nucleosome and is inaccessible to CENP-CCD at the surface of the nucleosome
(Figure 9B, Figure 11, and movie S1 in Falk et al., 2015), so we conclude that it is
stabilized concomitantly with the shape change that brings H2A/H2B dimers
together.
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Figure 13. HXMS of peptides spanning the β-sheet at the interface in H4 (A) and
H2A (B).
In each panel, the peptide is shown from a CENP-A nucleosome (left) and a CENP-A
nucleosome when in complex with CENP-CCD (right). Dotted blue lines serve as
guideposts to highlight the differences in m/z shifts between the two samples. A
blue asterisk denotes the centroid location of each peptide envelope, and the
numerical value in blue indicates the centroid mass of the peptide envelope as
determined by the ExMS data analysis software (Kan et al., 2011).

Figure 14. Faithful detection of 1-4 deuteron differences in HXMS of CENP-A
nucleosomes with and without CENP-CCD bound.
The indicated peptides are compared between two replicate datasets (set 1 and 2),
which represent two independent CENP-CCD purifications and two entirely
independent nucleosome reconstitutions. Changes of 1-2 deuterons are well within
the resolution of HXMS (Englander, 2006). The star symbol in the H2B diagram
indicates the position of fluorophores used in FRET experiments.
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Figure 15. Comparison of HX behavior of canonical nucleosomes to CENP-A
nucleosomes
bound by CENP-CCD.
HXMS data with H3 nucleosomes at the 104 s time point showing the three histone
subunits (H4, H2A, and H2B) common to the two types of nucleosomes. This is the
same time point shown for CENP-A nucleosome comparisons in Figure 9A. Peptides
spanning the H4/H2A interface show protection in CENP-A nucleosomes bound to
CENP-CCD as compared to H3 nucleosomes, but the protection is less pronounced
than the additional HX protection to CENP-A nucleosomes conferred upon binding
CENP-CCD (see Figure 9A).

2.3.3 CENP-C ALTERS NUCLEOSOME TERMINAL DNA
Because CENP-C might also affect the extent that DNA wraps the
nucleosomes, we reconstituted CENP-A nucleosomes using a 195–base pair (bp)
DNA sequence from α-satellite DNA (Harp et al., 1996) that contains a contiguous
sequence spanning the major binding site it occupies on human centromeres
(Hasson et al., 2013) (Figure 16A). We first overdigested CENP-A nucleosomes and
found very strong protection of 100 bp (Fig. S9 in Falk et al., 2015). Using a
subsequent restriction digest of the 100-bp digestion product, we found that they
were uniquely positioned, with their dyad precisely where the same-sized fragment
previously mapped with native centromeric particles (Hasson et al., 2013)(Fig. S9 in
Falk et al., 2015). CENP-A–containing nucleosomes have many discrete intermediate
digestion products before the strongly protected 100-bp fragment is generated
(Figure 16A,B, and Fig. S10 in Falk et al., 2015). When CENP-CCD is bound, digestion
products larger than a nucleosome core particle [e.g., >145 bp, where DNA strands
could cross at ~165 bp for conventional nucleosomes (Kornberg, 1977)] are missing
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at early time points (Figure 16B). This suggests that when CENP-CCD binds to the
nucleosome, the DNA above the dyad rarely crosses, as it would normally cross for
conventional nucleosomes. Second, digestion to the 100-bp final fragment proceeds
more quickly (Figure 16B). Thus, transient unwrapping of two helical turns (i.e.,
~20 bp) from each terminus of the nucleosome is enhanced when CENP-CCD is
bound.
To determine whether CENP-CCD binding leads to a steady-state structural
change of nucleosomal DNA, we used small-angle neutron scattering (SANS) with
contrast variation. When CENP-CCD binds to CENP-A nucleosome core particles, the
distance distribution profiles reflecting the shape in solution substantially
redistribute for both the protein- and DNA-dominated measurements (Figure 16C,
Fig. S11 and Table S3 in Falk et al., 2015). The increase in larger interatomic vectors
for the protein component is expected to accompany an additional component
(CENP-CCD). The pronounced redistribution of vectors to both smaller and larger
distances in DNA-dominated scattering when CENP-CCD is bound is attributed to
compaction of the nucleosome core (smaller vectors) and opening of the
nucleosome terminal DNA when CENP-CCD is bound (larger vectors).
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Figure 16. Alterations in the nucleosome terminal DNA upon CENP-CCD binding.
(A) Major micrococcal nuclease (MNase)–digested DNA fragments observed for
CENP-A nucleosomes assembled on its native centromere sequence. (B) MNase
digestion profiles of CENP-A nucleosomes in the absence (red) and presence (black)
of CENP-CCD. The black arrow (0.5 min) points to the 165-bp peak (DNA crossed at
the dyad). The asterisk (4 min) denotes the final 100-bp peak. (C) Scheme of SANS
contrast variation experiment together with paired distance distribution curves for
CENP-A nucleosomes alone (red) and bound by CENP-CCD (black) in the indicated
SANS contrast variation conditions.

2.3.4 CENP-C STABILIZES CENP-A AT CENTROMERES
We took two complementary approaches in cells to determine whether
CENP-A is stably retained at the centromere upon which it is initially deposited (see
the legend for Fig. S12 from Falk et al., 2015 that describes the motivation for these
experiments). First, we used cell cycle–synchronized fluorescence pulse labeling of
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CENP-A in “donor” cells and subsequent cell fusion with an “acceptor” cell line. The
donor cells express SNAP-tagged CENP-A that has been pulse labeled with
tetramethylrhodamine-Star (TMR*) to irreversibly label CENP-A (Jansen et al.,
2007) before cell fusion. The acceptor cells express yellow fluorescent protein
(YFP)–tagged CENP-A that is loaded at all centromeres, continuing even after fusion.
At time points through the subsequent cell cycle (Fig. S12 in Falk et al., 2015) until
the second mitosis (Figure 17A), we observed no detectable exchange of the TMR*labeled donor CENP-A to the acceptor centromeres in a shared nucleoplasm.
Quantitation of the fluorescence at each centromere in these heterokaryons yields a
bimodal distribution. The donor centromere group with high TMR* and low YFP
(Figure 17B, “x” symbols) has an average TMR* signal of 0.538 ± 0.005 (normalized
arbitrary units where the maximal measured TMR* signal in each heterokaryon
equals 1) (Figure 17C), whereas the acceptor centromere group with high YFP and
low TMR* (Figure 17B, triangle symbols) has an average TMR* signal of 0.055 ±
0.005 (Figure 17C). These data indicate that once assembled at a centromere, an
individual CENP-A molecule is stably maintained at that particular centromere.
As a complementary approach to test CENP-A stability at individual
centromeres, we used a photoactivatable version of CENP-A (CENP-A-PAGFP). We
induced expression of CENP-A to the extent that it is present at locations throughout
the nucleus, but with clear enrichment at centromeres, and then activated a defined
region of each cell nucleus (Figure 17D, 0 hours postphotoactivation). CENP-APAGFP signal is quantitatively retained at the activated centromeres and does not
accumulate at unactivated centromeres (Figure 17D,E), indicating that there is
negligible exchange between centromeres, consistent with our cell fusion results. In
contrast, CENP-A-PAGFP signal in bulk chromatin decays, with about half of the
protein removed by 8 hours after photoactivation.
To investigate whether CENP-C stabilizes CENP-A at centromeres, we
combined SNAP labeling of CENP-A with CENP-C depletion (Figure 17), for which
we generated a cell line with a chromosomally integrated, doxycycline-inducible
CENP-C short hairpin RNA cassette. In our SNAP system, CENP-C depletion leads to
a dramatic decrease in the retention over 24 hours of the existing pool of CENP-A at
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centromeres (Figure 17G,H). Without CENP-C depletion, the average retention of
CENP-A is slightly >100% (112% ± 63% SD), an increase that is explained by having
a small pool of prenucleosomal CENP-A in the cell population that is labeled by the
TMR* pulse and subsequently incorporated into centromeres. Nascent CENP-A
deposition is also decreased when CENP-C is depleted (fig. Figure 18C)—consistent
with its proposed role in the CENP-A assembly reaction (Erhardt et al., 2008; Moree
et al., 2011)—but this would only affect incorporation of the small prenucleosomal
pool in the CENP-A retention measurements (Figure 17G,H). Thus, our findings
implicate CENP-C in stabilizing CENP-A nucleosomes at centromeres. We cannot
rule out the possibility that removal of CENP-C in turn removes another centromere
component that stabilizes CENP-A nucleosomes, but we favor the idea that CENP-C
is the key molecule for stabilizing CENP-A nucleosomes based on its direct binding
to it.
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Figure 17. Depletion of CENP-C reduces the high stability of CENP-A at
centromeres.
(A to C) Cells expressing SNAP-tagged CENP-A were pulse-labeled with TMR*, then
fused with cells expressing YFP-tagged CENP-A. Representative images (A) show a
cell in the second mitosis after fusion; insets show 3x magnification. X-means
clustering was used to classify YFP only (triangles) or YFP and TMR* (“x” marks)
centromeres (B), and mean (± SEM) TMR* intensity was calculated for each group
(C). (D and E) Cells expressing high levels of CENP-A-PAGFP were photoactivated in
bulk (box) and centromeric (circle) chromatin. Representative images (D) show a
subset of centromeres in a single z section. Fluorescence intensity was quantified at
0 and 8 hours after photoactivation [(E), mean ± SEM]. (F) CENP-C knockdown
begins causing cell death 4 days post-induction (mean ± SD). (G and H) Cells with (+
Dox) and without (– Dox) CENP-C depletion were pulse-labeled with TMR* (day 2),
and the relative CENP-A-SNAP signals were analyzed (day 3). Quantification shows
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CENP-A-SNAP signal retained at day 3 (>2500 centromeres plotted with mean ± SD).
Scale bars, 5 μm.

Figure 18. CENP-C knockdown effects on retention and assembly of CENP-A at the
centromere.
(A) Immunoblot of CENP-C levels in inducible CENP-C knockdown cells at indicated
timepoints after Dox addition, compared to the cells without Dox. Whole cell lysate
dilutions from parental cells were used to measure the extent of CENP-C
knockdown. α-tubulin levels were used as a loading control. CENP-C depletion
requires several days prior to when cell death occurs (Figure 17F) following
mitotic kinetochore failure (Fukagawa and Brown, 1997), so there is an
experimental window of time in which we can test if CENP-A nucleosome retention
persists after the majority of CENP-C protein has been depleted (Figure 17F,G).
SNAP labeling of the existing pool of CENP-A (Figure 17G [Day 2]) combined with
monitoring cell number allows one to account for the entire pool of CENP-A in the
dividing cell population during the course of the experiment (Bodor et al., 2013).
This approach also overcomes the limitation of the CENP-A-PAGFP approach
(Figure 17D) where measurements beyond ~8 hr become problematic due to cell
divisions. (B) Immunoblot of CENP-A levels in parental and CENP-A-SNAP cell lines.
Asterisk denotes non-specific band. (C) We performed a quench-chase-pulse
experiment where cells were synchronized using a double-thymidine block, preexisting CENP-A was quenched with a non-fluorescent label, and the nascent pool of
CENP-A was pulse-labeled with TMR* 6.5 hours post-release just prior to loading.
Left, representative maximum projected immunofluorescence images of CENPASNAP csells. Right, representative images of CENP-A-SNAP + CENP-C knockdown
cells. Insets are a 3x magnification of selected representative centromeres. Scale bar
= 5 μm.
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Figure 19. The reduction of CENP-A retention upon CENP-C knockdown is
independent of new CENP-A chromatin assembly.
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To determine whether CENP-C knockdown could reduce centromeric CENP-A levels
in the absence of new CENP-A assembly, we quantified CENP-A retention upon codepletion of CENP-C and HJURP. (A) Schematic of pulse-chase experiment to track
CENP-A levels, combined with knockdown of both CENP-C and HJURP. Cells with (+
Dox) and without (-Dox) CENP-C depletion were co-transfected with shRNAencoding plasmid targeting nucleotides 1288-1306 of HJURP (pSRP-HJURP) (Foltz
et al., 2009) or the control plasmid (pSRP). A plasmid encoding GFP was cotransfected at a 9:1 (shRNA:GFP) ratio to mark transfected cells. The cells were
pulse-labeled with TMR* (Day 2) and the CENP-A-SNAP signals were analyzed at
day 2 and 3. (B) Quantification of CENP-A-SNAP signal retained at day 3. For each
condition, >700 centromeres in GFP-positive cells were quantitated using the
Centromere Recognition and Quantitation macro (Bodor et al., 2012) in ImageJ, and
each TMR* value at day 3 was divided by its average TMR* value at day 2, then
normalized to the - Dox, mock-transfected condition and plotted as mean ± s.d. (C)
Representative images of GFP positive cells. CENP-C knockdown upon dox
treatment was confirmed separately. Insets are 3x magnification. (D) We performed
a quenchchase-pulse experiment on the same transfected cells used for panels A-C
to assess whether or not the HJURP knockdown compromised new CENP-A
assembly. By quenching pre-existing CENP-A with a non-fluorescent substrate and
performing the TMR* labeling after 24 hours, we exclusively examine the pool of
CENP-A-SNAP that had been newly synthesized and loaded onto centromeres. We
TMR* labeled immediately after quenching and confirmed the lack of detectable
TMR* signal in all conditions. (E) Representative images showing that transfection
of HJURP shRNA abolishes new CENP-A loading. Note the assembly of CENP-A in the
untransfected cells (GFP negative) adjacent to those that received HJURP shRNAs
(GFP positive). Scale bars = 5 μm.

Figure 20. Summary model for collaboration of CENP-C with CENP-A nucleosomes
in specifying centromere location.
At the centromere, there is a high local concentration of CENP-A, which results in a
high local concentration of CENP-C. Together, CENP-A and CENP-C collaborate to
form a stable complex that maintains the epigenetic mark of the centromere. In the
chromatin arms, CENP-A levels do not reach a sufficient threshold to recruit CENP-C
and CENP-A is quickly turned over. Our experiments support the idea that CENP-Acontaining nucleosomes prefer an atypical shape in the absence of CENP-C, but
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adopt a conventional overall histone octamer shape when CENP-C binds. In
addition, our reconstitutions on native centromere DNA of octameric CENP-A
nucleosomes very closely match the DNA wrapping properties of CENP-A
nucleosomes isolated from functional human centromeres (Hasson et al., 2013),
especially when CENP-C is bound (Figure 16B). This is in stark contrast to halfnucleosomes (termed hemisomes; i.e. one copy each of CENP-A, H4, H2A, and H2B)
that wrap 65 bp of DNA (Furuyama et al., 2013) and have been proposed by others
to be the major form at centromeres (Bui et al., 2012; Henikoff et al., 2014).
Importantly, until now CENP-C has been considered primarily as a protein that
recognizes CENP-A and bridges centromeric chromatin to other proteins important
for centromere and kinetochore function (Carroll et al., 2010; Erhardt et al., 2008;
Guse et al., 2011; Kato et al., 2013; Przewloka et al., 2011; Screpanti et al., 2011;
Tomkiel et al., 1994) and helping target new CENP-A chromatin assembly at the
centromere each cell cycle (Erhardt et al., 2008; Moree et al., 2011), but our findings
that its binding directs changes to the shape and dynamics of the nucleosome
suggest that it could also play a role in the special stability of CENP-A at
centromeres in a manner analogous to allosteric regulation of enzymes. This has
potential implications for chromatin regulation at diverse chromosome locations, as
such a feature has not been reported for some other non-catalytic nucleosome
binding proteins studied to date, like RCC1 and Sir3 (Armache et al., 2011; Makde et
al., 2010), but now is worth considering for these and other nucleosome binding
proteins. Directing a structural change upon binding of one component to a
macromolecular complex to alter its behavior is a general strategy in biology, and
our work with CENP-C importantly illustrates that a nucleosome—in this case, the
special type at the centromere—is no exception.

2.4. DISCUSSION
CENP-A nucleosomes are highly stable at the centromeres upon which they
are initially assembled. This stability is possible through collaboration with CENP-C.
Along with the intranucleosomal rigidity of CENP-A and histone H4, where the key
interfacial amino acids are important for accumulation at centromeres (Bassett et
al., 2012; Black et al., 2004; Sekulic et al., 2010), the physical changes imposed by
CENP-C combine to make CENP-A nucleosomes at centromeres very long-lived
(Figure 20). Our data support a model of a steady-state octameric histone core
where H2A/H2B dimers can exchange from either terminus of the CENP-A
nucleosome. At the center, there is an essentially immobile (CENP-A/H4)2
heterotetramer (Bodor et al., 2013)(Figure 17 and Figs. S12 to S14 in Falk et al.,
2015). Thus, the physical properties related to CENP-A nucleosome stability at
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centromeres are tied to the intrinsic properties of the (CENP-A/H4)2
heterotetramer (Bassett et al., 2012; Black et al., 2004; Sekulic et al., 2010) and the
extrinsic properties imposed by CENP-C (Figure 8, Figure 9, Figure 16, Figure 20).

2.5. METHODS
2.5.1. FRET EXPERIMENTS (BY SAMANTHA FALK)
Recombinant human H2B was mutated using QuikChange (Stratagene) to
contain a single cysteine (K120C or S123C) and then purified as described for the
wildtype H2B (Sekulic et al., 2010). Lyophilized protein was dissolved in unfolding
buffer (6 M Gnd-HCl, 10 mM Tris-HCl pH 7.5 at 20ºC, 0.4 mM TCEP) for 1 hr at RT
and a 30-molar excess of either maleimido coumarin 343 (C343) or maleimido
rhodamine B (RhB) dissolved in DMF was added dropwise to the protein. The
reaction proceeded overnight shielded from light and was quenched with 10 mM
DTT and run over a PD-10 column (GE Healthcare) to separate out free dye. Labeled
H2B was then mixed with equimolar amounts of H2A for dimer reconstitution and
purification using previously established methods (Dyer et al., 2004; Sekulic et al.,
2010). Labeling efficiencies, E, ranged from 45-90% and were calculated by
spectroscopy using the Beer-Lambert law using the following equation (Lakowicz,
2006): E = [(A280 – (CF Amax)/εproteinl]/(Amax/εfluorophorel) (1) where A280 is the
absorbance of protein at 280 nm, Amax is the absorbance of fluorophore at its
maximum wavelength, εprotein and εfluorophore are the molar extinction
coefficients for protein and fluorophore, respectively, l is the pathlength, and CF is
the correction factor for contribution to the protein A280 from the fluorophore.
Labeling efficiency was further confirmed by SDS-PAGE (Coomassie Blue staining)
and mass spectrometry (Figs. S1 and S2 in Falk et al., 2015). α-satellite DNA derived
from a sequence described by Harp, et al. (Harp et al., 1996) or the 601 DNA
sequence described by Lowary and Widom (Lowary and Widom, 1998) were used
in nucleosome assembly reactions. Briefly, a 145 bp region derived from a human αsatellite sequence with 25 bp of flanking DNA on each side was cloned into the
pUC19 plasmid using EcoRI and XbaI restriction sites. The α-satellite DNA monomer
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was then amplified from the plasmid by PCR using primers specific to the flanking
DNA regions. The complete α-satellite sequence is: 5’CGTATCGCCTCCCTCGCGCCATCAGATCAATATCCACCTGCAGATTCTACCAAAAGTGTA
TTTGGAAACTGCTCCATCAAAAGGCATGTTCAGCTCTGTGAGTGAAACTCCATCATCACA
AAGAATATTCTGAGAATGCTTCCGTTTGCCTTTTATATGAACTTCCTGATCTGAGCGGGC
TGGCAAGGCGCATAG- 3’, with the 145 bp α-satellite region underlined. Typically,
DNA from multiple 96-well PCR reactions were pooled, ethanol precipitated,
resuspended in TE buffer and purified by anion- exchange chromatography. Widom
601 DNA was purified as described (Hasson et al., 2013). Nucleosomes were
assembled on either DNA sequence and uniquely positioned using the gradual salt
dialysis method followed by thermal shifting for 2 hr at 55°C (Dyer et al., 2004).
Assembly was assessed by native PAGE (ethidium bromide and Coomassie Blue
staining) and by SDS-PAGE (Coomassie Blue staining). As mentioned above, the
fluorophores for FRET measurements were C343, serving asan energy donor (D),
and RhB, serving as an acceptor (A). C343 and RhB were selected because their
calculated R0 (Förster radius; distance at which energy transfer efficiency is 50%) is
58 Å, which is within the range of predicted dimer distances where energy transfer
would be most sensitive to changes in FRET efficiency. For synthesis of
fluorophores, all solvents and reagents were obtained from standard commercial
sources and used as received. Selecto silica gel (Fisher Scientific, particle size 32-63
µm) was used for column chromatography. 1H NMR spectra were recorded on a
Varian Unity 400 MHz spectrometer. Mass spectra were obtained on a MALDI- TOF
MS Microflex LRF instrument (Bruker Daltonics), using α-cyano-4-hydroxycinnamic
acid as a matrix. The compound maleimido C343 was synthesized by a CDMTassisted peptide coupling of C343 and 1-(2-Aminoethyl)pyrrol-2,5-dione. 1-(2Aminoethyl)pyrrol-2,5-dione was synthesized as described (Richter et al., 2012).
C343 was dissolved in DMF at 0°C, 2-chloro-4,6-dimethoxy- 1,3,5-triazine and Nmethylmorpholine (NMM) were added, and the mixture was stirred for 1 hr. 1-(2Aminoethyl)pyrrol-2,5-dione and NMM were dissolved separately in DMF and
added dropwise to the C343 mixture. The reaction was stirred at 0°C for 2 hr and
then warmed to room temperature and stirred for 12 hr. The solvent was removed
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under vacuum and the residue was purified by column chromatography (silica gel,
DCM). The fraction containing maleimido C343 was collected, the solvent was
evaporated, and the product was dried under vacuum. 1H NMR (CDCl3, δ): 8.94 (s,
1H), 8.57 (s, 1H), 6.99 (d, 2H, 3J = 3.5 Hz), 6.70 (s, 2H), 3.80 (t, 1H, 3J = 5.8 Hz), 3.65
(m, 2H), 3.34 (m, 4H), 2.88 (t, 2H, 3J = 6.3 Hz), 2.77 (t, 2H, 3J = 6.1 Hz), 1.97 (m, 4H).
For MALDI-TOF, the m/z (mass-to-charge ratio) calculated for C22H21N3O5 was
407.15; the following species were found; 407.102 [M]+ and 429.767 [M+Na]+.
Maleimido RhB was synthesized by a HBTU-assisted peptide coupling of RhB
piperazine amide (Nguyen and Francis, 2003) and N- maleimidoglycine (Kassianidis
et al., 2006). 1H NMR (CDCl3, δ): 7.78-7.72 (m, 3H), 7.53-7.51 (m, 1H), 7.29 (m, 2H),
7.10-7.05 (br s, 2H), 6.72 (s, 2H), 6.70 (s, 2H), 4.38 (s, 2H), 3.66-3.55 (m, 8H), 3.493.41 (m, 8H) 1.33 (t, 12H, 3J = 7 Hz). For MALDI-TOF, the m/z calculated for
C38H42N5O5+ was 648.32; the following species were found; 648.358. Steady-state
emission measurements were performed on a FS900 spectrofluorometer
(Edinburgh Instruments), equipped with a photon-counting R2658P PMT
(Hamamatsu). Samples were excited at 450 nm, the wavelength at which the
absorbance of an equimolar mixture of C343 and RhB is dominated by C343
(>99%), and measurements were performed using dilute solutions (ODmax< 0.1) in
a Spectrosil quartz cuvette (1 cm optical path length, Starna Cells). As a result, only
negligible RhB emission is observed under these conditions in the absence of FRET.
Emission spectra were corrected by the detector quantum yield and normalized by
the incident light intensity at the excitation wavelength. The final emission spectra
used in quantum yield calculations (see below) are expressed in counts (photons)
per second (CPS). Absorbance measurements were performed using a LAMBDA 35
UV/Vis spectrophotometer (PerkinElmer). FRET efficiency was calculated based on
donor quenching in the presence of an acceptor fluorophore (Forster, 1946; Lorenz
et al., 1999; Stryer and Haugland, 1967)). The quantum yield of fluorescence was
calculated using the following equation (Crosby and Demas, 1971): ΦS =
ΦR[(AR(λR)/AS(λS)][nS2/nR2][DS/DR] (2) where Φ is quantum yield, A(λ) is the
absorbance value at the designated excitation wavelength, n is the refractive index
of the solution (nS = 1.333 and nR = 1.361), and D is the integrated emission
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spectrum. The subscripts S and R refer to the sample and reference solutions,
respectively. Rhodamine 6G in 100% ethanol was used as a reference actinometer
(ΦR= 0.95) (Kubin and Fletcher, 1982).
Because of the nature of nucleosome reconstitutions, nucleosomes
reconstituted with both C343- and RhB-labeled dimers (i.e. our FRET samples)
contain some percentage of C343-only nucleosomes. Both C343- and RhB-labeled
dimers exhibited ~90% labeling efficiency, meaning that ~10% of the dimers used
in a reconstitution reaction are unlabeled. This leads to a mixture of nucleosomes
characterized by the following equation:
UU + DU + DD + DA + AA + AU = 1 (3) where UU represents the subset of
nucleosomes that contain two unlabeled dimers, DU represents the subset of
nucleosomes that contain one C343-labeled dimer and one unlabeled dimer, DD
represents the subset of nucleosomes with two C343-labeled dimers, DA represents
the subset of nucleosomes with one C343-labeled dimer and one RhB-labeled dimer,
AA represents the subset of nucleosomes with two RhB-labeled dimers, and AU
represents the subset of nucleosomes with one RhB-labeled dimer and one
unlabeled dimer. Because we are using donor quenching to calculate FRET
efficiency, we only consider C343-containing species, so equation 3 is simplified to
the following equation: a + b = 1 (4) where a represents the normalized population
of DU and DD nucleosomes and b represents the normalized population of DA
nucleosomes in the FRET sample. Both a and b can be calculated using the known
labeling efficiencies of both donor-labeled and acceptor-labeled dimers determined
from spectroscopy and mass spectrometry analysis.
In order to account for the subset of DU and DD nucleosomes present in our
FRET samples when measuring donor quenching, a separate control sample of
C343-only nucleosomes are reconstituted and measured alongside every
experimental sample. The following equation is then used to calculate the quantum
yield of C343 in nucleosomes containing both C343 and RhB dimers: ΦDA = [ΦT a(ΦDD)]/b (5), where ΦDA is the quantum yield of C343-RhB nucleosomes (DA),
ΦT is the total quantum yield of all C343-containing nucleosomes (DU + DD + DA),
ΦDD is the quantum yield of C343-only nucleosomes (DU + DD), and a and b
51

represent the fraction of C343-only nucleosomes and C343-Rhb nucleosomes in a
sample, respectively, determined as described above. ΦT and ΦDD are calculated
from the FRET sample and the C343-only sample, respectively, using equation 2
above.
FRET efficiency, ΦFRET, is then determined based on the following equation
(Lakowicz, 2006): ΦFRET = 1-(ΦDA/ΦDD) (6). The distance, r, between the two
fluorophores is then calculated using the following equation (Lakowicz, 2006): r =
R0[(1/ΦFRET)-1]1/6 (7) where R0 is the Förster radius. For the C343/RhB pair, the
R0 was calculated to be 58 Å, using the following equation (Lakowicz, 2006): R0 =
9790(Jκ2ΦDDn-4)1/6 Å (8) where J is the spectral overlap integral for C343/RhB
pair, ΦDD is the quantum yield of C343, n is the refractive index of the solvent
(n=1.333), and κ2=2/3 is the orientation factor for freely rotating fluorophores
(Lakowicz, 2006). Our assumption of orientational averaging as in the case of freely
rotating transition dipole moments was confirmed by our anisotropy measurements
(see below). The measured anisotropy for the fluorophore pair was found to be less
than 0.2 (fig. S1 and Table S1 in Falk et al., 2015), confirming that usage of formula
(7) was appropriate for estimation of interchromophoric distances. Steady-state
fluorescence anisotropy measurements were performed on a QuantaMaster
spectrophotometer (PTI). Samples were diluted to 0.5-1.0 µM in 150 mM NaCl, 20
mM Tris-HCl pH 7.5 at 4°C, 1 mM EDTA, 1 mM DTT and excited at 450 nm for C343
and 567 nm for RhB. Anisotropy, r, was calculated in FeliX32 software using the
following equation (Lakowicz, 2006): r = (IVV – G IVH)/(IVV + 2G IVH) (9) where
IVV is the parallel polarized fluorescence intensity, IVH is the perpendicular
polarized fluorescence intensity, and G is the correction factor for the setup.
Lifetime measurements, τ, were performed using a FluoroLog fluorometer (Horiba
Scientific). The excitation source was an LED (NanoLED), lmax=441 nm with an
average repetition rate of 1 MHz. Samples were in 150 mM NaCl, 20 mM Tris-HCl pH
7.5 at 4°C, 1 mM EDTA, 1 mM DTT at 0.5-1.0 µM. Emission was measured at 491 nm
using a bandpass filter (5 nm). Lifetimes were fitted exponentially using DAS6
software (Horiba Scientific).
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2.5.2. HXMS
CENP-A mononucleosomes were reconstituted with the same 195 bp αsatellite DNA described above in the FRET studies and concentrated to 0.9 mg/ml
with Centricon concentrators (Millipore, Billerica, MA). Recombinant human CENPCCD consisting of the central domain only (a.a. 426-537, the plasmid for recombinant
human CENP-CCD expression was a generous gift from A. Straight, Stanford, USA)
was GST-tagged and purified over a GST column followed by PreScission protease
cleavage (GE Healthcare) and ion-exchange chromatography and prepared in a
buffer containing 20 mM Tris pH 7.5, 200 mM NaCl, 0.5 mM EDTA, 1 mM DTT. To
form complexes with CENP-CCD, 2.2 moles of recombinant CENP-CCD were added per
mole of CENP-A nucleosomes. To the nucleosome-only sample the buffer used for
CENP-CCD preparation was added so that the chemical composition of the buffers
were identical in all cases. Deuterium on-exchange was carried out by adding 5 µL of
each sample (containing approximately 4 µg of nucleosomes or complex) to 15 µL of
deuterium on-exchange buffer (10 mM Tris, pD 7.5, 0.5 mM EDTA, in D2O) so that
the final D2O content was 75%. Reactions were quenched at the indicated time
points by withdrawing 20 µL of the reaction volume, mixing in 30 µL ice cold quench
buffer (2.5 M GdHCl, 0.8% formic acid, 10% glycerol), and rapidly freezing in liquid
nitrogen prior to proteolysis and LC-MS steps. HX samples were individually melted
at 0°C then injected (50 µl) and pumped through an immobilized pepsin (Sigma)
column at initial flow rate of 50 µl/min for 2 min followed by 150 µl/min for
another 2 min. Pepsin was immobilized by coupling to Poros 20 AL support (Applied
Biosystems) and packed into column housings of 2 mm x 2 cm (64 µL) (Upchurch).
Protease-generated fragments were collected onto a C18 HPLC trap column (800
µm x 2 mm, Dionex) and eluted through an analytical C18 HPLC column (0.3 x 75
mm, Agilent) by a linear 12-55% buffer B gradient at 6 µl/min (Buffer A: 0.1%
formic acid; Buffer B: 0.1% formic acid, 99.9% acetonitrile). The effluent was
electrosprayed into the mass spectrometer (LTQ Orbitrap XL, Thermo Fisher
Scientific). The SEQUEST (Bioworks) software program was used to identify the
likely sequence of parent peptides using nondeuterated samples via tandem MS.
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MATLAB based MS data analysis tool, ExMS, was used for data processing (Kan et al.,
2011).

2.5.3. MNASE DIGESTIONS (BY NIKOLINA SEKULIC)
Nucleosomes were assembled using the same 195 bp α-satellite DNA
sequence used in FRET studies using the same assembly approach described above.
Nucleosomes were digested for various times with 2 U/µg of MNase (Roche) at
room temperature (22°C). Reactions were terminated with the addition of
guanidine thiocyanate and EGTA. The DNA was isolated using a MinElute PCR
purification kit (Qiagen) and analyzed on an Agilent 2100 Bioanalyzer.

2.5.4. SANS (BY NIKOLINA SEKULIC)
Nucleosome core particles were assembled on the α-satellite 145 bp
sequence described above. The sequence was cloned in tandem copies separated by
EcoRV sites in pUC57. The 145 bp fragments were released by EcoRV digestion and
purified away from the backbone by anion exchange chromatography. Following
nucleosome reconstitutions, performed as described above, the nucleosomes were
purified by preparative electrophoresis (Prep Cell, BioRad) using a 5% native gel to
separate free DNA and any other non-nucleosomal species (Dyer et al., 2004). SANS
experiments were performed at the National Institutes of Standards and Technology
Center for Neutron Research NG-3. Samples were prepared by dialysis at 4°C against
matching buffers containing 20% or 80% D2O for a minimum of 3 hr using a 6-8
kDa cutoff D-tube dialyzer (Novagen). Samples were centrifuged at 10,000 X g for 5
min at 4°C and then loaded into Hellma quartz cylindrical cells (outside diameter of
22 mm) with 1 mm path lengths and maintained at 6ºC during the experiment.
Sample concentrations were determined by Bradford analysis and optical
absorbance at 260 nm. Scattered neutrons were detected with a 64 cm × 64 cm twodimensional position-sensitive detector with 128 × 128 pixels at a resolution of 0.5
cm/pixel. Data reduction was performed using the NCNR Igor Pro macro package
(Kline, 2006). Raw counts were normalized to a common monitor count and
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corrected for empty cell counts, ambient room background counts and non-uniform
detector response. Data were placed on an absolute scale by normalizing the
scattered intensity to the incident beam flux. Finally, the data were radiallyaveraged to produce scattered intensity, I(q), versus q curves. The scattered
intensities from the samples were further corrected for buffer scattering and
incoherent scattering from hydrogen in the samples. Data collection times varied
from 0.5-2 hr, depending on the instrument configuration, sample concentration
and buffer conditions. Sample-to-detector distances of 11 m (q-range 0.006-0.043 Å1, where q = 4πsin(θ)/λ, where λ is the neutron wavelength and 2θ is the scattering
angle), 5 m (q-range 0.011–0.094 Å−1), and 1.5 m (detector offset by 20.00 cm, qrange 0.03–0.4 Å−1) at a wavelength of 6 Å and a wavelength spread of 0.15 were
collected for each contrast point. We observed good agreement between Rg and I(0)
values determined from either inverse Fourier analysis using GNOM or from Guinier
analysis. The program MuLCH (Whitten et al., 2008) was used to calculate
theoretical contrast and to analyze contrast variation data. Distance distribution
curves were normalized for total molecular mass for the complex.

2.5.5. SNAP LABELING EXPERIMENTS AND CELL FUSIONS (BY
EVAN SMOAK AND SAMANTHA FALK)
CENP-A-SNAP HeLa cells for fusion experiments were labeled with TMR*
(NEB) as described previously and subjected to a double thymidine block with a
final thymidine concentration of 2 mM (Bodor et al., 2013; Jansen et al., 2007). YFPCENP-A HeLa cells (Black et al., 2007b), CENP-A-SNAP Hela cells (Jansen et al.,
2007), and SNAP-tagged core histone (H3.1, H3.3, H4, and H2B)-expressing HeLa
cells (Black et al., 2007b; Bodor et al., 2013) are all established lines. After labeling
with TMR*, CENP- A-SNAP HeLa cells were trypsinized, counted, and co-seeded onto
poly-D-lysine (Sigma-Aldrich) treated coverslips along with an equivalent number
of HeLa cells constitutively expressing YFP-CENP-A. Cells were arrested in growth
medium (DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/mL
penicillin, and 100 µg/mL streptomycin) containing 2 mM thymidine for 17 hr. Cells
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were then washed 3x with PBS, fused with 50% PEG-1500 (Roche) for 30 s and
subsequently washed in PBS and placed in media containing 24 µM deoxycytidine to
release from thymidine block. After 9 hr, cells were blocked again with media
containing thymidine for 17 hr. Cells were released from thymidine with DMEM
media containing 24 µM deoxycytidine and nocodazole was added 7 hr post-release
at a final concentration of 400 ng/mL. Coverslips were fixed and processed for
immunofluorescence at the timepoints outlined in Fig. S12A in Falk et al, 2015.
HeLa-based cell lines for inducible CENP-A-SNAP with and without shRNAs, and
constitutive CENP-A-SNAP with inducible shRNAs directed against CENP-C were
generated by recombinase-mediated cassette exchange (RMCE) using the HILO
RMCE system (a generous gift from E.V. Makeyev, Nanyang Technological
University, Singapore (Khandelia et al., 2011)). pEM784 was used to express
nuclear-localized Cre recombinase. pEM791 was modified for inducible expression
of CENP-A-SNAP-HA3, CENP-A-SNAP-HA3 plus 2 shRNAs against CENP-C (5’tgctgttgactttctaccttgaaggagttttggccgctgactgactccttcaatagaaagtcaa-3’ and 5’tgctgacaagtttgttcttggactcagttttggccactgactgactgagtccaaacaaacttgt-3’), constitutive
CENP- A-SNAP-HA3 driven by the EF1α promoter plus 2 shRNAs against CENP-C,
and CENP-A- PAGFP respectively. CENP-C knockdown was induced in constitutive
CENP-A-SNAP cell lines by treating for 48 hr with 2 µg/mL doxycycline prior to
TMR* labeling for pulse-chase experiments to measure the retention of CENP-A
protein at centromeres. Cells were fixed either immediately after labeling or again
24 hr later. Cell number was also determined at these time points, so that the total
level of CENP-A turnover could be calculated, as described (Bodor et al., 2013). For
experiments to measure the amount of new CENP-A assembly with or without
CENP-C knockdown, cells were treated with 50 ng/mL of doxycycline during a
double thymidine block procedure that spanned 48 hr. Following release from the
double thymidine block, CENP-A- SNAP was quenched with SNAP-Cell Block (NEB)
then released for 6.5 hr to allow for new synthesis of CENP-A-SNAP protein. The
nascent pool of CENP-A-SNAP protein was then pulse-labeled with TMR*, and the
cells were cultured for an additional 17.5 hr prior to fixation and processing for
immunofluorescence. A separate sample was labeled with TMR* immediately after
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the quench step to confirm successful quenching of ‘old’ CENP-A. For
immunofluorescence, cells were fixed in 4% formaldehyde for 10 min at room
temperature followed by permeabilization using PBS + 0.5% Triton X-100. Samples
were stained with DAPI before mounting with Vectashield medium (Vector
laboratories). The following primary antibodies were used: mouse mAb anti-CENPA (1:1000 Enzo), rabbit pAb anti-CENP-C (1:2000) (Bassett et al., 2010), and mouse
mAb anti-HA.II antibody (1:1000, Covance). AlexaFluor488- and AlexaFluor647conjugated secondary antibodies were obtained from Invitrogen and were used at
1:1000. Images were captured at 23°C using software (LAF; Leica) by a chargecoupled device camera (ORCA AG; Hamamatsu Photonics) mounted on an inverted
microscope (DMI6000B; Leica) with a 100x 1.4 NA objective. For each sample,
images were collected at either 0.2 µm z- sections (Figure 17A, Figure 19, and S1215 in Falk et al., 2015) or 0.49 µm z-sections (Figure 17D,G and Fig. S16 in Falk et al.,
2015) that were subsequently deconvolved using identical parameters. The z-stacks
were projected as single two- dimensional images and assembled using PhotoShop
(version 13.0; Adobe), ImageJ (1.48v) (Schneider et al., 2012), and Illustrator
(version 16.0; Adobe). To quantify fluorescence intensity in cell fusions, individual
centromeres from non-deconvolved maximum projections were selected and the
intensity of both TMR* and YFP signal were determined after subtracting the
background fluorescence measured from adjacent regions of the cell using ImageJ.
For each unique fusion, the levels of fluorescence for both channels were
normalized to the highest measured value in that channel, leading to normalized
values for YFP intensity and TMR* intensity for each centromere in the fused cell.
Thus, each centromere is a data point that has an associated TMR* and YFP value
assigned to it, which were then run through the machine learning x-means
clustering algorithm of Weka (Hall et al., 2009; Pelleg and Moore, 2000), which
partitions the data points into n clusters based on their closeness to an assigned
mean value. This generated the two groups of data points (YFP only and YFP +
TMR*) in the plot seen in Figure 17B. To quantify fluorescence intensity in
experiments with CENP-C knockdown, the Centromere Recognition and
Quantification (CRaQ) macro (Bodor et al., 2012) was run in ImageJ with standard
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settings using a reference channel and DAPI. Total CENP-A staining was used as the
reference channel to define ROIs for quantification of TMR* intensity. CENP-A
fluorescence intensity values at the final time point were normalized to reflect the
total pool of labeled CENP-A by accounting for the increase in cell number in the
dividing cell populations following TMR* pulse. 2800-4200 centromeres from >70
cells were analyzed for each time point.

2.5.6. PAGFP EXPERIMENTS (BY EVAN SMOAK)
CENP-A-PAGFP cells were generated with the RMCE system (Khandelia et al.,
2011), as described above, and expression was induced with 1 µg/mL doxycycline 2
days prior to photoactivation and continued for the duration of the experiment.
Cells were cultured in growth medium at 37°C in a humidified atmosphere with 5%
CO2. For live imaging, cells were plated on 22 x 22 mm glass coverslips (#1.5;
Thermo Fisher Scientific) coated with poly-D-lysine (Sigma-Aldrich). Coverslips
were mounted in magnetic chambers (Chamlide CM-S22-1, LCI) using growth
medium without phenol red (Invitrogen). Temperature was maintained at 37°C with
5% CO2 using an environmental chamber (Incubator BL; PeCon GmbH).
Evaporation of media was prevented by applying a thin layer of mineral oil over the
media within the magnetic chamber. Prior to photoactivation, a single plane image
of the unactivated nucleus was acquired to be used for background subtraction.
Cells were subsequently photoactivated by defining an ROI surrounding ~half of the
nucleus and then activated using a pointable 405 nm laser (CrystaLaser) set to 10%
power and one repetition using iLAS2 software run through MetaMorph, followed
by acquisition of an image of a single z-plane. Cells were then followed by DIC for 8
hr, at which point a final single plane image was acquired. Images were acquired
with a confocal microscope (DM4000; Leica) with a 100x 1.4 NA objective lens, an
XY Piezo-Z stage (Applied Scientific Instrumentation), a spinning disk (Yokogawa
Corporation of America), an electron multiplier charge-coupled device camera
(ImageEM; Hamamatsu Photonics), and a laser merge module equipped with 488
nm and 593 nm lasers (LMM5; Spectral Applied Research) controlled by MetaMorph

58

software (Molecular Devices). To quantify the retention of CENP-A-PAGFP in bulk
chromatin, a 25 x 25 pixel region-of-interest (ROI) was drawn in ImageJ on a region
of photoactivated bulk chromatin and the average fluorescence was recorded.
Recorded fluorescence measurements were corrected for background by
subtracting the fluorescence value of the pre-photoactivated ROI. This corrected
average fluorescence of the ROI was then multiplied by the area of the ROI in order
to calculate the average fluorescence of the area. These area fluorescence
measurements of the bulk chromatin ROI for each cell were averaged to generate
the final numbers for comparison. Upon overexpression, CENP-A initially assembles
into nucleosomes at centromeres and at locations throughout the genome (Heun et
al., 2006; Lacoste et al., 2014). Functional centromeres do not spread throughout
chromosomes under these conditions. We note that there is a small soluble pool of
CENP-A in bulk chromatin that is mobile throughout the nucleus, but this does not
significantly contribute to quantification and does not diffuse to the unactivated
portion of the nucleus in earlier time points. To quantify the retention of CENP-APAGFP in centromeric chromatin, single planes were thresholded to create ROIs
around all visibly photoactivated centromeres and the average fluorescence as well
as the total centromeric area were both recorded. Fluorescence measurements were
corrected for background by subtracting the fluorescence value of the prephotoactivated ROIs. This corrected average fluorescence of the ROI was then
multiplied by the area of the ROIs in order to calculate the average fluorescence of
the area. These area fluorescence measurements of the centromeric chromatin ROIs
for each cell were averaged to generate the final numbers for comparison.

2.5.7. CELL LETHALITY ASSAY
Constitutive CENP-A-SNAP HeLa cells with doxycycline-inducible shRNAs
directed against CENP-C were seeded in 6-well plates in triplicate at 8.4 x 104 cells
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per well and with daily introduction of 2 µg/mL dox. Cells were collected and
stained with 0.4% Trypan Blue (CellGro) and counted on a hemocytometer to
calculate the percentage of cell death based on trypan blue uptake.

2.5.8. IMMUNOBLOTTING
Samples derived from whole cell lysates were separated by SDS-PAGE and
transferred to a nitrocellulose membrane for immunoblotting. Blots were probed
using the following antibodies: human ACA (2 µg/mL, Antibodies Incorporated),
rabbit anti-CENP-C (1.7 µg/mL) and mouse mAb anti-α-tubulin (1:4000, SigmaAldrich). Antibodies were detected using a horseradish peroxidase-conjugated
secondary antibody at 1:10,000 (human) and 1:2000 (rabbit or mouse) (Jackson
ImmunoResearch Laboratories) and enhanced chemiluminescence (Thermo
Scientific).
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CHAPTER 3: CENTROMERES ARE MAINTAINED BY
FASTENING CENP-A TO DNA AND DIRECTING AN
ARGININE ANCHOR-DEPENDENT NUCLEOSOME
TRANSITION
Chapter 3 is based on the following publication:
Guo, L.Y., Allu P.K., Zandarashvili, L., McKinley, K.L., Sekulic, N., Fachinetti, D.,
Logsdon G.A., Jamiolkowski, R.M., Cleveland, D.W., Cheeseman, I.M., and
Black, B.E. Centromeres are maintained by fastening CENP-A to DNA and
directing an arginine anchor-dependent nucleosome transition. Nature
Communications, 8, 15775 doi: 10.1038/ncomms15775 (2017).
Chapter 3 also includes my contribution in the following manuscript, which is
shown in Figure 27 in this chapter:
McKinley, K.L., Sekulic, N., Guo, L.Y., Tsinman, T., Black, B.E., and Cheeseman,
I.M. (2015). The CENP-L-N complex forms a critical node in an integrated
meshwork of interactions at the centromere-kinetochore interface. Molecular
Cell 2015 Dec 17;60(6):886-98.

3.1. ABSTRACT
Maintaining centromere identity relies upon the persistence of the epigenetic
mark provided by the histone H3 variant, CENP-A, but the molecular mechanisms
that underlie its remarkable stability remain unclear. Here, we define the
contributions of each of the three candidate CENP-A nucleosome-binding domains
(two on CENP-C and one on CENP-N) to CENP-A stability using gene replacement
and rapid protein degradation. Surprisingly, the most conserved domain, the CENPC motif, is dispensable. Instead, the stability is conferred by the unfolded central
domain of CENP-C and the folded N-terminal domain of CENP-N that becomes
rigidified 1000-fold upon crossbridging CENP-A and its adjacent nucleosomal DNA.
Disrupting the ‘arginine anchor’ on CENP-C for the nucleosomal acidic patch
disrupts the CENP-A nucleosome structural transition and removes CENP-A
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nucleosomes from centromeres. CENP-A nucleosome retention at centromeres
requires a core centromeric nucleosome complex where CENP-C clamps down a
stable nucleosome conformation and CENP-N fastens CENP-A to the DNA.

3.2. INTRODUCTION
The centromere is the specialized region of chromatin that directs accurate
chromosome segregation in cell division (McKinley and Cheeseman, 2016;
Westhorpe and Straight, 2015). The centromere recruits the proteinaceous
kinetochore, which attaches to spindle microtubules during mitosis or meiosis. A
model for the epigenetic specification of centromere identity has emerged wherein
preexisting nucleosomes with a histone H3 variant named centromere protein A
(CENP-A)(Earnshaw and Rothfield, 1985; Palmer and Margolis, 1985) direct the
local assembly of newly synthesized CENP-A (Black and Cleveland, 2011; Fachinetti
et al., 2013), with CENP-A deposition occurring once per cell cycle following
completion of mitosis (Jansen et al., 2007; Schuh et al., 2007). Critically, this model
relies on the stable maintenance of CENP-A nucleosomes at a single site on each
chromosome throughout the remainder of the cell cycle.
Indeed, relative to the other H3 variants (i.e. H3.1 and H3.3) that turnover in
chromatin (Bodor et al., 2013; Falk et al., 2015; Nashun et al., 2015), CENP-A
experiences essentially no detectable turnover once assembled at a centromere
(Bodor et al., 2013; Fachinetti et al., 2013; Falk et al., 2015; Jansen et al., 2007), and
the stability has been measured out to >1 year where it preserves centromere
identity in oocytes that are arrested in a prophase-like state during the entire fertile
lifespan of female mice (Smoak et al., 2016). Particularly in the female germline or
any somatic cell types that do not undergo very rapid divisions, maintaining
centromere identity between rounds of CENP-A nucleosome assembly is critical for
faithful chromosome inheritance. Thus, defining the molecular processes that confer
the extraordinary stability of CENP-A nucleosomes is of outstanding interest in
chromosome biology.
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To date, both intrinsic features (i.e. those encoded in the sequence of CENP-A,
itself) and extrinsic factors (i.e. constitutive centromere components that bind
directly to CENP-A nucleosomes) have been considered as candidates that
contribute to this distinctive stability. Residues that rigidify the interface between
CENP-A and its partner histone, H4, are necessary but not sufficient for this stability
(Bassett et al., 2012; Black et al., 2004; Falk et al., 2015; Sekulic et al., 2010), so
extrinsic factors must be considered. The only two proteins of the constitutive
centromere associated network (CCAN) known to make specific contacts with
CENP-A nucleosomes on all functional mammalian centromeres are CENP-C and the
CENP-N subunit of the CENP-L-N complex (Carroll et al., 2009, 2010; Kato et al.,
2013; McKinley et al., 2015). Between these components of the CCAN, there are a
total of three nucleosome-binding domains: two on CENP-C (the central domain
[CENP-CCD a.a. 426-537](Carroll et al., 2010) and the CENP-C motif [CENP-CCM a.a.
736-758](Kato et al., 2013)) and one comprised of the N-terminal portion of CENPN (CENP-NNT a.a. 1-240)(Carroll et al., 2009; McKinley et al., 2015).
For the two nucleosome binding domains of CENP-C, CENP-CCD and CENP-CCM
each are proposed to engage the CENP-A nucleosome through similar histone
contact points and without any local secondary structure of their own (Kato et al.,
2013). CENP-CCD is conserved in mammals (Kato et al., 2013), was mapped initially
as the primary CENP-A nucleosome contact site, and has high specificity for CENP-A
nucleosomes versus its counterparts with canonical H3 (Carroll et al., 2010). CENPCCD also directs a structural transition of the CENP-A nucleosome that changes the
shape of the octameric histone core, slides the gyres of the nucleosomal DNA past
one another, and generates both surface and internal rigidity to the histone subunits
(Falk et al., 2015, 2016). CENP-CCM, on the other hand, is conserved from yeast to
humans, and represents the only identified nucleosome-binding domain in species
lacking a conserved CENP-CCD (Carroll et al., 2010). CENP-CCM is the only CENP-A
nucleosome binding domain for which there exists atomic-level structural
information, with a crystal structure of it bound to a canonical nucleosome in which
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the 6 a.a. C-terminal tail of CENP-A replaces the corresponding region of histone H3
(Kato et al., 2013). This structure revealed that CENP-CCM uses a so-called ‘arginine
anchor’ to recognize the acidic patch on the H2A-H2B dimer (Kato et al., 2013). An
arginine anchor is the shared feature of a diverse set of nucleosome binding
proteins studied to date (Armache et al., 2011; Barbera et al., 2006; Makde et al.,
2010; McGinty et al., 2014; Morgan et al., 2016), establishing an emerging paradigm
for nucleosome recognition (McGinty and Tan, 2016).
Prior reports have suggested that either or both of the nucleosome binding
domains of CENP-C could be important for its own localization to centromeres
(Carroll et al., 2010; Kato et al., 2013; Lanini and McKeon, 1995; Milks et al., 2009;
Trazzi et al., 2002; Yang et al., 1996). CENP-NNT recognizes the CENP-A nucleosome
via the CENP-A Targeting Domain (CATD(Black et al., 2004))(Carroll et al., 2009;
Fang et al., 2015; McKinley et al., 2015), but it is not known whether its binding site
on the nucleosome extends to other histones in a similar manner as the CENP-C
nucleosome binding domains (Kato et al., 2013). While a prior study using labeled
CENP-N and CENP-C expressed in reticulocyte extracts suggested that they can coexist on the same nucleosome, there existed a need to use purified components to
resolve proposals for CENP-C and CENP-N to bind to the same (Carroll et al., 2010)
or different (Fang et al., 2015; Nagpal et al., 2015) CENP-A nucleosomes, and to
study the nature of such a combined complex. Depletion of CENP-C reduces CENP-A
nucleosome stability (Falk et al., 2015), but this finding does not delineate between
a role for CENP-CCD or CENP-CCM. Also, CENP-C depletion leads to partial removal of
the CENP-L-N complex (McKinley et al., 2015), so it remains possible that CENP-NNT
is responsible for CENP-A nucleosome retention. Thus, it is currently unclear which
of the CENP-C or CENP-N domains is important for maintaining centromere identity
and the extent to which they may cooperate to stabilize centromeric chromatin.
Here, we define the contributions of each of the three nucleosome binding
domains present within the CCAN for maintaining centromere identity. To do this,
we use a combination of gene editing, rapid inducible degradation of centromere
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components, biochemical reconstitution, hydroxyl radical footprinting, and
hydrogen/deuterium exchange coupled to mass spectrometry (HXMS). Our data
establish an essential Core Centromeric Nucleosome Complex (CCNC) that is critical
for CENP-A stability and maintenance of centromere integrity.

3.3. RESULTS
3.3.1 CENP-CCD CONFERS STABILITY TO CENP-A
NUCLEOSOMES
Upon embarking on our effort to define the molecular processes that confer
stability to CENP-A nucleosomes, we first turned our attention to CENP-C. We
reasoned that if either or both of the nucleosome binding domains of CENP-C were
indeed required for its localization to centromeres (Carroll et al., 2010; Kato et al.,
2013; Lanini and McKeon, 1995; Milks et al., 2009; Trazzi et al., 2002; Yang et al.,
1996), then we could not accurately define which of the domains may confer
stability to CENP-A. To define the requirements for these domains in the absence of
endogenous CENP-C, we employed a human DLD-1 cell line in which both alleles of
CENP-C are tagged with an auxin-inducible degron (AID)(Holland et al., 2012;
Nishimura et al., 2009) and EYFP tags (Fachinetti et al., 2015) (Figure 21a). In this
background, we introduced untagged versions of either wild type or mutant CENP-C
proteins, constitutively expressed from a unique genomic locus (Figure 21b). The
AID-EYFP-tagged CENP-C with an otherwise wildtype protein coding sequence is
degraded to below the level of detection within 30 min of addition of the synthetic
auxin, indole-3-acetic acid (IAA)(Figure 22a-d). This allowed us to exclusively
detect the rescue constructs with an antibody directed against CENP-C (Figure 21ce). Since all constructs are expressed at roughly equal levels as the AID-EYFP-tagged
version prior to IAA treatment, there is an expected drop in the amount that is
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detectable at centromeres after IAA treatment even with the wildtype full-length
version [CENP-C(FL); Figure 21d,e, and Figure 22e,f]. The removal of the CD led to
partially diminished CENP-C localization, whereas removal of the CM had little
effect, even when removed in combination with the CD (Figure 21d,e). Thus, the CD
and CM are not strictly necessary for CENP-C localization, consistent with the fact
that CENP-C makes multiple other direct contacts within the meshwork of the CCAN
(Klare et al., 2015b; McKinley et al., 2015; Nagpal et al., 2015).
Previously, we found that slow reduction of CENP-C (via shRNA treatment)
causes a marked decrease in the retention of SNAP-tagged and
tetramethylrhodamine-Star (TMR*) pulse-labeled CENP-A at centromeres (Falk et
al., 2015). This strategy allows us to monitor the pool of CENP-A nucleosomes
existing prior to the pulse labeling (Bodor et al., 2013; Falk et al., 2015; Jansen et al.,
2007), so that any effects of CENP-C depletion on nascent CENP-A assembly (Carroll
et al., 2010; Erhardt et al., 2008; Moree et al., 2011) do not complicate our analysis.
Therefore, we next tested whether these domains of CENP-C are required for the
retention of CENP-A at centromeres. We first added the SNAP tag to endogenous
CENP-A using CRISPR-Cas9-mediated genome editing (Figure 21f, and Figure 22gj), and confirmed that rapid removal of CENP-C-AID-EYFP with no rescue causes a
dramatic decrease over 24 h of the existing pool of CENP-A at centromeres (Figure
22k-m). CENP-C(FL) rescued CENP-A retention, whereas replacement with CENPC(∆CD) resulted in a marked decrease in CENP-A retention (Figure 21g-i). In
contrast, CENP-C(∆CM) did not diminish CENP-A retention (Figure 21g-i).
Therefore, CENP-CCD is required for the retention of CENP-A at centromeres.
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Figure 21. CENP-CCD is the only nucleosome binding domain of CENP-C required for
retention of CENP-A nucleosomes.
(a) Schematic of CENP-CAID-EYFP/AID-EYFP cells. (b) Rescue constructs constitutively
expressed at unique FRT site. FL=full length. (c) Immunoblot of CENP-CAID-EYFP/AIDEYFP cells (with and without 4 h of auxin-induced CENP-C depletion), using an
antibody generated against CENP-C (a.a. 1-198). (d) Representative images, in
which the loss of YFP signal verifies depletion of CENP-C-AID-EYFP after 24 h of IAA,
and CENP-C antibody then exclusively detects rescue constructs. (e) Quantitation of
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d. (f) Schematic for SNAP-tagging CENP-A at its endogenous locus. (g) Schematic
for pulse-chase experiment in which CENP-CAID-EYFP/AID-EYFP cells expressing rescue
constructs of either CENP-C(FL) or CENP-C domain deletion mutants were pulselabeled with TMR* and assessed for retention of the existing pool of CENP-A
molecules. (h) Representative images from experiment diagrammed in g. (i)
Quantitation of h. See also Figure 22k-m. All graphs are shown as mean ±95%
confidence interval (n>2000 centromeres in all cases).
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Figure 22. Compromised retention of centromeric CENP-A nucleosomes upon rapid
auxin-induced degradation of CENP-C.
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(a) Schematic of CENP-CAID-EYFP/AID-EYFP cells. (b) Timecourse of CENP-C-AID-EYFP
signal after various lengths of IAA treatment. (c) Quantitation of b. Mean ± 95%
confidence interval (n>2000 centromeres in all cases). (d) Immunoblot of CENPCAID-EYFP/AID-EYFP cells using anti-CENP-C and anti-α-tubulin after various lengths of
IAA treatment. (e) CENP-CAID-EYFP/AID-EYFP cells expressing full-length, untagged
CENP-C rescue construct at the unique FRT site. Prior to IAA treatment, anti-CENP-C
antibody detects both the rescue construct and the CENP-C-AID-EYFP at the
endogenous gene locus. After IAA treatment, the AID-tagged CENP-C is depleted (as
verified by the loss of YFP signal), and anti-CENP-C antibody exclusively detects the
rescue construct. (f) Quantitation of e. Since both CENP-C-AID-EYFP and the rescue
construct are present in the cell prior to IAA addition, there is an expected drop
(~2-fold) in centromeric CENP-C signal upon rapid removal of the AID-tagged
CENP-C. Mean ± 95% confidence interval (n>2000 centromeres in all cases). (g)
Schematic for SNAP-tagging CENP-A at its endogenous locus by CRISPR/Cas, in
CENP-CAID-EYFP/AID-EYFP cells. (h) Schematic for screening clones by genomic PCR.
Incorporation of the repair template containing SNAP is expected to result in a 2.2
kb PCR product. (i) PCR with genomic DNA extracted from parental cells and a
heterozygous clone in which one allele in which CENP-A is SNAP-tagged by CRISPR.
(j) Verification of presence of SNAP-tagged CENP-A by immunoblot with anticentromere antibodies (ACA). In addition to CENP-A, ACA also recognizes CENP-B,
which here serves as a loading control. The heterozygous clone has both
endogenous CENP-A as well as SNAP-tagged CENP-A. (k) Schematic of the clone
used for all TMR* experiments in this study (CENP-CAID-EYFP/AID-EYFP cells with CENPA that is SNAP-tagged at its endogenous locus), and schematic of pulse-chase
experiment to measure CENP-A retention at the centromere after complete
depletion of CENP-C. (l) Representative images from experiment diagrammed in k.
(m) Left: Quantitation of panel l, shown with all datapoints (n>2000 centromeres in
all cases), and displayed as in our prior study (Falk et al., 2015). Right: Plotting these
same data as a bar graph showing mean ± 95% confidence interval (Cumming et al.,
2007). For TMR* experiments with CENP-C rescue constructs (Figure 21g-i, Figure
25d,e, and Figure 35d-f), the value of the -IAA condition is normalized as 100%,
and the value of the +IAA condition is normalized as 0%.

3.3.2 THE ARGININE ANCHOR OF CENP-CCD STABILIZES
CENP-A
We next determined whether or not the stability CENP-CCD imparts to CENPA nucleosomes is attributable to the CENP-A nucleosome structural transition (Falk
et al., 2015, 2016). We reasoned that by reducing the contact points of the CENP-CCD
with the H2A-H2B dimer (Kato et al., 2013) that we could generate a version of
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CENP-C that could bind to CENP-A nucleosomes but not drive the nucleosome
structural transition (Falk et al., 2015, 2016) that we predicted would be central to
stabilizing CENP-A at centromeres. We chose two adjacent arginines (R521 and
R522) within the CENP-CCD that are proposed to contact an acidic patch of the
nucleosome on the surface of the H2A-H2B dimer (Kato et al., 2013), and performed
quantitative binding studies on CENP-A nucleosomes in which one histone subunit
(H2B) is fluorescently labeled at a site (at the position corresponding to K120) distal
to the binding surface of CENP-CCD (Figure 23a) We reasoned it was likely that
existing isothermal calorimetry data (Kato et al., 2013) (that used canonical
nucleosomes with the C-terminal 6 a.a. of CENP-A appended to conventional H3)
does not clearly distinguish altered binding from a complete loss of binding; since the
complex binding surface for CENP-CCD on the nucleosome involves 3 different
histone subunits and a nucleosome structural transition for bona fide CENP-A
nucleosomes (Falk et al., 2015, 2016), complicating the interpretation of
thermodynamic measurements. Instead, our native PAGE analyses would clearly
distinguish unbound, bound, and higher-order aggregates that can form with the
WT protein at very high concentrations. We find that while the binding affinity of
CENP-CCD R521A is close to that of WT CENP-CCD, CENP-CCD R522A exhibits a 2 to 3fold decrease in binding affinity (Figure 24a,b). The discrete mobility on native
PAGE of the CENP-A nucleosome core particle (NCP)-CENP-CCD complex is lost in
R522A, but preserved in R521As (Figure 24a,c). Therefore, both mutations
preserve the ability to bind to the NCP, but that the R522A may perturb the highly
ordered nature of the complex that CENP-CCD forms with the NCP. Meanwhile,
mutation of one of the hydrophobic residues (W530) proposed to contact the
hydrophobic tail of CENP-A abolishes binding to CENP-A nucleosomes (Figure 23be).
We then measured the effects of these mutations using HXMS, an approach
that revealed HX protection that maps unambiguously to the buried center of the
nucleosome to a region encapsulating a -sheet that forms between H2A and H4,
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coinciding with the CENP-A nucleosome structural transition conferred by WT
CENP-CCD (Falk et al., 2015). HX measures the rate of amide proton exchange along
the polypeptide backbone of proteins, and protection occurs through stabilization of
H-bonds within secondary structure (Englander, 2006) (i.e., within histone -helices
or between the -strands that form with loop L1/L2 contacts between histone pairs
like CENP-A and H4 (Black et al., 2004; Falk et al., 2015)) or via direct backbone
interactions (Englander, 2006). Reconstitution of complexes at the concentrations
and high nucleosome saturation required for the clear interpretation of HXMS
experiments (see Methods) were achieved with WT, R521A, and R522A versions of
CENP-CCD (Figure 24c). HXMS analysis revealed that CENP-CCD(R521A) forms a
similar complex as wildtype CENP-CCD, with protection of the surface helices of the
CENP-A NCP as well as the interior H2A-H4 interface (Figure 24d)(Falk et al.,
2015). On the other hand, although CENP-CCD(R522A) still binds to CENP-A NCPs
(Figure 24a-c), its mode of binding is grossly perturbed: it still contacts and
stabilizes the H4 α2 helix on the surface of the NCP, but the HX protection is reduced
at the other surface helices (one each on CENP-A and H2A)(Figure 24d). We
interpret these results to mean that the reduced HX protection on the surface of
H2A is directly due to the removal of the CENP-CCD arginine anchor. The altered
dynamics in HX are extended to reduce protection at a contact site with CENP-A
(near CENP-C a.a. 530) that lies between the CENP-CCD N-terminal (CENP-C a.a. 522)
nucleosome contact point (on H2A) and its C-terminal (near CENP-C a.a. 535)
contact point (on H4)(Kato et al., 2013) (Figure 24d-f, h). Most importantly,
removal of the arginine anchor by the R522A mutation leads to loss of HX protection
at the H2A-H4 interface at the interior of the nucleosome (Figure 24d, g, i). Since
CENP-C(R522A) binding fails to stabilize the internal H4/H2A interface similar to
CENP-C(∆519-533), which is missing the entire region required for binding to
CENP-A nucleosomes, we predicted that both mutants would also fail to confer
CENP-A stability. After generating the respective cell lines (Figure 25a), and adding
IAA to remove CENP-C-AID-YFP, all mutants localize to centromeres to a level
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equivalent to the wild type protein (Figure 25b,c). We measured retention of
TMR*-labeled CENP-A, and found that both CENP-C(∆519-533) and CENP-C(R522A)
were markedly reduced in their ability to retain CENP-A at centromeres, whereas
the CENP-C(R521A) mutation had no effect (Figure 25d,e). The R522A result is
particularly striking, indicating that R522 is the key arginine anchor of CENP-CCD
and providing a prime example of how an arginine anchor on a nucleosome binding
protein can be a lynchpin for a central biological process such as maintaining
centromere identity. Together with our HXMS results, these data strongly indicate
that stabilization of the interior of the CENP-A nucleosome requires the H2A-H2B
contacts via R522 of CENP-C and that the stability of CENP-A nucleosomes due to
CENP-C at functional centromeres can be attributed exclusively to the CENP-CCD.

Figure 23. CENP-CCD(W530A) fails to bind to CENP-A nucleosomes.
(a) Schematic for labeling H2B K120C with Cy5, subsequent refolding with H2A to
form histone dimers, and reconstitution into nucleosomes. (b) SDS-PAGE gels
stained with Coomassie Blue of CENP-CCD WT and mutant proteins used for binding
assays shown in this figure and Figure 24. (c) Representative native PAGE analysis
of CENP-A NCPs harboring Cy5-labeled histone H2B that have been incubated with
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the indicated concentrations of CENP-CCD(W530A). Only low level of binding to the
nucleosome was observed for the W530A mutant. (d) Quantitation of three
independent experiments (values shown are mean ± SD) performed as in panel c.
Note that for some data points, the error bars are too small to be visible in the
graph. The apparent Kd for W530A was not determined (ND) because of insufficient
binding. (e) The W530A mutant does not assemble with CENP-A nucleosomes to an
extent that would make an HXMS experiment useful or interpretable. CENP-CCD
mutants incubated with CENP-A nucleosomes containing Cy5-H2B. CENP-CCD
(R522A) can form a complex with CENP-A nucleosomes (under the same conditions
as those used to assemble nucleosomes for the HXMS experiments in Figure 24),
while at this concentration, CENP-CCD (W530A) displays very little binding to CENPA nucleosomes (note that the majority of the nucleosomes in the presence of W530A
are unbound from the mutant CENP-C protein). The high proportion of unbound
nucleosomes would dominate the HXMS experiment and would not be capable for
making a useful comparison to wild type or R522A versions of CENP-C.
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Figure 24. The arginine anchor of CENP-CCD is critical for the CENP-A nucleosome
structural transition.
(a) Representative native PAGE analysis of CENP-A NCPs harboring Cy5-labeled
histone H2B that have been incubated with the indicated concentrations of CENPCCD (WT or the indicated mutants). Each reaction contains 200 nM nucleosomes. Cy5
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fluorescence was detected on a Typhoon Phosphorimager, and CENP-C binding
retards the mobility. Both WT and R521A show crisp shifts to bands with 1 or 2
copies of CENP-C bound to the nucleosome. R522A exhibits a more smeary
appearance when bound to the CENP-A nucleosome (see also panel c), and the
species with a single molecule of CENP-CCD(R522A) was not clearly resolved. Listed
on the graphs are apparent Kd values for these binding experiments (values shown
are mean ± SD; n = 3). (b) Quantitation of three independent experiments (values
shown are mean ± SD) performed as in panel a. Note that for some data points, the
error bars are too small to be visible in the graph. (c) CENP-A NCPs in complex with
WT or mutant CENP-CCD, as assessed by native PAGE stained with ethidium bromide
(EtBr) and then Coomassie Blue. (d) HXMS of all histone subunits of the CENP-A
NCP from a single timepoint (104 s), showing regions that exhibit additional
protection from HX upon binding of CENP-CCD(R521A) or CENP-CCD(R522A). Each
horizontal bar represents an individual peptide, placed beneath schematics of
secondary structural elements of the CENP-A nucleosome. When available, we
present the data from all measurable charge states of each of the unique peptides
(here and in the similarly formatted plots in the experiments presented in Figure
29 and Figure 32). (e-i) Representative peptides from various histone regions,
comparing protection from exchange when the nucleosome is bound to CENP-CCD
R521A versus R522A, showing faithful detection of differences between the two
mutants across multiple replicate experiments (plotted as the mean ± SD; n = 3).
Asterisks denotes differences that are statistically significant (p<0.05; Student’s ttest).
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Figure 25. The arginine anchor of CENP-CCD is required for CENP-A nucleosome
stability at centromeres.
(a) Rescue constructs constitutively expressed at the unique FRT site in CENP-CAIDEYFP/AID-EYFP cells. FL=full length. (b) Representative images showing localization of
CENP-C rescue constructs in CENP-CAID-EYFP/AID-EYFP cells after 24 h of IAA treatment.
Scale bar indicates 10 µm. (c) Quantitation of b. (d) Representative images
showing CENP-A retention as measured by TMR* assay in cells, similar to schematic
in Figure 21g. Scale bar indicates 10 µm. (e) Quantitation of d. All graphs are
shown as mean ± 95% confidence interval (n>2000 centromeres in all cases).

3.3.3 CENP-NNT FASTENS CENP-A TO NUCLEOSOMAL DNA
Although a substantial component (~50%) of CENP-A retention at
centromeres is attributable to the CENP-A nucleosome structural transition
conferred by CENP-CCD (Figure 25d,e), complete removal of CENP-C leads to a more
pronounced defect (Figure 25d,e, and Figure 22k-m), implying that an interacting
partner outside of the CENP-CCD also contributes to CENP-A retention. We next
considered the CENP-L-N complex because CENP-NNT directly contacts the CENP-A
nucleosome (Carroll et al., 2009; McKinley et al., 2015), but additionally requires
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CENP-C for its centromere localization (McKinley et al., 2015). Prior work found that
the interaction of CENP-L-N with CENP-C occurs in a region (CENP-C a.a. 235509)(McKinley et al., 2015) overlapping with the CD (CENP-C a.a. 426-537) but
outside of the histone contact residues (CENP-C a.a. 519-533). We found that CENPC235-425 binds to CENP-L-N at similar levels to CENP-C235-509 (Figure 26a), and that
CENP-C235-352 was sufficient for this interaction (Figure 28a). Consistent with this,
CENP-C(∆519-533) almost completely rescues CENP-L-N localization (Figure 26b,c
and Figure 28b,c). Taken together, our findings suggest that CENP-C and CENP-N
bind to each other with interaction interfaces that are distinct from their
nucleosome interaction interfaces. Thus, in principle, CENP-NNT and CENP-CCD could
both contribute to the stability of CENP-A nucleosomes at human centromeres.
CENP-N was previously known to directly bind to the CENP-A nucleosome
through its N-terminal domain (a.a. 1-289) (Carroll et al., 2009), and we further
narrowed down the minimal interaction down to a.a. 1-240, and CENP-N(1-240) is
heretofore referred to as CENP-NNT (Figure 27)(McKinley et al., 2015).
Prior work found that the interaction of CENP-L/N with CENP-C occurs in a
region (a.a. 235-509)(McKinley et al., 2015) overlapping with the CD (a.a. 426-537)
but outside of the histone contact residues (a.a. 519-533). We found that CENP-C235425 binds

to CENP-L/N at similar levels to CENP-C235-509 (Figure 26a), and that

CENP-C235-352 was sufficient for this interaction (Figure 28a). Consistent with this,
CENP-C(∆519-533) almost completely rescues CENP-L/N localization (Figure
26b,c, and Figure 28b,c). Taken together, our findings suggest that CENP-C and
CENP-N bind to each other with interaction interfaces that are distinct from their
nucleosome interaction interfaces. Thus, in principle, CENP-NNT and CENP-CCD could
both contribute to the stability of CENP-A nucleosomes at human centromeres.
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Figure 26. CENP-NNT crossbridges CENP-A to DNA.
(a) Coomassie Blue-stained SDS-PAGE of co-purification with described
protocol(McKinley et al., 2015) of CENP-L/His-CENP-NCT with GST-CENP-C235-509 and
GST-CENP-C235-425 by glutathione-agarose (Glut) or Nickel-NTA-agarose (Ni). (b)
Localization of CENP-L-N in CENP-CAID-EYFP/AID-EYFP cells before and after 24 Eh of IAA
treatment, assessed using anti-CENP-L(McKinley et al., 2015) (See Supplementary
Fig. 3b for images). (c) Localization of CENP-L-N in CENP-CAID-EYFP/AID-EYFP cells
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constitutively expressing the rescue constructs CENP-C(FL), CENP-C(∆CD), or CENPC(∆519-533), after 24 h of IAA treatment. (See Supplementary Fig. 3c for images) All
graphs are shown as mean ± 95% confidence interval (n>2000 centromeres in all
cases). (d) HXMS of all histone subunits of the CENP-A NCP from a single timepoint
(102 s), showing protection at CENP-A(79-83) upon binding to CENP-NNT. The first
two residues of each peptide are boxed in dashed black lines because exchange of
the first two backbone amide protons cannot be measured(Bai et al., 1993). (e,f)
Representative peptides spanning the CENP-A surface bulge over the time course.
The maximum number of deuterons possible to measure by HXMS for each peptide
is shown by the dotted line. All peptides are plotted at every timepoint as mean ±
SD from triplicate experiments. Note that for some data points, the error bars are
too small to be visible in the graph. (g) Schematic of the 5'-fluorescently labeled 147
bp α-satellite DNA sequence used in footprinting experiments. (h) Representative
hydroxyl radical footprinting experiment of CENP-A nucleosomes vs. CENP-A
nucleosomes in complex with CENP-NNT, with inset showing magnification of
positions -17 to -23. (i) Quantitation of band intensities from 3 independent
experiments, shown as mean ± SD normalized to DNA position -19 (this position
was chosen because it was expected to be very exposed for hydroxyl radicalmediated cleavage with and without CENP-NNT). Asterisks denotes differences that
are statistically significant (p<0.05; Student’s t-test). (j) A molecular model of the
CENP-A nucleosome (PDB 3AN2)(Tachiwana et al., 2011) in which the DNA
sequence was modified(Falk et al., 2016) to that used in the footprinting
experiment: CENP-A a.a. 79-83 is labeled in green, and DNA positions -21 and -22
are labeled in red.

Figure 27. CENP-N(1-240) is sufficient to bind to the CENP-A nucleosome.
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(a) Native gel showing binding of CENP-N(1-240)-His (referred to as CENP-NNT) to
CENP-A nucleosomes (b) 2-dimensional gel analysis of binding of CENP-NNT to
CENP-A nucleosomes. Left: native gel of CENP- A nucleosomes with increasing
amounts of CENP-NNT. The bands marked 1 and 2 were excised and run on an SDSPAGE gel (right) to confirm the species (histones and/or CENP-NNT) in the native gel
band.
[This figure consists of my contribution to McKinley et al., 2015]
To measure the location and magnitude of the stability conferred by CENPNNT to the CENP-A NCP, we performed HXMS on the assembled complex (Figure
26d, and Figure 28d). The only region on the entire NCP where we detected
additional protection from HX in the presence of CENP-NNT is within the CENP-A
targeting domain (CATD)(Black et al., 2004), at a discrete portion that spans the Cterminal region of the 1 helix and the N-terminal portion of L1 (Figure 26d-g, and
Figure 28e-j). This location corresponds to a major surface structural feature
unique to CENP-A nucleosomes: a bulge of opposite charge as the same site of
canonical nucleosomes containing H3 (Figure 26e)(Luger et al., 1997; Sekulic et al.,
2010; Tachiwana et al., 2011). The HXMS results are consistent with previous work
demonstrating that CENP-N recognizes the CATD (Carroll et al., 2009; McKinley et
al., 2015). The region of HX protection is centered around residues Arg80 and Gly81
on CENP-A (Figure 26d, inset), where mutations disrupt CENP-N binding (Fang et
al., 2015).
We next considered how CENP-N specifically recognizes CENP-A when it is in
a histone complex wrapped with DNA and how this might contribute to its function
at centromere. We employed a well-established approach for nucleosomes (Hayes et
al., 1990; Syed et al., 2010; Tullius, 1988), recently extended to CENP-A nucleosomes
assembled with a synthetic positioning sequence (Roulland et al., 2016) that
employs hydroxyl radical mediated cleavage of DNA. We used the same natural
CENP-A nucleosome positioning sequence from human centromeres (Falk et al.,
2015; Hasson et al., 2013) used in our HXMS experiments, but where it is endlabeled (Falk et al., 2016) for hydroxyl radical footprinting (Figure 26g). CENP-A
nucleosome positioning is strong enough to readily detect the expected ~10 bp
periodicity of protection from hydroxyl radical cleavage caused by each superhelical
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turn of the DNA on the surface of the histone octamer (Figure 26h). CENP-NNT
binding does not alter the phasing, but there is very strong added protection at -21
and -22 nt from the dyad axis of the nucleosome (Figure 26h,i). This location is
immediately adjacent to the bulged L1 of CENP-A that is protected from HX (Figure
26j). Thus, we envision a continuous binding surface that spans and crossbridges
CENP-A and nucleosomal DNA.
This raised the questions of whether the nucleosome binding surface of
CENP-NNT is an extended, unstructured segment, as in CENP-CCD, or a well-folded
domain. Fortunately, our HXMS experiments on the CENP-A nucleosome complex
with CENP-NNT yielded near complete coverage of both the histone fold domains of
each nucleosome subunit (Figure 26d) and CENP-NNT, itself (Figure 29), for which
there is little or nothing known regarding its structure and dynamics. For CENP-NNT,
we found substantial HX protection for the CENP-NNT molecule alone (Figure 29),
suggesting it is a folded domain. This protection was markedly increased—taking
100-1000 times as long to reach the same level of HX—upon binding to CENP-A
NCPs (Figure 29). The dramatic protection from HX on CENP-NNT upon binding to
the CENP-A NCP extended through its entire N-terminal ~200 a.a (Figure 29, and
Figure 30a-g). Residues ~209-240 were disordered both before and after binding
to CENP-A NCPs (Figure 29a and Figure 30h-i), indicating that this region is
unlikely to be involved in binding. Indeed, a further truncation of CENP-N1-205
retained the ability to bind to CENP-A nucleosomes (Figure 30j). Since there are key
residues for this interaction (R11 and R196)(Carroll et al., 2009) at each end of this
domain, it is likely that the folded nature of the CENP-NNT brings together key
residues that form the binding surface with CENP-A NCPs. Indeed, important
residues for CENP-A nucleosome binding are found at various locations across this
region of CENP-N (Carroll et al., 2009).
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Figure 28. CENP-L/NCT binds CENP-C235-352, and CENP-NNT binds the CENP-A
nucleosome surface bulge.
(a) SDS-PAGE showing co-purification performed as described(McKinley et al.,
2015) of fragments of GST-CENP-C with CENP-L/His-CENP-NCT, demonstrating that
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CENP-C235-352 is sufficient for the interaction with CENP-L/NCT. (b) Representative
images showing localization of CENP-L/N in CENP-CAID-EYFP/AID-EYFP cells before and
after 24 h of IAA treatment, assessed using anti-CENP-L(McKinley et al., 2015). See
quantitation in Fig. 4b. (c) Representative images showing localization of CENP-L/N
in CENP-CAID-EYFP/AID-EYFP cells constitutively expressing the rescue constructs CENPC(FL), CENP-C(∆CD), or CENP-C(∆519-533), after 24 h of IAA treatment, assessed
using anti-CENP-L(McKinley et al., 2015) . See quantitation in Figure 26c. (d) CENPA NCPs alone and in complex with CENP-NNT as assessed by native PAGE stained
with EtBr or Coomassie Blue, and schematic for HXMS experiment. (e) Evidence that
our HXMS experiments have minimal back-exchange. Cumulative distribution curve
of a representative fully deuterated (FD) sample (see the Methods for a description
of how FD samples are prepared), showing the extent of deuteration of all peptides
compared to the theoretical maximum amount of deuteration of each peptide (i.e., if
every amide proton were exchanged for a deuteron). The median deuteration was
~88% for the FD sample, therefore the back-exchange after the quench step was
only ~12%, which is well within the optimal range (better than most published
HXMS experiments(Walters et al., 2012)). (f-i) Representative peptides spanning
the α2 helix of CENP-A. We note that our data do not exclude that the binding site
might extend to adjacent surface residues on the N-terminal portion of α2
helix(Sekulic and Black, 2009; Tachiwana et al., 2011) that also lies within the CATD.
Even prior to CENP-NNT binding, this particular region (CENP-A a.a. ~85-111) of the
α2 helix of CENP-A undergoes HX too slowly (>12 days(Black et al., 2007a)) for us to
detect. All peptides are plotted at every time point as mean ± SD from triplicate
experiments. At every other location of the folded core of the octameric CENP-A
nucleosome, however, HX is fast enough that we could have measured changes if
imparted by CENP-NNT, but none were observed (See Fig. 4d). Note that for some
data points, the error bars are too small to be visible in the graph. (j) A peptide of
H2A a.a. 40-50, showing mild protection upon binding to CENP-N.
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Figure 29. CENP-NNT undergoes global stabilization upon binding to the CENP-A
nucleosome.
(a) HXMS of CENP-NNT from a single timepoint (104 s), showing substantial
protection from HX spanning the ~200 a.a. domain upon binding to CENP-A NCP.
(b-e) Representative peptides spanning CENP-NNT over the timecourse. All peptides
are plotted at every timepoint as mean ± SD from triplicate experiments. Note that
for some data points, the error bars are too small to be visible in the graph.

85

86

Figure 30. The N-terminal 205 amino acids of CENP-N constitute its minimal
nucleosome-binding domain.
(a-i) Representative peptides spanning various regions of CENP-NNT. CENP-NNT
experiences substantial protection from HX across its entire first ~200 amino acids
(a-g), indicating that it consists of a folded domain that becomes globally rigidified
upon binding to CENP-A NCPs. The residues 206-230 (h,i) reach full deuteration
even at the earliest timepoint, and show no difference upon binding to CENP-A
NCPs, which indicates that this is a disordered region potentially dispensable for
binding to CENP-A NCPs. The maximum number of deuterons possible to measure
by HXMS for each peptide is shown by the dotted line. All peptides are plotted at
every time point as mean ± SD from triplicate experiments. Note that for some data
points, the error bars are too small to be visible in the graph.
(j) Guided by HXMS data (a-i), we further truncated CENP-NNT into just its first 205
amino acids. Native PAGE shows CENP-A NCPs with increasing molar ratios of
CENP-N1-205, stained either with EtBr or Coomassie Blue. As expected, CENP-N1-205 is
sufficient for binding to CENP-A NCPs, supporting the notion that this is the minimal
nucleosome-binding domain on CENP-N.

3.3.4 THE CORE CENTROMERIC NUCLEOSOME COMPLEX
(CCNC)
Since the HX protection on CENP-A NCPs from CENP-NNT is discrete (Figure
26d) at a nucleosomal surface contact point that remains accessible after CENP-CCD
binding (Falk et al., 2015; Kato et al., 2013), it seemed reasonable to reconstitute
nucleosome complexes with both domains bound simultaneously. Using established
conditions that generate a complex with one copy of CENP-CCD bound to each face of
the nucleosome (Falk et al., 2015; Kato et al., 2013), we added increasing amounts of
CENP-NNT (Figure 31a). We observed a concentration-dependent and stepwise
formation of complexes where one and two copies of CENP-NNT bound to the CENPA NCP complex containing two copies of CENP-CCD (Figure 31a,b). The complexes
were stable through native PAGE analysis, and the dominant species contained
equimolar amounts (i.e. two copies each) of each core histone (CENP-A, H4, H2A,
and H2B), CENP-CCD, and CENP-NNT (Figure 31b). We term this complex the Core
Centromeric Nucleosome Complex (CCNC)(Figure 31c, Figure 32a,c). The complex
was purified by preparative native PAGE (Figure 32c) and is also stable through
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sucrose gradient (Figure 32d,e), indicating that the CCNC is stable throughout the
lengthy (several hours) separation, even with no gel matrices involved whatsoever.
CENP-A nucleosomes within the CCNC experience protection from HX at
multiple sites (Figure 31e,f, and Figure 32b,f-i) corresponding to the additive
contributions of CENP-CCD (Falk et al., 2015) and CENP-NNT (Figure 31d-f).
Furthermore, the rigidity conferred to CENP-N is measured out to 100,000 s of
exchange, and exhibits clear EX2 behavior at all timepoints—without any evidence
of bimodal peaks or any other fast exchanging species that could have corresponded
to a substantially populated unbound, unprotected state—thus providing
unambiguous evidence that the complex is stable in solution even on timescales of
~28 h (Figure 31d). The CCNC exhibits surface protection on CENP-A, H4, and H2A
and protection at the internal interhistone H2A-H4 β-sheet that are all conferred by
CENP-CCD (Falk et al., 2015), as well as the surface bulge protection at the 1-helix
and L1 conferred by CENP-NNT (Figure 31e,f and Figure 32g-i). The discrete HX
protection pattern emphasizes the specific nature of CCNC assembly in solution.
CENP-CCD, itself, undergoes rapid HX, consistent with CENP-CCD existing as a
primarily linear polypeptide lacking defined secondary structure(Kato et al., 2013),
although there is reduced HX at the earliest timepoints within ~a.a. 515-537 when
bound to CENP-A nucleosomes (Figure 33). Within the CCNC, CENP-NNT still
experiences massive slowing of HX across most of its folded nucleosome-binding
domain, with exception of its a.a. 99-122 region, suggesting that its mode of
nucleosome binding could be altered at that specific location by the co-presence of
CENP-CCD (Figure 34). Thus, in the context of the CCNC, each non-histone subunit
acts in a complementary way to stabilize the particle: CENP-CCD binding directs a
structural transition of the nucleosome that stabilizes the interior of the octameric
histone core and stabilizes surfaces helices on three of the histone subunits (Figure
31e,f), whereas CENP-NNT stabilizes the CENP-A surface bulge on the nucleosome
surface (Figure 31e,f) and crossbridges it to the adjacent DNA (Figure 31g-i).

88

Figure 31. CENP-CCD and CENP-NNT simultaneously bind to the same CENP-A NCP
and generate internal and surface stability.
(a) Coomassie Blue-stained native PAGE of binding reactions with CENP-NNT and
CENP-CCD and CENP-A NCPs. (b) Indicated bands from native PAGE excised and run
on SDS-PAGE. (c) Schematic of formation of the core centromeric nucleosome
complex (CCNC). (d) A representative peptide of CENP-NNT (a.a. 9-21) that shows
substantial protection upon binding to CENP-A nucleosomes. The peptide is shown
from CENP-NNT alone (left) vs. as part of the core centromeric nucleosome complex
(CCNC) (right). Dotted red lines serve as guideposts to highlight the differences in
m/z shifts between the two samples. A red asterisk denotes the centroid location of
each peptide envelope, and the numerical value in blue indicates the centroid mass
of the peptide envelope. It is important to note that this peptide exhibits clear EX2
behavior at all timepoints when part of the CCNC (without any evidence of bimodal
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peaks), indicating that this complex is stable in solution even on timescales of
100,000 s (~28 hr). (e) HXMS of all histone subunits of the CENP-A NCP from a
single timepoint (104 s). (f) Regions showing substantial protection from HX
mapped onto the structure of the CENP-A NCP (PDB ID 3AN2). Left: the exposed
CENP-A bulge, to which CENP-N binds. Middle: the surface helices to which CENP-C
binds. Right: internal histone-histone contacts that undergo stability upon CENP-C
binding.
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Figure 32. CENP-A NCPs in complex with both CENP-NNT and CENP-CCD experience
additive HX protection.
(a,b) Experimental scheme for HXMS of the CENP-A NCP in complex with both
CENP-NNT and CENP-CCD. (c) Purification of the complex of CENP-A nucleosomes
bound to CENP-CCD and CENP-NNT (the CCNC) by preparative native PAGE (“Prep
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Cell”). Fractions are collected as they are eluted out of the bottom of the gel. The
native PAGE is stained both by ethidium bromide (For DNA) and Coomassie Blue
(for protein). (d) Sucrose gradient elution profiles of CENP-A nucleosomes, CENP-A
nucleosomes in complex with CENP-CCD and CENP-NNT, and the CENP-CCD and CENPNNT proteins alone. Complexes were subject to a linear 5-30 % sucrose gradient with
centrifugation at 35,000 rpm for 13 hr at 4°C. The samples were fractionated from
top to bottom, and each fraction was analyzed for absorbance at 280 nm (for
nucleosome and complex) or 260 nm (for CENP-C and CENP-N proteins alone). The
absorbance values are plotted, with the highest value in each run normalized to 1.0.
(e) SDS-PAGE gels stained with Coomassie-Blue, showing input and peak fractions
of CENP-A nucleosomes bound to CENP-CCD and CENP-NNT (the CCNC). (f-i)
Representative peptides within the CCNC. (f) A histone peptide that shows no
difference between CENP-A nucleosomes vs. the CCNC. (g-i) Histone peptides
spanning the CENP-A surface bulge (g), and the β-sheet region between histone H4
and H2A (h,i) over the timecourse. The maximum number of deuterons possible to
measure by HXMS for each peptide is shown by the dotted line. All peptides are
plotted at every time point as mean ± SD from triplicate experiments. Note that for
some data points, the error bars are too small to be visible in the graph.
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Figure 33. CENP-CCD lacks detectable secondary structure and binds the histone
surface of CENP-A nucleosomes with residues ~515-537.
(a) CENP-CCD peptides alone vs. when in complex with CENP-A nucleosomes, at the
101 s, 4°C timepoint (which is the earliest timepoint we can test, and is equivalent to
100 s at room temperature [RT]). This shows that CENP-CCD, when alone, is
disordered and is mostly completely exchanged even at this earliest timepoint.
CENP-CCD when in complex with CENP-A nucleosomes shows some mild protection
in the a.a. 513-537 region, which encompasses the region that contacts CENP-A
nucleosomes (~a.a. 519-533). Each horizontal bar represents an individual peptide
from CENP-CCD alone or in complex with CENP-A nucleosomes and is color-coded
for percent deuteration. (b) CENP-CCD peptides alone versus when in complex with
CENP-A nucleosomes versus when part of the CCNC, at the 101 s (RT) timepoint.
Again, some mild protection is seen in the a.a. 513-537 region when CENP-CCD is
bound to CENP-A nucleosomes or part of the CCNC, but CENP-CCD still overall lacks

93

secondary structure in three instances. Thus, because protection is so minor at such
an early timepoint (10 s), the presence of CENP-N does not cause the gain of
secondary structure or any other change that would otherwise lead to strong
protection from HX.

Figure 34. The HXMS behavior of CENP-NNT in the presence and absence of CENPCCD.
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(a-l) Representative peptides of CENP-NNT across the timecourse, either unbound or
bound to CENP-A NCPs (in the presence or absence of CENP-CCD). The maximum
number of deuterons possible to measure by HXMS for each peptide is shown by the
dotted line. All peptides are plotted at every time point as mean ± SD from triplicate
experiments. Note that for some data points, the error bars are too small to be
visible in the graph. Across most of the folded nucleosome-binding domain of CENPNNT, the massive slowing of HX is similar in the presence or absence of CENP-CCD (ac, g-k). Within a region that maps unambiguously to a.a. 99-122, however, CENP-N
only exhibits substantial HX protection when bound alone to the CENP-A NCP (d-f).
This suggests that a very local region (i.e. between a.a. 99-122) has a structural
change in the presence of CENP-C that leads to the change in HX behavior we
observe. The region C-terminal of a.a. 206 is disordered regardless of whether
CENP-NNT is bound to the NCP (l, also see Figure 30).

3.3.5 CENP-A NUCLEOSOME STABILITY REQUIRES BOTH
CENP-C AND CENP-N
The finding that a stable CCNC can be assembled from its component parts
(Figure 31) supports the notion that CENP-N provides stability to centromeric
chromatin that cannot be attributed to CENP-CCD. To test this notion, we focused our
analysis back on our cell lines where the levels of the two components can be
modulated. CENP-C and CENP-N display partially interdependent localization to
centromeres in human cells (McKinley et al., 2015), complicating the analysis of
their interactions with CENP-A. During the 24 h timescale in which we measure
CENP-A retention at centromeres, CENP-C removal also leads to loss of most but not
all CENP-L-N (Figure 26b, and Figure 28b). CENP-N removal, using a similar AIDtagging approach of both CENP-N alleles(McKinley et al., 2015), reduces CENP-C
levels at centromeres by ~half (Figure 36a-c). Interestingly, CENP-N-AID removal
produces a pronounced defect in CENP-A retention (Figure 35a-c), suggesting a
direct role of CENP-N in CENP-A retention, since reducing CENP-C levels by half is
unlikely to be responsible for the full magnitude of this effect. Importantly,
combined removal of CENP-N (by siRNA treatment) and CENP-C (by IAA treatment)
had an additive effect, severely compromising CENP-A retention (Figure 35d-f, and
Figure 36d,e). This indicates that the low level of CENP-L-N remaining after 24 h of
CENP-C depletion (Figure 26b, and Figure 28b) accounts for the residual stability
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to CENP-A nucleosomes not accounted for by the CENP-CCD alone (Figure 24d,e).
More importantly, this supports a model wherein CENP-C and CENP-N are roughly
equal partners necessary to form the CCNC and maintain CENP-A nucleosome levels
at centromeres (Figure 37).

Figure 35. CENP-C and CENP-N collaborate to maintain CENP-A nucleosomes at
centromeres.
(a) Schematic for experiment in which CENP-NAID-EGFP/AID-EGFP cells expressing CENPA-SNAP at a unique FRT site were pulse-labeled with TMR* and assessed for
retention of the existing pool of CENP-A molecules. (b) Representative images from
experiment diagrammed in a. Scale bar indicates 10 µm. (c) Quantitation of b. (d)
Schematic of experiment, in which CENP-CAID-EYFP/AID-EYFP cells were treated with
siCENP-N or siGAPDH and pulse-labeled with TMR*, and the relative CENP-A-SNAP
signals were analyzed after 24 h (with or without CENP-C depletion by IAA
treatment). (e) Representative images from experiment described in d. Scale bar
indicates 10 µm. (f) Quantitation of e. The value of the “siGAPDH, -IAA” condition is
normalized as 100%, and the value of the “siCENP-N, +IAA” condition is normalized
as 0%. All graphs are shown as mean ± 95% confidence interval (n>2000
centromeres in all cases).
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Figure 36. Effect of CENP-N depletion on centromeric CENP-C and CENP-T levels.
(a) AID-tagged CENP-N was depleted by 24 h of IAA in CENP-NAID-EGFP/AID-EGFP cells,
then assessed for centromeric CENP-C localization, and disappearance of CENP-NAID-EGFP. (b) Quantitation of centromeric CENP-C intensity before and after 24 h
IAA treatment. Mean ± 95% confidence interval (n>2000 centromeres in all cases).
(c) Quantitation of centromeric CENP-N-AID-EGFP intensity before and after 24 h
IAA treatment. Mean ± 95% confidence interval (n>2000 centromeres in all cases).
(d) CENP-CAID-EYFP/AID-EYFP cells were subject to CENP-N depletion via siRNA, as in
Figure 35d, and assessed for centromeric CENP-T localization. (e) Quantitation of
centromeric CENP-T intensity. As expected, CENP-T levels are markedly reduced in
the presence of CENP-N depletion (Logsdon et al., 2015; McKinley et al., 2015;
Samejima et al., 2015), which indicates the expected impact of substantial CENP-N
depletion by the siRNA approach used here and in the experiment in Figure 35d-f.
Mean ± 95% confidence interval (n>2000 centromeres in all cases).
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Figure 37. Model of the physical basis for the stability of CENP-A nucleosomes
within the CCNC.
See text for the details of our model of centromere maintenance. We note that CENPCCD is shown as an elongated oval that represents a structured loop that has no
conventional secondary structure, despite having been historically called a
“domain”. Also, a flexible linker is shown between CENP-CCD and the CENP-C contact
point with the CENP-L-N complex, in line with proposals that CENP-C largely exists
as an extended and unfolded protein that may span >100 nm at mitotic kinetochores
(Screpanti et al., 2011; Wan et al., 2009; Ye et al., 2016). Additionally, it is also not
known if there is a fixed or variable distance at centromeres from the CENP-C-L-N
contact point to the CENP-A nucleosome. It is also unclear if this contact point on
CENP-C with CENP-L-N is a folded domain or if it contacts one or both subunits of
CENP-L-N.

3.4. DISCUSSION
Our physical studies of CENP-A nucleosome complexes combined with gene
replacement and rapid depletion of the non-histone CCAN proteins, CENP-C and
CENP-N, provide the molecular basis for the extraordinary stability of CENP-A
nucleosomes that is at the heart of the epigenetic mechanism that maintains the
identity of centromere location on every chromosome. At steady-state, we envision
that the relevant nucleosome required to maintain centromere identity has ~147 bp
of DNA wrapped around an octameric histone core containing two copies each of
CENP-A, H4, H2A, H2B, and two copies each of CENP-C and CENP-N. CENP-C binding
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confers the most pronounced physical changes in the CENP-A nucleosome structural
transition that alters nucleosome shape, enhances the tendency of CENP-A
nucleosomes to sample states with 20 bp of DNA unwrapping at each nucleosome
terminus, and confers internal and surface rigidity to the histone core(Falk et al.,
2015, 2016). CENP-N, while having a more discrete impact on the histone core of the
NCP (Figure 26), has a binding site that crossbridges a key DNA contact point on
the NCP to the (CENP-A/H4)2 heterotetramer (Figure 26g-j). We expect that
normally these are the direct chromatin contacts at the interface with the
kinetochore, including those recently reconstituted with purified components (Weir
et al., 2016). Though, since contacts between CENP-A and the other CCNC
components can be bypassed in mitosis (Hoffmann et al., 2016), CCNC function may
be more relevant to maintaining centromere identity during the remainder of the
cell cycle.
Independent recognition of a single nucleosome by two different chromatin
components, as we find occurs within the CCNC, has not been well studied in any
chromatin context. The small but growing list of physical studies of nucleosome
recognition proteins (Armache et al., 2011; Barbera et al., 2006; Makde et al., 2010;
McGinty et al., 2014; Morgan et al., 2016) uniformly involves a key contact point
between an arginine anchor with the nucleosomal acidic patch (McGinty and Tan,
2016). Three previous studies had claimed that mutation of R522 (or its
corresponding position in Xenopus CENP-C) disrupts centromere targeting of CENPC, but none provided a definitive answer for mammalian CENP-C: one study was
done in Xenopus extracts (Carroll et al., 2010), and the two studies in human cells
used truncated CENP-C transgenes that were overexpressed (Kato et al., 2013; Song
et al., 2002). Our study advances the field in part because it interrogates the
nucleosome-binding domains of CENP-C in a gene replacement system, using one in
which the endogenous CENP-C is rapidly and completely removed, and the
replacement CENP-C constructs are untagged, full-length, and expressed at near
endogenous levels (Figure 21c). More broadly, our findings show a remarkable role
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for an arginine anchor beyond their established role in nucleosome recognition
(McGinty and Tan, 2016) to a role in altering nucleosome shape and function. R522A
preserves the ability of CENP-C to bind to CENP-A nucleosomes (Figure 24a-c) and
accumulate at centromeres (Figure 26b,c), but we pinpoint a role for R522 for
CENP-A maintenance at the centromere (Figure 26d,e), driving the nucleosome
structural transition that stabilizes the interior of the CENP-A nucleosome (Figure
24d,e). It is possible that mutation of another residue within CENP-CCD could also
retain binding while compromising the CENP-A nucleosome structural transition,
but disruption of the R522 arginine anchor in our gene replacement systems
indicates that this common feature in diverse nucleosome binding proteins can play
an important functional role, beyond the role of molecular recognition.
CENP-CCD is particularly remarkable because its high specificity for CENP-A
nucleosomes is mediated by a very small feature (the 6 a.a. C-terminal tail)(Carroll
et al., 2009), but its binding confers stabilization that spreads throughout much of
the octameric core of the nucleosome as well as to the position of the DNA gyres
(Falk et al., 2015, 2016). Remarkably, CENP-CCD does this without having any
defined secondary structure of its own.
Most aspects of the mechanism used by CENP-NNT contrast starkly with that
used by CENP-CCD. The only notable similarity is that CENP-NNT uses a small feature
on the surface of the CENP-A nucleosome to achieve its high specificity of binding to
CENP-A nucleosomes. In contrast to the widespread HX protection conferred to the
NCP by CENP-CCD, the only HX protection we observed with CENP-NNT maps to loop
L1 (Figure 26d-f). Our findings provide clear biophysical evidence that CENP-NNT
recognizes NCPs without accessing the acidic patch on H2A-H2B at all, making it
unique relative to other nucleosome recognition domains studied to date (Armache
et al., 2011; Barbera et al., 2006; Makde et al., 2010; McGinty et al., 2014; Morgan et
al., 2016) and leaving open that site on the NCP for CENP-CCD to bind. CENP-NNT
itself is a folded domain (again, in contrast to CENP-CCD) even prior to engaging the
CENP-A NCP (Figure 29, Figure 30, Figure 34). Its discrete contact points on Loop
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1 of CENP-A and the adjacent nucleosomal DNA 21-22 bp from the dyad axis of
symmetry stabilizes its own secondary structure (Figure 26, Figure 30, Figure 34).
Therefore, the combination of previous work (Carroll et al., 2009, 2010, Falk et al.,
2015, 2016; Fang et al., 2015; Kato et al., 2013) and the work presented here shows
that CENP-CCD and CENP-NNT defy expectations in that the unfolded one (CENP-CCD)
generates substantial structural changes in the NCP (Figure 31e-f and (Falk et al.,
2015; Kato et al., 2013)), whereas the folded one (CENP-NNT) changes core histone
dynamics only very locally at the points of contact with CENP-A and its adjacent
nucleosomal DNA (Figure 26d-j). Furthermore, our combined HXMS and hydroxyl
radical footprinting shows that CENP-N fastens CENP-A to its adjacent DNA,
providing an example of a crossbridging mechanism for maintaining nucleosomeencoded epigenetic information that perhaps represent a more general mode for
maintaining nucleosome-encoded epigenetic information involving other histone
variants (or post-translationally modified canonical histones).
A steady-state CCNC complex required to faithfully maintain CENP-A
retention at centromeres does not necessitate that all components exhibit matched
turnover rates, themselves. H2A-H2B dimers can come on and off through partial
disassembly of nucleosomes, as with canonical nucleosomes. CENP-C and CENP-N
could similarly exchange, and indeed both proteins display dynamic behaviors at
centromeres (Hellwig et al., 2011; Hemmerich et al., 2008; Smoak et al., 2016), with
CENP-N varying in quantity at the centromere depending on the cell cycle stage
(Fang et al., 2015; Hellwig et al., 2011; McKinley et al., 2015). We note that H2A-H2B
are not nearly as stable at centromeres as CENP-A and H4 (Bodor et al., 2013; Falk
et al., 2015). The binding mode for CENP-NNT suggests an explanation for this: CENPCCD binding protects all of the core histones from dissociating from DNA, but CENPNNT would only protect CENP-A and H4. The hydrophobic stitches between CENP-A
and H4 themselves provide yet another required feature to rigidify the particle and
maintain it at centromeres (Bassett et al., 2012; Black et al., 2004; Sekulic et al.,
2010).
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In conclusion, our findings demonstrate that the individual CENP-CCD and
CENP-NNT subunits independently bind to the nucleosome with non-overlapping
effects on the stability and/or shape of the nucleosome (Figure 37). When both
proteins are present, they impart additive effects on the physical properties of
CENP-A nucleosomes. At any given time, there are multiple molecules of CENP-C and
CENP-N present at the centromere—both directly bound to the CENP-A
nucleosomes and directly bound to each other—in a manner that locks in
centromere location. By tying faithful inheritance of chromosomes to an epigenetic
mark in which the CCNC acts as the fundamental repeating unit, mammals have
evolved a remarkably resilient form of chromatin.

3.5. METHODS
3.5.1. GENERATION OF CELL LINES
Using DLD-1 Flp-In T-Rex cells stably expressing Tir1(Holland et al., 2012) with
CENP-CAID-EYFP/AID-EYFP (Hoffmann et al., 2016) as a starting point, endogenous CENPA was tagged with C-terminal SNAP using CRISPR/Cas9-mediated genome
engineering. The sgRNA was designed to target the 3’UTR of CENP-A. The
oligonucleotides (5'-CACCGCTGACAGAAACACTGGGTGC-3' and 5'AAACGCACCCAGTGTTTCTGTCAGC-3') were annealed and inserted into pX330
which already contains Cas9 (Ran et al., 2013). To generate the repair template, the
SNAP-3xHA sequence (Jansen et al., 2007) followed by a viral 2A peptide (Kim et al.,
2011) and the neomycin resistance gene was synthesized as a gBlock (Integrated
DNA Technologies), and 5’ and 3’ homology arms of ~800 bp each were amplified
from DLD-1 genomic DNA by PCR. All three pieces were inserted into a pUC19
backbone using HiFi DNA Assembly (NEB). The repair template and pX330 were cotransfected with Lipofectamine 2000 (Invitrogen) in 9:1 ratio, and selected after 5
days using 750 µg/ml G418. To isolate monoclonal cell lines, cells were subject to
limiting dilution after G418 selection. To screen clones, PCR of genomic DNA was
performed for every clone (using primers 5'-CCTTCCCCACTCCTTCACAGGC-3' and
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5'-CCTGTGAAAGAGGATGAGCTTACC-3'); insertion of the SNAP tag results in a PCR
product of 2243 bp (whereas the PCR product is 614 bp if the allele is unmodified).
Clones containing SNAP-tagged CENP-A were further validated by immunoblotting
and TMR* visualization. Stable cell lines constitutively expressing CENP-C rescue
constructs were generated by Flp/FRT recombination. Domain deletions and point
mutants of CENP-C were generated by PCR site-directed mutagenesis, and the
sequences of all constructs (WT and mutant versions) were validated by DNA
sequencing. CENP-C constructs were inserted into a pcDNA5/FRT vector and cotransfected with pOG44 (Invitrogen), a plasmid expressing the Flp recombinase,
into cells with Lipofectamine 2000 (Invitrogen) according to manufacturer’s
instructions. Following selection in 400 µg/ml Hygromycin B, colonies were pooled
into polyclonal cell lines. CENP-NAID-EGFP/AID-EGFP cells expressing CENP-A-SNAP were
also generated by Flp/FRT recombination: CENP-A-SNAP was inserted into a
pcDNA5/FRT vector and co-transfected with pOG44 into CENP-NAID-EGFP/AID-EGFP cells
(McKinley et al., 2015) and selected with Hygromycin B as described above.

3.5.2. CELL CULTURE
The indicated DLD-1 derivatives described above were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 100 U ml-1 penicillin and 100 µg ml-1 streptomycin. All cell lines were
maintained with 2 µg ml-1 puromycin (Sigma). Cell lines in which CENP-A is SNAPtagged by CRISPR/Cas9-mediated genome editing were maintained with 750 µg ml-1
G418. Cell lines containing CENP-C rescue constructs introduced by Flp/FRT
recombination were maintained with 400 µg ml-1 Hygromycin B. CENP-NAID-EGFP/AIDEGFP

cells with CENP-A-SNAP at the FRT site were maintained in 300 µg ml-1 G418

and 400 µg ml-1 Hygromycin B. To induce degradation of AID-tagged CENP-C or
CENP-N, indole-3-acetic acid (IAA; Sigma) was prepared in water and added to cells
at 500 µM for the indicated amounts of time.
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3.5.3. IMMUNOBLOTTING
Samples derived from whole cell lysates were separated by SDS-PAGE and
transferred to a nitrocellulose membrane for immunoblotting. Blots were probed
using the following primary antibodies: rabbit anti-CENP-C (1.7 µg ml-1)(Bassett et
al., 2010), mouse mAb anti-α-tubulin (1:4000, Sigma-Aldrich #T9026), or human
Anti-Centromere Antibodies (ACA) (2 µg ml-1, Antibodies Incorporated #15-235).
The blots were subsequently probed using the following HRP-conjugated secondary
antibodies: Donkey Anti-Human IgG (1:10,000, Jackson ImmunoResearch
Laboratories #709-035-149), Amersham ECL Mouse IgG (1:2,000, GE Life Sciences
#NA931), Amersham ECL Rabbit IgG (1:2,000, GE Life Sciences #NA934V).
Antibodies were detected by enhanced chemiluminescence (Thermo Scientific).

3.5.4. SNAP LABELING EXPERIMENTS
DLD-1 cells were pulse-labeled with 2 µM TMR* (NEB) in complete medium for 15
min at 37°C, washed with PBS and incubated in the culture medium for 2 h to allow
excess TMR* to diffuse out of cells. Cells were then either fixed immediately (for the
“0 h” timepoint), or cultured for another 24 h in the presence or absence of 500 µM
IAA to induce degradation of the AID-tagged CCAN protein (for the “24 h”
timepoints). Cell number was also determined at these timepoints using a
hemocytometer, so that the total level of CENP-A turnover could be calculated, as
described(Bodor et al., 2013; Falk et al., 2015): CENP-A turnover was calculated as
[(TMR* intensity at 24 h)/(Avg TMR* intensity at 0 h)]*(Change in cell number).
SiRNA knockdown of CENP-N was performed as described(Logsdon et al., 2015).
Briefly, cells were treated with 20 µM CENP-N siRNAs (siGENOME SMARTpool;
Dharmacon, GE Life Sciences #M-015872-02-0005), or GAPDH siRNAs (ONTARGETplus GAPD Control; Dharmacon, GE Life Sciences #D-001830-01-05).

3.5.5. IMMUNOFLUORESCENCE AND MICROSCOPY
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For experiments involving CENP-A, CENP-C, or CENP-T immunofluorescence,
DLD-1 cells were fixed in 4% formaldehyde for 10 min at room temperature and
quenched with 100 mM Tris (pH 7.5) for 5 min, followed by permeabilization using
PBS containing 0.1% Triton X-100. For experiments involving CENP-L
immunofluorescence, DLD-1 cells were pre-extracted with PBS containing 0.1%
Triton X-100 for 30 s, fixed with 4% formaldehyde for 10 min and quenched with
100 mM Tris (pH 7.5) for 5 min. All coverslips were then blocked in PBS
supplemented with 2% FBS, 2% BSA, and 0.1% Tween prior to antibody
incubations. The following primary antibodies were used: mouse mAb anti-CENP-A
(1:1000, Enzo Life Sciences #ADI-KAM-CC006-E), rabbit pAb anti-CENP-C (1.7 µg
ml-1)(Bassett et al., 2010), rabbit pAb anti-CENP-T (1 µg ml-1)(Gascoigne et al.,
2011b), and rabbit pAb anti-CENP-L (1:1000)(McKinley et al., 2015). Secondary
antibodies conjugated to fluorophores were used: Cy3 Goat anti-Rabbit (1:200,
Jackson ImmunoResearch Laboratories #111-165-144) and Cy5 Donkey anti-Mouse
(1:200, Jackson ImmunoResearch Laboratories #715-175-151). Samples were
stained with DAPI before mounting with VectaShield medium (Vector Laboratories).
Images were captured at room temperature on an inverted fluorescence microscope
(DMI6000 B; Leica) equipped with a charge-coupled device camera (ORCA AG;
Hamamatsu Photonics) and a 40x oil immersion objective. Images were collected at
0.59 µm z-sections and subsequently deconvolved using identical parameters. To
display as figures, the z stacks were projected as single two-dimensional images and
assembled using ImageJ (NIH). To quantify fluorescence intensity of centromeres,
the CraQ macro(Bodor et al., 2012) was run in ImageJ with standard settings using
DAPI and total CENP-A staining as the reference channel to define ROIs for
quantification of TMR* intensity. One representative experiment is displayed from 2
or more independent experiments. At least 2000 centromeres were analyzed for
each timepoint.

3.5.6. RECOMBINANT PROTEIN PURIFICATION
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Human histones and CENP-A were prepared as described (Sekulic and Black,
2016a; Sekulic et al., 2010). Briefly, histones H2A and H2B are expressed as
monomers in inclusion bodies and purified under denaturing conditions, then
refolded into H2A-H2B dimers. (CENP-A/H4)2 is expressed off of a bicistronic
construct as a soluble heterotetramer and purified by hydroxyapatite column
followed by cation exchange. Recombinant human CENP-CCD consisting of the
central domain (a.a. 426-537) was expressed from a plasmid kindly provided by A.
Straight (Stanford)(Carroll et al., 2010; Falk et al., 2015). CENP-C is expressed as a
GST fusion protein and affinity-purified on a glutathione column. GST is then cleaved
by PreScission protease and separated from CENP-C by cation exchange(Carroll et
al., 2010; Falk et al., 2015; Sekulic and Black, 2016a). sPCR site-directed
mutagenesis was performed to generate CENP-CCD(R521A) and CENP-CCD(R522A),
and they were expressed and purified using the same protocol as wildtype CENPCCD. Recombinant human CENP-NNT-His was purified with a protocol adapted from a
previous study(McKinley et al., 2015): CENP-NNT-His was grown in BL21(DE3)pLysS
cells for 6 h at 18°C, and purified on a 1 ml HisTrap FF column (GE Healthcare) via
FPLC, with elution buffer of 50 mM sodium phosphate pH 8.0, 500 mM NaCl, 250
mM imidazole, 1 mM βME, and 50% glycerol. PCR-directed mutagenesis was
performed to generate the further truncated construct, CENP-N1-205-His, and it was
purified with the same protocol as CENP-NNT-His. Sequential purifications of
complexes co-expressing GST- and His-tagged subunits were performed as
described(McKinley et al., 2015). Briefly, complexes were first purified on Niagarose, and the elution was bound to glutathione agarose, washed three times, and
eluted.

3.5.7. ASSEMBLY OF NCPS AND COMPLEXES
Six identical repeats of a 147 bp DNA sequence derived from an α-satellite
sequence from the human X chromosome (Yang et al., 1982) was cloned into a
pUC57 backbone, with each repeat separated by an EcoRV site. The sequence of
each repeat is 5’-
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ATCAAATATCCACCTGCAGATTCTACCAAAAGTGTATTTGGAAACTGCTCCATCAAAAGG
CATGTTCAGCTCTGTGAGTGAAACTCCATCATCACAAAGAATATTCTGAGAATGCTTCCG
TTTGCCTTTTATATGAACTTCCTCGAT-3’. This sequence corresponds to the major
binding site that the CENP-A nucleosome occupies on human centromeres (Hasson
et al., 2013). Preparation of DNA for NCP assembly was performed as described
(Sekulic and Black, 2016a). Briefly, the plasmid described above was grown,
isolated, and subjected to EcoRV digestion followed by separation of plasmid and
insert by anion chromatography using Source 15Q resin (GE Healthcare). With the
purified DNA, CENP-A NCPs were assembled and uniquely positioned using gradual
salt dialysis followed by thermal shifting for 2 hr at 55°C (Dyer et al., 2004; Sekulic
and Black, 2016b). Formation of complexes with CENP-CCD was performed as
described (Falk et al., 2015), in which 2.2 moles of CENP-CCD were added per mole of
CENP-A NCPs. To form the complex with CENP-NNT, 4 moles of recombinant CENPNNT-His were added per mole of CENP-A NCPs. To form the complex with both
CENP-NNT and CENP-CCD, 4 moles of CENP-NNT-His and 2.2 moles of CENP-CCD were
added per mole of CENP-A NCPs. Complexes were analyzed by 5% native PAGE,
stained with ethidium bromide to visualize DNA and Coomassie Brilliant Blue to
visualize protein components. Following formation of complexes (or NCPs, in the
case of the nucleosome-alone sample), samples were purified by preparative
electrophoresis (Prep Cell, BioRad) using a 5% native gel to isolate the relevant
complex from other species, such as free DNA (Dyer et al., 2004).

3.5.8. BINDING ASSAYS (WITH PRAVEEN KUMAR ALLU)
Recombinant human H2B K120C was purified as described for wildtype H2B (Falk
et al., 2015) from inclusion bodies. Lyophilized protein was dissolved in unfolding
buffer (7 M urea, 10 mM Tris-HCl pH 7.5 at 20°C, 0.4 mM TCEP) for 1 hr at RT and a
15-fold molar excess of sulfo-Cy5-maleimide (Lumiprobe) was dissolved in DMSO
and added dropwise to the protein. The reaction proceeded overnight shielded from
light and was quenched with 5 mM sodium 2-sulfanylethanesulfonate (MESNA) and
run over a PD-10 column (GE Healthcare) to separate out free dye. Labeled H2B was
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then mixed with equimolar amounts of H2A for dimer reconstitution and
purification using established methods (Dyer et al., 2004; Sekulic et al., 2010), but
using SDS-PAGE gels to determine concentrations of H2A and labeled-H2B
monomers for refolding. Three independent assays were performed for calculating
apparent Kd values for CENP-C WT and mutant proteins using CENP-A nucleosomes
with labelled Cy5-H2B prepared on 147 bp DNA by gradient dialysis. Briefly, 200 nM
of nucleosomes were incubated with increasing concentration of CENP-C WT or
CENP-C mutants in TCS buffer (20 mM Tris-Cl pH 7.5, 1 mM EDTA, and 1 mM DTT)
and incubated on ice for 1 hr before separating by 5 % native PAGE. After
electrophoresis, gels were analyzed in a Typhoon 9200 imager (GE Healthcare), and
the percentage of unbound vs. unbound nucleosomes were quantified using ImageJ.
The apparent Kd values were calculated from the binding curve fitted from three
independent experiments.

3.5.9. HXMS
Deuterium on-exchange was carried out by adding 5 µL of each sample (containing
approximately 4 µg of NCPs or the indicated complex) to 15 µL of deuterium onexchange buffer (10 mM Tris, pD 7.5, 0.5 mM EDTA, in D2O) so that the final D2O
content was 75%. Reactions were quenched at the indicated timepoints by
withdrawing 20 µL of the reaction volume, mixing in 30 µL ice cold quench buffer
(2.5 M GdHCl, 0.8% formic acid, 10% glycerol), and rapidly freezing in liquid
nitrogen prior to proteolysis and LC-MS steps. HX samples were individually melted
at 0°C then injected (50 µl) and pumped through an immobilized pepsin (Sigma)
column at initial flow rate of 50 µl min-1 for 2 min followed by 150 µl min-1 for
another 2 min. Pepsin was immobilized by coupling to Poros 20 AL support (Applied
Biosystems) and packed into column housings of 2 mm x 2 cm (64 µL) (Upchurch).
Protease-generated fragments were collected onto a TARGA C8 5 µm Piccolo HPLC
column (1.0 x 5.0 mm, Higgins Analytical) and eluted through an analytical C18
HPLC column (0.3 x 75 mm, Agilent) by a linear 12-55% buffer B gradient at 6 µl
min-1 (Buffer A: 0.1% formic acid; Buffer B: 0.1% formic acid, 99.9% acetonitrile).
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The effluent was electrosprayed into the mass spectrometer (LTQ Orbitrap XL,
Thermo Fisher Scientific).

3.5.10. HXMS DATA ANALYSIS
The SEQUEST (Bioworks) software program was used to identify the likely
sequence of parent peptides using non-deuterated samples via tandem MS.
MATLAB-based MS data analysis tool, ExMS, was used for data processing (Kan et
al., 2011). For all peptides found by SEQUEST, ExMS first analyses the nondeuterated sample to identify the peptide envelope centroid values as well as the
chromatographic elution time ranges of each parental non-deuterated peptide.
ExMS then uses the information from the non-deuterated analyses to identify
deuterated peptides in each sample of the HXMS timecourse. Each individual
deuterated peptide is corrected for loss of deuterium label during HXMS data
collection (i.e., back exchange after quench) by normalizing to the maximal
deuteration level of that peptide, which we measure in a “fully deuterated” (FD)
reference sample. The FD sample are prepared in 75% deuterium just as is done in
the on-exchange experiment, but under acidic denaturing conditions (0.5% formic
acid), and incubated overnight so that each amide proton undergoes full exchange.
The extent of back-exchange is calculated by comparing the extent of full
deuteration as measured in the FD sample to the theoretical maximal deuteration
(i.e., if no back-exchange occurs), which takes into account the 75% deuterium
content of the samples. The median extent of back-exchange in our datasets is
~12% (Figure 28e), which is within the range for the lowest amount of deuterium
loss ever reported for bottom-up HXMS (10% ± 5%)(Walters et al., 2012). For
comparing two different HXMS datasets, we can plot the percent difference of each
peptide, which is calculated by subtracting the percent deuteration of one sample
from that of another, and plotted according to the color legend in 10% increments
(as in Figure 24d, Figure 26d, Figure 29a, Figure 31e). We can also calculate the
number of deuterons within each peptide that are exchanged at each timepoint, and
plotted as in Figure 26e-f, Figure 29b-e, and Figure 28f-j, Figure 30a-i, Figure
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32f-i, and Figure 34. These plots include data from 3 separate exchange reactions,
with each data point shown as mean ± SD.

3.5.10. HYDROXYL RADICAL FOOTPRINTING
(BY PRAVEEN KUMAR ALLU)
CENP-A nucleosomes assembled with HEX-labeled 147 bp α-satellite DNA (Falk et
al., 2016) were reconstituted and then purified using a sucrose gradient. 4 µg of
HEX-labeled CENP-A nucleosomes alone or complexed to CENP-NNT were used in
each reaction. The hydroxyl radical cleavage reaction was initiated by addition of 5
µl of 40 mM FeAmSO4/80 mM EDTA, 2 M ascorbate, and 2.4% H2O2 to a 30 µl
reaction mixture. Each reaction was carried out for 5min at room temperature, and
terminated with 200 µl of stop solution (0.1% SDS, 25 mM EDTA, 1% glycerol, and
100 mM Tris, pH 7.4). Further phenol/chloroform extraction and ethanol
precipitation was carried out to extract DNA fragments. Samples were separated by
denaturing PAGE (10% polyacrylamide, 7 M urea, 88 mM Tris–borate, and 2 mM
EDTA, pH 8.3)(Falk et al., 2016). Gels were imaged on a Typhoon 9200 imager (GE
Healthcare). Band intensities were quantified from ImageJ from three independent
experiments.

3.5.11. SUCROSE GRADIENT SEDIMENTATION
(BY PRAVEEN KUMAR ALLU)
100 µg of CENP-A nucleosomes or the CCNC complex were subjected to 5-30%
sucrose gradient centrifugation at 165,000g on a SW60 rotor (Beckman Coulter) for
13 h at 4°C. The samples were fractionated from top to bottom, and each fraction
was analyzed for absorbance at 260 nm (for nucleosome and complex) or 280 nm
(for CENP-C and CENP-N proteins alone).
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CHAPTER 4: IDENTIFICATION OF CDK-DEPENDENT
HJURP PHOSPHOSITES
Chapter 4 consists of my contributions to the following manuscript, and is the result
of our collaboration with the Ben Garcia lab at the University of Pennsylvania (with
postdoctoral researcher Xing-Jun Cao):
Stankovic, A., Guo, L.Y., Bodor, D.L., Mata, J.F., Cao, X., Bailey, A.O., Shabanowitz, J.,
Hunt, D.F., Garcia, B.A., Black, B.E., and Jansen, L.E.T. A dual inhibitory mechanism
restricts centromeric chromatin assembly to G1 phase. Molecular Cell, 2017 Jan
19;65(2):231-246.

4.1. ABSTRACT
Maintenance of genomic stability requires accurate propagation of
centromere location with every cell division. Replication of centromeric DNA in S
phase must be followed by loading of new CENP-A molecules into centromeric
chromatin, to prevent loss of CENP-A nucleosomes from successive dilutions. But
unlike canonical histones, CENP-A loading is not coupled to DNA replication, but
rather occurs exclusively after mitotic exit. This unique timing is controlled by
cyclin-dependent kinases 1 and 2 (Cdk1/2), whose activity prevents CENP-A loading
until the decline of Cdk1/2 activity in telophase/G1, but the targets of Cdk
regulation are unknown. By combining the powerful methods of stable isotope
labeling by amino acids in cell culture (SILAC), affinity-purification of the CENP-Acontaining chromatin assembly complex with HJURP and its partner histone H4,
titanium dioxide enrichment of phosphopeptides, as well as high-resolution mass
spectrometry, we quantitatively measured the changes of multiple phosphorylation
sites on CENP-A-containing complexes upon Cdk inhibition. We will present the
results of these experiments, including findings that putative Cdk sites on HJURP are
heavily phosphorylated in early mitosis, and are rapidly dephosphorylated upon
Cdk inhibition. In contrast, putative Cdk sites on the CENP-A N-terminal tail remain
phosphorylated even after Cdk inhibition. All of these post-translational
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modifications are strong candidates to participate in the regulation of the CENP-A
chromatin assembly pathway.

4.2. INTRODUCTION
Centromere location is specified epigenetically by the histone H3 variant
termed centromere-protein A (CENP-A). Epigenetic inheritance of centromere
location requires newly expressed CENP-A to be loaded into centromeric chromatin
at each cell cycle. Contrary to canonical histones, CENP-A loading does not occur at
the same time as DNA replication, but instead occurs following mitotic exit (Jansen
et al., 2007). This unique loading mechanism is driven by cyclin-dependent kinases,
whose activity during S, G2, and M phases sequesters CENP-A in a “prenucleosomal
complex” where it is bound to its chaperone HJURP and its histone partner H4, and
this inhibition is relieved as Cdk activity declines during mitotic exit (Silva et al.,
2012). We sought to identify the Cdk targets that control this unique timing of
CENP-A.
Stable isotope labeling with amino acids in cell culture (SILAC) is a robust
tool of quantitative phosphoproteomics. SILAC entails in vivo metabolic
incorporation of "heavy" 13C- or 15N-labeled amino acids into proteins during
normal cell growth and division. Light and heavy peptides can be distinguished by
predictable mass differences. Since there is no chemical difference (other than
isotopic composition) between light and heavy amino acids, comparative cell
populations exhibit identical biochemical and cellular properties (Mann, 2006).

4.3. RESULTS
4.3.1 IDENTIFICATION OF CDK-DEPENDENT
PHOSPHORYLATION SITES ON THE CENP-A CHROMATIN
ASSEMBLY COMPLEX BY QUANTITATIVE PHOSPHOPROTEOMICS
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HJURP, the CENP-A specific chaperone is a phospho-protein and features
several putative Cdk sites, making it a prime candidate for cell cycle control of
CENP-A assembly. To precisely determine which residues are phosphorylated in the
relevant cell cycle window, we used stable isotope labeling by amino acids in cell
culture (SILAC) coupled to mass spectrometry. The SILAC approach allows for direct
and accurate quantitation of changes in phosphorylation levels of residues. We
grew two parallel cultures of cells stably expressing CENP-A-GFP (Bailey et al.,
2013), one in normal media (“light”) and one in media in which the essential amino
acids lysine and arginine are replaced with their heavy isotopes (“heavy”). Both
cultures were arrested in mitosis, one of which was subsequently released into early
G1 phase by Roscovitine treatment (Figure 38, left, and
Figure 39). We harvested and combined equal numbers of the heavy/light cells
after 30 min of Roscovitine (or DMSO only) treatment. At this stage HJURP is
partially dephosphorylated (based on shift in SDS-PAGE mobility of the
phosphorylated HJURP pool) (
Figure 39b,c), but has not completed centromere chromatin assembly (Jansen et al.,
2007; Silva et al., 2012). We then isolated GFP-tagged CENP-A from the soluble
fraction, which co-purified the relevant endogenous pool of HJURP. We detected 6
phosphorylated residues corresponding to putative Cdk consensus sites within
HJURP, all of which were dephosphorylated to varying degrees upon mitotic exit,
ranging from 25-70% decrease relative to mitotic values (Figure 38b, right,
Figure 39, and Table 1). In contrast, unphosphorylated peptides and previously
reported phospho-sites on the CENP-A N-terminal tail (Bailey et al., 2013), which
reside within Cdk consensus motifs, remain unaffected by forced mitotic exit,
indicating that protein levels of CENP-A and HJURP remain unaffected and that
HJURP is specifically targeted for dephosphorylation upon G1 entry. Three of the
identified residues correspond to recently reported phospho-sites (Müller et al.,
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2014; Wang et al., 2014), and our analysis shows that these (S412, S448, S473) are
neither the sole nor the most responsive sites to the silencing of mitotic Cdk activity.

Figure 38. HJURP and is dephosphorylated upon mitotic exit.
(a) (Top) Schematic representation of HJURP protein, along with previously
recognized domains (CENP-A binding domain (Scm3), conserved domain (CD),
HJURP C-terminal domain 1 and 2 (HCTD1 and 2)) and the position of identified
phospho-sites by SILAC in b. Amino acid sequences flanking phospho-sites are
annotated. (b) Schematics of SILAC experiment. Cells stably expressing GFP-CENP-A
were grown to equilibrium in either light or heavy medium and arrested in mitosis
by STLC treatment. The light cells were released into G1 by Roscovitine treatment
for 30 min. At this stage HJURP is partially dephosphorylated (based on shift in SDSPAGE mobility of the phosphorylated HJURP pool) (
Figure 39b,c), but has not completed centromere chromatin assembly. Heavy and
light cells were combined in equal numbers, followed by GFP-pull down of the
prenucleosomal CENP-A complex containing the relevant endogenous HJURP pool,
trypsin digestion, phosphopeptide enrichment and analysis by LC-MS/MS. (See
more detailed schematic in
Figure 39a). (c) Phosphorylated Cdk sites are listed. The L/H ratio of a
representative non-phosphorylated peptide is shown as internal control, (d) L/H
ratios of Cdk consensus sites within the N-terminal tail of CENP-A. (See Table 1 for
data from two additional replicate experiments)
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Figure 39. Strategy for SILAC experiment with Roscovitine-induced mitotic exit.
(a) Schematic of SILAC experiment. (b) Western blots for the mitotic marker
H3pS10 indicating cell cycle position of HeLa S3 cells. Cell were arrested in mitosis
with the Eg5 inhibitor STLC followed by treatment with DMSO control or
Roscovitine (light cells) to force mitotic exit caused by Cdk inhibition. (c) Western
blots for HJURP (isolated from soluble fraction) showing dephosphorylation (as
seen by shift in SDS-PAGE mobility of phosphorylated HJURP) upon Roscovitine
treatment of "light" cells. Based on this, we harvested cells after 30 minutes of
Roscovitine (or DMSO) treatment, balancing between HJURP dephosphorylation and
completion of HJURP-mediated centromeric chromatin assembly.
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Figure 40. Representative chromatograms and spectra of HJURP and CENP-A
phosphopeptides in SILAC
Extracted ion chromatograms of all phosphopeptides from Figure 38, showing coelution of phosphopeptide pairs (left panels), and representative mass spectra
showing isotopic envelopes of light vs. heavy peptides (right panels).
Phosphopeptides from “light” (Roscovitine-treated) cells are colored in pink, while
the phosphopeptides from “heavy” (mock-treated) cells are colored in dark red.
Each peptide pair is separated by a predictable mass difference (calculated from the
number of lysines and arginines in the peptide), which is labeled with dotted lines
between the monoisotopic peaks of light and heavy peptides. (a) A representative
unphosphorylated HJURP peptide as internal control. (b-g) HJURP
phosphopeptides. (h-i) CENP-A phosphopeptides.
(Roscovitine-treated)/(Mock-treated)
Ratio
Experimen
t #1
(Forward
labeling)

Experimen
t #2
(Reverse
labeling)

Experimen
t #3
(Reverse
labeling)

VTPLPSLApSPAVPAPGYCSR

0.32

nd

0.30

HJURP
pS412

WLIpSPVK

0.72

nd

0.62

HJURP
pS448

EYCLpSPR

0.53

nd

nd

HJURP
pS473

GGPApSPGGLQGLETR

0.48

0.37

0.42

pSPGQMTVPLCIGVSTDK

0.23

nd

0.25

YCLKpSPGQMTVPLCIGVSTD
K

0.28

nd

0.30

LPSpSPLGCR

0.46

0.48

0.39

pSPpSPTPTPGPSR

nd

0.93

nd

RpSPpSPTPTPGPSR

nd

1.01

nd

0.87

0.98

nd

Phosphosite(s)
covered

Phosphopeptide

HJURP
pS185

HJURP
pS595
HJURP
pS642
CENP-A
pS16+pS1
8

RRpSPpSPTPTPGPSR
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CENP-A
pS16

RRpSPSPTPTPGPSR

0.94

1.13

nd

Table 1. G1/Mitotic Ratios of HJURP and CENP-A phosphopeptides are
reproducible.
Data from three independent SILAC experiments (the data described in Figure 38,
Figure 39, and
Figure 40 are displayed in the column labeled “Experiment #1”). For the forward
labeling experiment, the “light” cells are treated with Roscovitine while the “heavy”
cells are mock-treated. For reverse labeling experiments, the “light” cells are mocktreated while the “heavy” cells are treated with Roscovitine. Red residues are the
sites where phosphate groups were unambiguously mapped. Bolded residues are
the Cdk consensus motifs in each peptide. (nd=no data)

4.4. DISCUSSION
Maintenance of genomic stability requires accurate propagation of
centromere location across cell divisions. Cyclin-dependent kinases (Cdks) are a
critical controller of the unique, exquisitely regulated mechanism of CENP-A
replenishment at the centromere. Our SILAC effort enables us to quantitatively
map the landscape of Cdk-regulation on the CENP-A prenucleosomal complex,
including the endogenous HJURP protein. We detected 6 Cdk consensus sites within
HJURP, all of which declined in the level of phosphorylation after Cdk inhibition, to
varying degrees. In contrast, Cdk consensus sites on the CENP-A N-terminal tail that
are known to be heavily phosphorylated4 remain phosphorylated even after Cdk
inhibition. Total protein levels of both HJURP and CENP-A were nearly identical
between the light and heavy cells, since their unphosphorylated peptides had
light/heavy ratios of approximately one. These results are consistent with recent
reports that the three HJURP phosphosites within its HCTD1 are Cdk targets (Müller
et al., 2014; Wang et al., 2014) but our present data reveal that those particular sites
are not the sole targets of Cdk regulation of HJURP, nor are they the most responsive
to the silencing of Cdk1 and Cdk2 that recapitulates what occurs during mitotic exit.
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4.5. METHODS
4.5.1. SILAC AND AFFINITY PURIFICATION OF
PRENUCLEOSOMAL HJURP/CENP-A/H4 COMPLEX
SILAC labelling medium (MEM Eagle Joklik Modification) deficient in lysine
and arginine was reconstituted according to manufacturer's instructions (SigmaAldrich), and supplemented with normal lysine and arginine (Sigma-Aldrich) for
“light” medium, and 50 mg/ L

13C6,15N2-lysine

and 50 mg/L

13C6, 15N4-arginine

(Silantes) for “heavy” medium. Both media were supplemented with 10% dialyzed
FBS (Gemini), GlutaMax (Gibco), 1 mM HEPES, 1% Pen/Strep, MEM non-essential
amino acids (Gibco), and 120 mg/L proline to prevent arginine-to-proline
conversion. Two parallel cultures of previously characterized HeLaS3 cells stably
expressing localization and purification (LAP)-tagged CENP-A (Bailey et al., 2013)
were cultured in spinner flasks for at least 6 cell doublings to allow full
incorporation of the stable isotope-containing amino acids. Heavy isotope labeling
efficiency of ~98% was confirmed by mass spectrometry after trypsin digestion of
proteins extracted from heavy-labeled cells. To enrich for mitotic cells, both cultures
were treated with 50 µM S-trityl-L-cysteine for 17 h. Subsequently, the "light" cells
were treated with 100µM R-Roscovitine (AdipoGen) for 30 min while the "heavy"
cells were mock-treated with DMSO. Cell cycle status and HJURP phospho-status
was monitored by immunoblotting for H3pS10 (Upstate) and an anti-HJURP
antibody generated against a C-terminal fragment (1 µg/ml)(Bassett et al., 2012),
respectively. Cell pellets from 1.4 x 109 of "light" and "heavy" cells were combined in
1:1 ratio. Affinity purification of the prenucleosomal HJURP/CENP-A/H4 complex
was performed as previously described (Bailey et al., 2013) except that protein
elution was performed with 2% SDS and heating at 95°C.

4.5.2. MASS SPECTROMETRY AND DATA ANALYSIS
Purified CENP-A and associated proteins were precipitated using pre-chilled
acetone (4 X volume) followed by successive washing. Dried protein pellets were
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reconstituted with 0.1% RapiGest SF Surfactant (Waters) in 100 mM NH4HCO3, pH
8.0. Resuspended proteins were reduced using DTT, alkylated with iodoacetamide,
and digested using trypsin. Since trypsin cleaves only after lysines and arginines,
this ensures that every resulting peptide will contain at least one lysine or arginine,
so that the all heavy peptides are distinguishable from their corresponding light
peptides by predictable mass differences. Rapidgest was removed by adding 0.5%
TFA and incubation for 30min at 37°C. The sample was thenThe peptides were
desalted with StageTips (Thermo), followed by phosphoenrichment
phosphopeptide enrichment by TiO2 prior to analysis by Q-Exactive Hybrid
Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific). The pFind
search engine was used to search the UniProt human protein database to identify
peptides (Wang et al., 2007). Quantification was done using extracted-ion
chromatograms (XICs) of each light and heavy peptide pair, and L/H ratio
represents the ratio of total area under each elution peak.
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CHAPTER 5: CONCLUSION
5.1. SUMMARY
The centromere is a critical region in chromatin upon which assembles the
proteinaceous kinetochore complex, and it is known that the histone variant H3 is
the epigenetic marker of centromere location. How centromere identity is
propagated across cell and organismal generations is a crucial question for biology,
since any loss or spurious duplication of centromere location can have disastrous
consequences for the cell. CENP-A is known to be remarkably stable at the
centromere, and the underlying mechanism for its stability had been poorly
understood. In Chapter 2, we identify the role of an essential binding partner, CENPC, in reshaping CENP-A nucleosomes and stabilizing it at the centromere. We show
by multiple structural methods that CENP-C not only binds to CENP-A nucleosomes,
but also alters its physical properties. Not only is this a breakthrough for the
centromere field that attributes the extraordinary stability of CENP-A to its essential
binding partner, but it presented the first example of how a non-catalytic
nucleosome binding protein can alter nucleosome conformation.
Although Chapter 2 contains exciting findings, we did not rule out the
possibility that the effect of CENP-C on CENP-A stability is indirect, and does not
depend on its direct binding to CENP-A nucleosome—since after all, the depletion of
CENP-C is a bit of a “sledgehammer approach” that removes many other proteins
from the centromere. To show this directly, we would need to take a more surgical
approach, to make perturbations in the interaction between CENP-A and CENP-C
without derailing the entire CCAN network. Therefore, in Chapter 3, we pinpointed a
mechanism by which CENP-C drives such a structural transition in the CENP-A
nucleosome via a critical arginine anchor, and we use gene-editing approaches to
confirm this mechanism in a CENP-A maintenance assay. By making point mutations
in this gene replacement system, we conducted the cleanest set of CENP-C structurefunction studies to date, sand correlate the loss of the biophysical structural
transition to the decrease of CENP-A retention in cells. We also show that another
“friend” of CENP-A at the centromere, CENP-N, also plays a role in stabilizing CENP-
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A nucleosomes. We assemble a core centromeric nucleosome complex with the
nucleosome-binding domains of CENP-C as well as CENP-N, another critical binding
partner of CENP-A at the centromere. We demonstrate that CENP-C and CENP-N can
simultaneously engage and rigidify the CENP-A nucleosome at the centromere, and
that they both play a role in stabilizing the CENP-A nucleosome in cells.
In Chapter 4, we shed insight into the exquisitely regulated mechanism of
nascent CENP-A assembly, which is restricted to a specific phase of the cell cycle.
Using the powerful, quantitative SILAC approach, we identify multiple Cdkdependent phosphorylation sites on the CENP-A chaperone, HJURP, and we measure
their exact G1/mitotic ratios. These sites are likely candidates for the regulation of
CENP-A assembly.

5.2. FUTURE DIRECTIONS FOR CHAPTERS 2 AND 3
In Chapters 2 and 3, we have elucidated the role of two critical binding
partners, CENP-C and CENP-N, in stabilizing CENP-A at the centromere in cells, and
we have also reconstituted and examined biophysically the core centromeric
nucleosome complex, consisting of the CENP-A nucleosome bound to CENP-CCD and
CENP-NNT. Our work opens up many new questions that are just waiting to be
investigated.

5.2.1. TOWARD A STRUCTURE FOR THE CCNC
Our finding that as CENP-NNT binds to the CENP-A nucleosome, it makes only
a small footprint on CENP-A (at its exposed Loop1) by HXMS, but almost the entire
CENP-N N-terminal domain (~200 amino acids) is globally and dramatically
stabilized upon binding to the CENP-A nucleosome. We are first to show that CENPNNT, even before binding to the nucleosome, is a folded domain. And upon engaging
with the CENP-A nucleosome, it experiences this striking stabilization of its
secondary structure throughout the already-folded domain. For a long time in the
field, CENP-N has been notoriously difficult to work with biochemically, since it is
known to have low solubility in solution and a tendency to form aggregates. While
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we have improved purification of CENP-NNT which greatly extended its “shelf life”,
our finding provides an explanation for why CENP-NNT tends to be better behaved
when in complex with CENP-A nucleosomes: the complex stays stable for weeks in
solution, whereas CENP-N on its own (in the absence of glycerol) will precipitate out
of solution in a matter of days. Since the complex is well-behaved, obtaining a
structural model of the CCNC, either by crystallography or by cryoelectron
microscopy (cryo-EM), would obviously be large leaps for the centromere field. Our
HXMS indicate that CENP-CCD and CENP-NNT bind simultaneously to different
regions on the CENP-A nucleosome, that CENP-CCD is linear and disordered while
CENP-N has inherent secondary structure (e.g., helices and sheets). A structure of
the CCNC will likely unveil the secondary structure of CENP-N, and provide a
valuable model for how both proteins engage with the CENP-A nucleosome.

5.2.2. STRUCTURE-FUNCTION STUDIES OF CENP-N
We have shown that rapid auxin-induced degradation of the CENP-N protein
results in a decrease in CENP-A stability, and that the domain of CENP-N responsible
for this stability is likely its N-terminal domain, which directly interacts with the
CENP-A nucleosome. Although previous reports have proposed R11 and R196 of
CENP-N as critical residues for this interaction (Carroll et al., 2009), this is unlikely
to be the complete picture, since CENP-N likely makes multiple contacts with the
nucleosome. We cannot use our HXMS to pinpoint the crucial residues in CENP-N,
since the entire N-terminal domain undergoes dramatic stabilization in secondary
structure.
The first strategy for structure-function studies might be to make smaller
domain deletions with the N-terminal domain of full-length CENP-N. Our HXMS data
shows that CENP-N 205-240 are disordered before and after binding to the CENP-A
nucleosome, so that is unlikely to be a region involved in the interaction with the
CENP-A nucleosome. Within CENP-N 1-205, the a.a. 87-98 region also seems more
disordered than its surrounding regions, suggesting that it is possible that CENP-NNT
exists as two folded domains (e.g., a.a. 8-86 and a.a. 99-193), with a.a 87-98 as a
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flexible linker between the two domains. (However, it is also possible that this
region is simply a long loop). One strategy would be to start with CENP-N(∆8-86)
and CENP-N(∆99-193) to test in a CENP-A-SNAP assay, to see whether one or both
of these sub-domains are required for stabilizing CENP-A at the centromere, and
then hone in on point mutants. It would then be interesting to test the
phenotypically interesting CENP-N mutants as recombinant proteins, by first testing
whether they can still make complexes with CENP-A nucleosomes, and if so, testing
such complexes in HXMS to examine the effects of these mutants on the protection
of CENP-A, as well as the protection of the CENP-N protein itself.

5.2.3. TOWARD BIOPHYSICAL ELUCIDATION OF A LARGER
CCNC
In our study, we reconstituted the minimal CCNC that includes the CENP-A
nucleosome bound to CENP-C(426-537) and CENP-N(1-240). An obvious extension
of this study would be to attempt to reconstitute and biophysically characterize a
larger complex. In Figure 37, we summarize that not only does CENP-C and CENP-N
individually bind the same CENP-A nucleosome, CENP-C also interacts with the
CENP-L/N subcomplex (via CENP-C a.a. 235-352, which we mapped in Figure 28). A
recent study assembled a seven-submit CCAN subcomplex (Weir et al., 2016), but
there is much structural insight yet to be learned about the these subunits work
together to establish and maintain centromeric chromatin.

5.2.4. CELL CYCLE DEPENDENCE OF THE ROLES OF CENP-C
AND CENP-N IN STABILIZING THE CENP-A NUCLEOSOME
We have shown that CENP-C and CENP-N both serve critical roles in
stabilizing the CENP-A nucleosome at centromeres, but it is still unknown whether
their protective roles are most crucial in a specific phase of the cell cycle, or if they
are providing stability to CENP-A nucleosome throughout the entire cell cycle. Sphase is especially intriguing, since the CENP-A nucleosome could be especially
vulnerable in S phase, since chromatin undergoes some disruption and subsequent
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restoration as it passes through the replication fork (Probst et al., 2009). For CENPA to be stably transmitted in each cell division, CENP-A nucleosomes need to
correctly reassembled behind the replication fork. This process is a crucial, yet
poorly understood aspect of centromere inheritance, and it is possible that its
binding partners at the centromere are important at the step. While the proteins of
the CCAN are constitutively present at the centromere, their localization is dynamic
(Fang et al., 2015; Hellwig et al., 2011; Hemmerich et al., 2008). CENP-N exchanges
quickly throughout the cell cycle but slows down during late S-phase, at which time
its levels at the centromere is increased, and CENP-N is loaded into centromeric
chromatin in late S phase (Fang et al., 2015; Hellwig et al., 2011; Hemmerich et al.,
2008). CENP-C, on the other hand, is known to be dynamically exchanging across
most of the cell cycle, but relatively more stably bound during S phase (Hemmerich
et al., 2008).
Therefore, based on the literature, and from our own data, we speculate that
CENP-N may play a role for stabilizing (possibly through reassembling) CENP-A
nucleosomes after they are disrupted by the replication fork. As CENP-N levels rise
in late S-phase, it could mark the centromeres that have completed replication
(Stellfox et al., 2013), and lock CENP-A onto the adjacent DNA (by binding to both
DNA as well as CENP-A).

5.2.5 SINGLE MOLECULE FRET ANALYSES OF THE CCNC
Past FRET experiments have shown that CENP-C locks the CENP-A
nucleosome into a more compact conformation (Falk et al., 2015, 2016). However,
we do not yet have dynamic information about nucleosome fluctuations: i.e.,
whether the CENP-A nucleosome stably resides in one state (without fluctuating), or
whether they fluctuate between two or more discrete states. It is already known
that CENP-A nucleosomes are less compact than H3 nucleosomes (Falk et al., 2015,
2016), but it would be interesting to test whether fluctuations (if they exist) differ
between CENP-A nucleosomes vs. H3 nucleosomes. Could both types of
nucleosomes exist in open vs. closed states, but just that CENP-A spends more time
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occupying the open state? (Or is it that only CENP-A nucleosomes can access this
open state?) We already expect CENP-C to affect CENP-A nucleosome
conformation. But does it do so through dynamics? And of course, how does CENP-C
affect CENP-A nucleosome dynamics? If nucleosomes indeed fluctuate between two
or more discrete states, CENP-C could change the nucleosome in two possible ways:
either a) CENP-C binding drives the equilibrium and partition of those states
towards the closed state, or b) CENP-C preferentially binds the closed state and
blocks fluctuations back to the open state (like a ratchet). Or, if nucleosomes stably
reside in an open state (without fluctuating) until being bound by CENP-C, we would
expect it to change the conformation to a closed state that is also stable. And of
course, does CENP-N change dynamics of the CENP-A nucleosome?

5.3. FUTURE DIRECTIONS FOR CHAPTER 4
In Chapter 4, we identified the Cdk-dependent phosphorylation sites on the
CENP-A chaperone, HJURP, using a quantitative phosphoproteomics approach.
These sites could be critical sites of the regulation of CENP-A assembly. Previous
attempts to characterize HJURP mutants in cells have involved massively
overexpressing HJURP, which complicates the analyses, especially for claims for
gain-of-function HJURP mutants (Müller et al., 2014). Instead, we will examine
HJURP phosphomutants by HJURP replacement in diploid cells, to aim to arrive at
unambiguous answers for whether (and how) HJURP phosphomutants affect HJURP
function. One method is by adding AID tags onto HJURP in our DLD-1 Flp-In TRex
cells, which would allow us to rapidly deplete HJURP protein, a method that was
successful for CENP-C (in Chapters 2 and 3). We can subsequently introduce
exogenous HJURP rescue mutants into the unique FRT site, which can be either
constitutive or inducible (if containing a Tet operator). If the rescue construct is
made inducible, we can modulate the level of expression by varying the amount of
doxycycline to add to the culture media, which would allow us to arrive at nearendogenous levels of HJURP expression. Additionally, generation of phosphospecific HJURP antibodies would be helpful in characterizing the phosphomutants.
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5.4. FINAL THOUGHTS
In the human body, about one hundred billion cells divide over the course of
a single day. The process that ensures faithful transmission of genetic material
across cell and organismal generations is an exquisitely regulated process, and is
undoubtedly one of the most important processes in all of eukaryotic life. Our work
has shed insight into the epigenetic maintenance of centromere identity, which is
fundamental in ensuring accurate segregation of chromosomes during cell division.
The location of the centromere, encoded by CENP-A, is a crucial piece of information
for each chromosome—if that information is lost or duplicated, it can result in
chromosome breakage, aneuploidy, and cell death.
The inheritance of CENP-A can be viewed as one of the purest examples of
“epigenetics”, a term first coined by the English embryologist Conrad Waddington in
the 1940s to mean “above genetics”. Ever since the human genome was sequenced,
“epigenetics” has come to mean heritable changes that are not caused by alteration
of the genetic code itself—in other words, the hope that human beings are more
than just the sum of our genes. It is quite an astonishing result of evolution— that
this crucial task of long-term inheritance of centromeric location has fallen on the
shoulders not of any DNA sequence, but rather a histone variant. It makes sense,
then, that the centromere is quite a sacred place in the chromosome, built with
multiple mechanisms for protecting the robustness of this epigenetic mark. The
faithful perpetuation of centromere identity relies on the extraordinary long-term
stability of the CENP-A molecule, and this thesis provides evidence that CENP-A
does not do it alone, but rather with the help of friends at the centromere.
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APPENDIX A: PROTOCOLS FOR CHAPTERS 2 AND 3
A1. GENE-EDITING OF DLD-1 CELLS BY CRISPR/CAS
A1A. EXTRACTING GENOMIC DNA
Day 1:
1. Make 1ml DNA extraction buffer:
Recipe

Stock

Amount to add from
stock

100mM Tris HCl pH 7.4

1M Tris HCl pH 7.5 at 4C

100µl (1:10)

200mM NaCl

5M NaCl

40µl (1:25)

5mM EDTA

0.5M EDTA

10µl (1:100)

0.2% SDS

20% SDS

10µl (1:100)

1mg/ml Proteinase K

2.5mg/ml stock

400µl

ddH2O

440µl
Total: 1ml

2. Lyse pellet in 600µl DNA extraction buffer
-

I've tried either lysing cells directly off of a dish after PBS wash, using a
cell scraper to collect cells, or trypsinizing the cells and washing the pellet
before adding the DNA extraction buffer-- either should work.

-

Also, you can adjust the volume of buffer based on how many cells you
are lysing: I've used 600ul for a 10cm dish which works fine if the cells
aren't too confluent. I've also used ~150-200ul for a well for a 12-well
plate.

3. Incubate for 30min at 37C (Note: had increased from 0.1mg/ml, which is for
doing an overnight incubation at 55C). Lysate should be goopy after
incubation.
4. In Eppendorf tube, add equal volume phenol:chloroform:isoamyl alcohol
(25:24:1) vortex to mix. (Remember to dispose of phenol waste in special
container)
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5. Centrifuge 14,000rpm for 5min at RT.
6. Prepare a fresh tube with 0.1V of 3M sodium acetate, pH 5.5 (or 4M
ammonium acetate)
7. Transfer upper phase to the fresh tube (should see a white layer between
upper and lower phases).
8. Add 2V ice cold 100% EtOH. DNA will become visible.
9. Vortex to mix. Leave overnight at -20C.
Day 2:
1. Centrifuge 14,000rpm for 15min at 4C to pellet DNA. Aspirate
supernatant.
2. Wash pellet with 70% ice cold EtOH to remove excess salt.
3. Centrifuge 14,000rpm, 15min at 4C to pellet DNA. Aspirate supernatant.
4. Allow pellet to air-dry.
5. Resuspend pellet in 10mM Tris-HCl, pH 8.0.
6. Measure concentration by Nanodrop.

A1B. DESIGNING GRNAS FOR CRISPR
The protocol described below uses the CENP-A C-terminus as an example, and is
adapted from Ran et al, 2013.
1. Obtain genomic sequence for gene of interest (CENP-A, in my case) from the
public domain. Use this sequence to design primers for genomic DNA
extraction from the specific cell lines to be used for targeting (DLD-1 cells, in
my case), to PCR up a region of <900bp (which is the limit at the sequencing
core) that spans the location of desired double-stranded break. In this case,
the desired location of the double-stranded break would be at the end of the
exon 4 (…LEEGLG), right before the TGA stop codon. Alternatively, one could
just use the genomic sequence from the public domain to design the gRNAs.
However, if there were polymorphisms between that sequence and the cell
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lines to be used that result in a sequence mismatch within the bases to which
the gRNA is expected to bind, then the gRNAs may not work.
2. Perform genomic DNA extraction on the cell lines (see “Protocol for genomic
DNA extraction”), and genomic PCR with the aforementioned primers. Send
for sequencing.
3. Using http://crispr.mit.edu, paste 200 bp of sequence (~100bp upstream
and downstream of the site of desired DSB) into the window. The site will
generate a list of possible gRNAs, each with a “quality score”, which
represents the inverse likelihood of off-target binding (see Figure 41).
a. Locate each gRNA on the sequence of the gene and determine the
location of the DSB (see Figure 42). To maximize efficiency of
cleavage, choose gRNAs that would cleave within ~30bp of ideal DSB
site. The shorter this distance, the better. If this distance is >100bp,
the gRNA is unlikely to work.
b. Among the gRNAs with a distance from ideal site of DSB of <30bp,
choose the gRNAs with the highest quality scores. I usually try 3
gRNAs concurrently, and continue with the one that is most efficient.
4. The pX330 plasmid (containing Cas9) contains BbsI sites for insertion of the
gRNA. If using this plasmid, order each gRNA as a pair of 20 bp oligos with
BbsI site appended (see Table 2).

Figure 41. List of gRNAs as generated for CENP-A-SNAP
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CRISPR List of possible gRNAs generated by http://crispr.mit.edu, including the
quality score (inverse likelihood of off-target binding).

Figure 42. Alignment of gRNAs with CENP-A sequence
Snapshot from SnapGene Viewer showing the locations of the gRNAs (labeled
by their oligo number) and their associated protospacer adjacent motif (PAM). Each
double-stranded break will be directed to 3 base pairs away from the PAM, and is
indicated by a cleavage arrow.
Location
of DSB

CENP-A
3’ UTR
CENP-A
Exon 4

CENP-A
Exon 4

Sequence of oligo

Oligo
number

CACCGCTGACAGAAACACTGGGTGC

LG-045

AAACGCACCCAGTGTTTCTGTCAGC

LG-046

CACCGCAACTGGCCCGGAGGATCCG

LG-033

AAACCGGATCCTCCGGGCCAGTTGC

LG-034

CACCGCCGGAGGATCCGGGGCCTTG

LG-035

AAACCAAGGCCCCGGATCCTCCGGC

LG-036

Distance
from ideal
site of DSB

Quality
score

12 bp

58

25 bp

85

17 bp

62

Table 2. List of the 3 successful gRNAs that cuts the CENP-A C-terminus.
Within the sequence of each oligo, the 20 bp sequence that anneals to the DNA are
bolded (and the unbolded, blue sequence are the BbsI site appended onto each oligo,
including an extra guanine).
5. Anneal each pair of oligos, using a protocol such as the one below:
a. Combine 1µl of oligo 1 (100µM), 1µl of oligo 2 (100µM), 1µl of NEB
Buffer 2.1, and 7µl of ddH2O.
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b. Run annealing program on thermocycler: start with 95°C for 1min,
then decrease by 5°C every minute, until temperature reaches room
temperature (i.e., 95°C for 1min, 90°C for 1min, 85°C for 1min… until
22°C)
6. Linearize pX330 backbone with BbsI
a. Important note: we have had poor experience with BbsI from NEB.
Instead, FastDigest BpiI (ThermoFisher #FD1014) is an isoschizomer
is a much more reliable alternate.
b. Protocol: Combine 2µg of pX330 with 2µl of BpiI, 4µl of 10X
FastDigest Buffer, and 26µl of ddH2O. Incubate at 37°C for 1hr. Verify
on agarose gel that backbone has been successfully linearized. Then
gel-extract (e.g., using QIAquick Gel Extraction Kit, from Qiagen).
7. Ligation: insert gRNA into pX330 backbone:
a. For each reaction, use 50ng of backbone (Bpil-cleaved pX330), and
calculate amount of insert to add:
length of insert
50ng backbone × (
) ×5=amount of insert to use (ng)
length of backbone
b. Set up ligation reactions (including backbone-only control).
Backbone-only
control

Backbone + insert

pX330 (BpiI-cut, gelextracted)

50ng

50ng

Insert (annealed
oligos, diluted 1:100 in
ddH2O)

0

Amount calculated
from previous
section

TaKaRa Solution I

5µl

5µl

ddH2O

Add to 10µl total

Add to 10µl total
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c. Incubate reactions at 14°C for 1hr. Then transform 1µl of each
reaction into competent cells. Grow up cultures and extract DNA by
Qiagen Miniprep kit.
d. Verify sequences by sequencing, using a sequencing primer that binds
to the U6 promoter (LG-053: GAGGGCCTATTTCCCATGATTCC).

A1C. DESIGNING REPAIR TEMPLATES FOR CRISPR
(using example of adding SNAP-NeoR to the CENP-A C-terminus)
1. Our repair templates have been designed in a pUC19 backbone, containing
the synthetic region for insertion flanked by ~800bp of homology on either
side (Figure 43). The repair template is thus put together by HiFi Assembly
(NEB) using 4 pieces: the linearized pUC19 backbone (by XbaI, in this case),
the 3’ and 5’ homology arms, and the synthetic region for insertion. For
SNAP-NeoR, the region for insertion was synthesized as a gBlock (IDT), while
the homology asrms were derived from PCR of genomic DNA from DLD-1
cells (see “Protocol for genomic DNA extraction”). The primers used for
amplifying each region are listed below (Table 3). I try to have overlapping
ends of 20-30 bp for every fragment.
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Figure 43. Plasmid map of repair template.

Section of repair
template
For 5’ homology
arm from DLD-1
genomic DNA
For synthetic
gBlock (containing
SNAP-NeoR)

Sequence of oligos used for PCR

Number of
oligo

F

GTGAATTCGAGCTCGGTACCCGGGGATCC
TCTAGAGGAACTCTCTCGTTTGTCCAC

LG-054

R

CCTCGAGAAGGCCGAGTCCCTCCTCAAG

LG-055

F

GCCTTGAGGAGGGACTCGG

LG-056

R

AAGACTGACAGAAACACTGGGTG

LG-057

R

ACGCCAAGCTTGCATGCCTGCAGGTCGAC
TAGTGCCTTTTCTCCCATACCACAG

LG-059

Table 3. Oligos used to generate each section of the repair template.
2. Set up reaction for HiFi Assembly (NEB), using NEBuilder (online tool) to
calculate amount of each DNA piece to add. I have had most success if all 4

135

pieces for the HiFi Assembly are all gel-extracted (using QiaQuick kit). See
Table 4 as example for setting up reaction. Add ddH2O to 10µl, and add 10ul
of NEBuilder HiFi DNA Assembly Master Mix (NEB). Incubate reaction at
50°C for 1hr. Then transform 2µl of this reaction into 50µl competent cells,
and plate the entire mix onto LB plates with appropriate antibiotic(s).
Gel-extracted DNA
fragment

bp

moles (for 1:1
ratio)

ng to add

pUC19 XbaI-cut

2686bp

0.100 pmol

166 ng

5’ arm

846bp

0.100 pmol

52.28 ng

SNAP-NeoR

1682bp

0.100 pmol

104.0 ng

3’arm

884bp

0.100 pmol

54.63 ng

Table 4. Example for setting up HiFi Assembly .
3. Grow up a few clones and obtain DNA by Miniprep. Screen clones by
diagnostic digest (500ng DNA is sufficient).
a. Expected sizes of fragments from NdeI + HindIII diagnostic digest of a
successful HiFi Assembly: 2423bp, 1824bp, 1070bp, 647bp. (See
Figure 44 for diagnostic digest of 8 clones, 6 of which were correct).
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Figure 44. Example of diagnostic
digest to screen for correct
assembly of repair template
Digest with NdeI and HindIII for 8
different clones obtained from
NEB HiFi Assembly. Clones 3-8
matched the predicted sizes of
fragments, indicating correct
assembly.

4. Verify by sequencing (note: need multiple primers to sequence the entire
region of interest spanning both homology arms and the synthetic region for
insertion).
5. Important! Make sure to mutagenize the repair template so that the gRNA
will not cut it. The easiest way would be to mutate the PAM sequence (i.e.,
mutate one of both of the Gs in NGG), if the PAM is in a non-coding region or
if the mutation can occur at a wobble base. If this is not possible, then mutate
~4 bases in the 20bp gRNA sequence.

A1D. TRANSFECTION AND SELECTION FOR CLONES
1. Transfect DLD-1 cells using Lipofectamine 2000 according to manufacturer’s
instructions. I transfect DLD-1 cells in 6-well plates at 80-90% confluency.
For each well, I have optimized to use 100ng of gRNA plasmid and 900ng of
repair template, with 10.5µl of Lipofectamine 2000.
2. Homology-directed repair will occur exclusively in S-phase. I usually wait ~5
days after transfection before beginning selection for clones (by G418

137

selection, this case, or by FACS if the repair template contains a fluorescent
protein).
3. Before beginning selection, verify that the CRISPR was successful in the
transfected cells. In this case, I performed immunofluorescence with anti-HA
antibody and looked for HA signal at centromeres. All three gRNAs that I
attempted (see Table 2) yielded HA-positive cells, with LG-045/046 having
had the highest efficiency (~1%).
4. Carry out selection for clones. In this case, I treated with 750µg/ml G418
(determined from G418 kill-curve in DLD-1 cells) for 7 days, combined the
surviving cells, and performed limiting dilution in 96-well plates (1 cell per
2-3 wells).
5. Expand clones that grow out of the 96-well plates. Once they get to the 12well stage, can begin extracting DNA to screen by genomic PCR. I have found
that DNA from half of a confluent 12-well is sufficient for genomic DNA
extraction.
6. Perform genomic PCR on clones.
a. In this case, I used two primers (SF59: CCTTCCCCACTCCTTCACAGGC
and SF60: CCTGTGAAAGAGGATGAGCTTACC) that span the location of
the DSB and insertion.
7. Validate clones by immunofluorescence and western blot.
a. In this case, I obtained both homozygous and heterozygous clones,
and this was evident by genomic PCR as well as by western blot
(Figure 45).
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Figure 45. Western blot of
clones from CRISPR/Casmediated gene editing in DLD1 cells to insert SNAP-tag at
the C-terminus of CENP-A.
ACA is used as primary
antibody. From this blot, it can
be determined that Clone #2
is tagged on one allele
(heterozygous), while Clones
#54 and #63 are tagged on
both alleles (homozygous).

A2. PULSE-CHASE SNAP EXPERIMENTS TO ASSESS CENP-A
MAINTENANCE
This protocol was adapted for DLD-1 cells from the methods used in Falk, Guo,
Sekulic, Smoak et al 2015. Specifically, it was used for the CENP-CAID-EYFP/AID-EYFP and
CENP-NAID-EGFP/AID-EGFP cells, to measure CENP-A-SNAP retention after 24 hours of
IAA treatment. This protocol can be adapted to assess additional cell lines (e.g., cell
lines with CENP-C rescue constructs at the FRT site), and also for different lengths of
IAA treatment.
Figure 46. Schematic for TMR*-labeling experiment
as described in this protocol.

Day 1:
1. Seed DLD-1 cells expressing CENP-A SNAP.
a. Seed 1 well in a 24-well plate (labeled “0 hr”), and another 2 wells in a
second 24-well plate (labeled “24 hr”). Each well should contain a
circular 13mm polylysine-coated coverslip. Seed these wells at 1 x 105
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cells/well, with ~500µl of media in each well, containing no
antibiotics.
b. Seed 1 well in a 6-well plate (labeled “0 hr”), and another 2 wells in a
second 6-well plate (labeled “24 hr”). These wells will be used only for
cell counting, therefore do not need coverslips in the wells. Seed these
wells at 5 x 105 cells/well, with ~2.5ml of media in each well,
containing no antibiotics (because the surface area of a well in a 6well plate is approximately 5 times that of a well in a 24-well plate).
c. Note: I have found it easier to seed the 0hr and 24hr cells on separate
plates (as described above), instead of seeding them on a same plate.
This way, I can directly fix the 0hr coverslip by adding 4%
formaldehyde directly to the well (followed by quench, and storage in
PBS) then store the entire plate at 4°C overnight (see detailed
protocol on immunofluorescence, on Day 3). I have found that this is
less stressful than trying to transfer the small 13mm coverslips out of
the plate prior to fixation, especially when working with multiple cell
lines in parallel.
Day 2
1. Pulse label cells with 2µM TMR* for 15min. Remember to turn off light in the
tissue culture hood when working with TMR*, since it is light-sensitive.
a. To reconstitute SNAP-Cell® TMR* (NEB S9105S), add 30µl tissue
culture-grade DMSO to the 30nmol of lyophilized TMR*. Rotate at
room temperature, in the dark, for 30min to mix.
b. Make TMR* solution in media:
i. Dilute TMR* 1:500 in media, and prepare to use 250µl of this
for each well in 24-well plate. Make a master mix to be used for
all the wells. Pipet up and down ~10 times after TMR* addition
to mix well. Then, spin clarify and transfer to new tube. Keep
this warm and in the dark until ready to add to cells.
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ii. Similarly, treat the 6-wells (for cell counting) similarly, but do
NOT need to TMR*-label these wells (since TMR* is expensive).
Instead, just dilute tissue-culture grade DMSO 1:500 in media,
and prepare to use 800µl for each well in 6-well plate. Keep
this warm and in the dark until ready to add to cells.
c. From the 24-well and 6-well plates, aspirate existing media out of
wells.
d. Wash each well carefully 2x with 1x PBS.
i. For this and all subsequent steps for handling cells, add
solutions to wells by aiming toward the sides of wells for
pipetting (instead of directly on top of cells), and letting the
solution slowly drip into the bottom of each well. This is surely
gentler on the cells.
ii. Note: others in the lab have noticed problems with cells
sloughing off the coverslips, and have found that using media
instead of PBS for washes can prevent this. But I have not
noticed a problem, so I have consistently stuck with using PBS
for washes.
e. Add 250µl of TMR* (1:500 mix) to each well in 24-well plate.
(Similarly, add 800µl of DMSO (1:500 mix) to each well in 6-well
plate). Put plates back in the incubators. Incubate for 15min exactly.
2. After 15min incubation, aspirate solutions out of wells, and carefully wash 2x
with PBS.
3. Add media into each well (500µl for 24-well plates, 2.5ml for 6-well plates),
with no antibiotics or drugs, and put plates back in incubators. Incubate for 2
hours.
a. This is a critical step, which serves to allow any unbound TMR* diffuse
out of cells. Without this step, the background TMR* signal would be
too high in the 0 hr timepoints, which would make analysis difficult.
Previously in HeLa cells (as in Falk*, Guo*, Sekulic*, Smoak* et al.
2015), this step had been only 30 min, but I have found that the TMR*
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background at the 0hr timepoint in DLD-1 cells is still too high after
30 min, and that extending this to 2hr greatly reduced this
background.
4. After the 2 hour incubation, the different plates will be treated differently:
a. For 24-well plates:
i. The “0 hr” coverslip:
1. Aspirate out the media
2. Add in 500µl of 4% formaldehyde (right into the well).
Incubate for 10min. Remember to keep plate in the
dark.
3. Remove formaldehyde, and quench with 500µl of
100mM Tris. Incubate for 5min.
4. Wash 2x with 1X PBS. For last wash, use large volume
(e.g., 1ml), and leave in the well. Wrap the entire plate
in foil and store at 4°C until tomorrow. Tomorrow,
resume immunofluorescence of this plate along with the
“24 hr” timepoints.
ii. The “24 hr” coverslips:
1. Aspirate out the media.
2. Carefully add in fresh media (500µl per well),
remembering to add 500µM IAA into the wells
designated for IAA treatment.
a. Write down the time of IAA addition, since this is
the beginning of the 24-hr IAA treatment period.
b. For 6-well plates:
i. The “0 hr” well:
1. Aspirate out media
2. Wash well 1x with 1X PBS
3. Add 500µl of trypsin, let cells detach from well. Then
add 500µl of media.
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4. Carefully transfer the entire 1ml into an Eppendorf
tube, making sure to monodisperse cells as best as
possible. Then count the cells. (Note: it is OK to not
count cells immediately, in order to align the “24 hr”
wells as best as possible, so that the time of IAA
addition is the same between the 24-well and the 6-well
plates. But if cells are not counted immediately, do plate
the tube on ice so that cells do not keep growing, and
count within ~1hr).
5. To count cells, carefully invert tube to mix wells (and/or
mix carefully with a transfer pipet), and load 10µl onto
the hemocytometer. The hemocytometer has 9 equally
sized squares. For my experiments, I always count 5
squares, calculate the average, then load a second time,
and count another 5 squares. If the averages between
the two loads differ by more than 15%, I count a third
load.
a. To calculate the number of total cells:
i. (Avg number of cells per square)*10000 =
Number of cells per ml.
b. Note: the hemocytometer is only considered
accurate if the number of cells per square is
between ~50 and ~200. Therefore, for this
protocol, in which I am seeding 5E5 cells per
well, I always add 500µl trypsin with 500µl
media so that I get between 50-100 cells per
square (which equals 5E5 to 1E6 cells total).
c. The cell counting is undoubtedly the most
tedious aspect of the entire protocol, but getting
accurate cell counts is absolutely crucial to make
the results interpretable. I have attempted to
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automate this process with the Countess
automated cell counter from ThermoFisher, but I
have found this unhelpful. (I got a large degree of
variability between loads, especially since DLD-1
cells are not as perfectly circular as the
fluorescent beads that they use for demo.
Therefore, it did not save me time to use the
Countess).
ii. The “24 hr” well:
1. Aspirate out the media.
2. Carefully add in fresh media (2.5ml per well),
remembering to add 500µM IAA into the wells
designated for IAA treatment. Try to do this step as
close in time as possible to the IAA addition in the 24well plate.
Day 3
1. After 24 hours of IAA addition:
a. For the “24 hr” timepoints in the 24-well plate:
i. Aspirate out media
ii. Fix by adding 500µl 4% formaldehyde for 10min.
iii. Remove formaldehyde and quench with 500µl 100mM Tris.
iv. Wash 2X with 1x PBS. At this point, pull the foil-wrapped 24well plate containing the “0 hr” timepoint coverslip out of the
4°C, and add this coverslip to all subsequent steps.
v. Remove 1x PBS and permeabilize coverslips with 500µl of
0.1% Triton in PBS. Incubate for 5min.
vi. Wash 2X with 1x PBS.
vii. Carefully transfer coverslips into a humidified chamber. For
me, I use a 15cm tissue culture dish, and place a piece of
parafilm on the bottom of the plate, upon which I place my
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coverslips (face up). I then place a few rolled-up sheets of wet
Kimwipes inside the plate to keep the chamber humidified.
viii. Add 75µl of IF Block (PBS supplemented with 2% FBS, 2% BSA,
and 0.1% Tween) to each coverslip, making sure the IF Block
spreads across the entire coverslip. Incubate for 20min at
room temperature. During incubation step, cover the dish with
foil.
ix. Wash coverslips 2X with 1x PBS.
x. Add 75µl of primary antibody mix to each coverslip. Incubate
for 1hr at room temperature. During incubation step, cover the
dish with foil.
1. For this protocol, my primary antibody mix is mouse
mAb anti-CENP-A (Enzo), diluted 1:1000 in IF Block.
xi. Wash coverslips 2X with 1x PBS.
xii. Add 75µl of secondary antibody mix to each coverslip. Incubate
for 1hr at room temperature. During incubation step, cover the
dish with foil.
1. For this protocol, my secondary antibody mix is Cy5
Donkey anti-Mouse (Jackson Labs), diluted 1:200 in IF
Block.
xiii. Wash coverslips 2X with 1x PBS.
xiv. Add 75µl of DAPI (Diluted 1:10,000 in PBST) to coverslips.
Incubate for 10min.
xv. Wash coverslips 2X with 2x PBST.
xvi. Mount coverslips to slides with 3.5µl of VectaShield.
xvii. Store slides in the dark at 4°C until ready to be imaged.
b. For the “24 hr” timepoints in the 6-well plate:
i. Count cells as described for Day 2.
Notes about imaging and analysis:
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1. Capture images at room temperature on an inverted fluorescence
microscope (DMI6000 B; Leica) equipped with a charge-coupled device
camera (ORCA AG; Hamamatsu Photonics) and a 40x oil immersion objective.
Use 0.59 µm z-sections (which I found to be sufficient for asynchronous
cells).
a. Note: I have tried this experiment with both 40x objective as well as
the 100x objective, and have gotten the same results. Using the default
parameters, CraQ will pick up more centromeres per cell in the 100x
images (~20 centromeres/cell for 100x, and ~9 centromeres per cell
for 40x). But because 40x images will contain many more cells per
field, I still obtain a greater n with 40x compared to 100x, so I have
stuck with imaging in 40x for these SNAP experiments.
2. I perform analysis on deconvolved images, since the deconvolved images will
be ultimately used for making figures. But I have found that using nondeconvolved images for quantitation does NOT change the trends of the
results.
3. To quantify fluorescence intensity of centromeres, run the CraQ macro on
ImageJ (Bodor et al., 2012) with standard settings using DAPI and total
CENP-A staining as reference channels to define ROIs for quantification of
TMR* intensity.
4. To calculate CENP-A turnover:

CENP-A turnover =

(TMR ∗ intensity at 24hr) − (Avg TMR ∗ intensity at 0hr)
(Cell number at 24hr)/(Cell number at 0hr)

5. The CENP-A turnover for untreated cells should be equal to 100%.

A3. PURIFICATION OF CENP-NNT-HIS
Protocol is adapted from McKinley et al., Mol Cell 2015.
Expression:
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1. Transform construct into pLysS and grow overnight at 37°C.
2. Grow starter culture overnight at 37°C.
3. Inoculate large flasks of LB + antibiotics with overnight culture.
4. Grow to OD 0.7-1 at 37°C.
5. Turn temperature down to 18°C, induce with 1mM IPTG, and grow for 6
hours. See Figure 47 for induction bands.
6. Freeze in lysis buffer at -80°C
a. Lysis buffer: 50mM Na phosphate pH 8.0, 300mM NaCl, 10mM
imidazole, 0.1% Tween, 1mM PMSF

Figure 47. Expression of
CENP-NNT in pLysS cells.

Lysis:
1. Thaw pellet in 37°C water bath and place on ice. Add PMSF, aprotinin, and
leupeptin/pepstatin. Incubate 15 minutes with occasional stirring.
2. Dounce with 10 plunges using the manual homogenizer.
3. Sonicate: 30 pulses on at 80%, keep on ice for 3min. Repeat for a total of 3
times.
4. Spin at 14700rpm at 4°C in SS-34 rotor for 30min. Take the supernatant, and
spin for another 30min.
a. Note: My experience has been that spinning at 30min just once still
leaves the lysate very viscous (which can result in clogging the
column). Adding another spin (or alternatively, making the spin
longer, such as 50min) has been helpful to reduce viscosity.
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Purification with 1ml HiTrap HP column (max pressure 0.3 MPa)
1. Make buffers.
a. Lysis buffer: 50mM Na phosphate pH 8.0, 300mM NaCl, 10mM
imidazole, 0.1% Tween
b. Wash buffer: 50 mM Na phosphate pH 8.0, 500 mM NaCl, 40 mM
imidazole, 0.1% Tween, BME, 20% glycerol
c. Elution buffer: 50 mM Na phosphate pH 8.0, 500 mM NaCl, 250 mM
imidazole, BME , 50% glycerol. Make sure to adjust pH to 8.0
2. Load clarified lysate (from ~2L of cells) onto column, no faster than 1
ml/min. Once loaded, start wash with Wash Buffer at 2 ml/min. Then elute
with Elution Buffer at 1 ml/min.
3. Note: Storage of CENP-N protein in 50% glycerol is crucial for long-term
stability. I have found that the fractions containing CENP-N are usually so
concentrated (~4mg/ml) that further concentration is not necessary. By
directly eluting in buffer containing 50% glycerol, further dilution is not
necessary. See Figure 48 for an example gel of final product of the CENP-N
purification. It is beneficial to perform an additional gel filtration step, which
gets rid of minor contaminants (Figure 48).
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Figure 48. SDS-PAGE gel of final
product of CENP-NNT purification.
The gel includes samples from
before and after the additional gel
filtration step.

A4. RECONSTITUTION OF CENP-A NUCLEOSOMES AND
ASSEMBLY OF THE CORE CENTROMERIC NUCLEOSOME
COMPLEX (CCNC)
This protocol of assembling CENP-A nucleosomes by stepwise dialysis is similar to
protocols prior described (Dyer et al., 2004; Luger et al., 1999; Sekulic and Black,
2016a), with a few modifications throughout.
1. First, measure concentrations of (CENP-A/H4)2 heterotetramer, H2A/H2B
heterodimer, and DNA.
2. Calculate volumes to add for each of the aforementioned components, so that
histones are present at 1 heterotetramer:2 heterodimers molar ratio.
Components should be concentrated enough that the final concentration of
DNA in the dialyzer can be ~0.7mg/ml. And calculate how much KCl stock to
add so that the starting reconstitution mix can be 2M KCl (to match the KCl
concentration of the Rb-High buffer).
3. Make buffers for reconstitution. Make sure all buffers are pre-cooled.
a. “RB-High” (high salt buffer): 10 mM Tris–HCl pH 7.5 at 4°C, 2M KCl, 1
mM EDTA, 1 mM DTT. Make 500ml of this.
b. “RB-Low” (low salt buffer): 10 mM Tris–HCl pH 7.5 at 4°C, 0.25M KCl,
1 mM EDTA, 1 mM DTT. Make 2L of this.
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c. “TCS-0” (buffer with no salt): 10 mM Tris–HCl pH 7.5 at 4°C, 1 mM
EDTA, 1 mM DTT. Make 1.5L of this.
d. Note: In the Rb-High and Rb-Low buffers, NaCl can be substituted for
KCl.
4. Assemble the reconstitution mixture by adding components in this order:
DNA, 4M KCl, CENP-A/H4, H2A/H2B, and Rb-High buffer.
5. Incubate mixture on ice for 30min and transfer to dialyzer of appropriate
size (after pre-wetting the dialyzer in Rb-High buffer)
6. Begin dialysis with flow rate of 1.6ml/min overnight (~16hr) using a twochannel peristaltic pump as described (Dyer et al., 2004; Luger et al., 1999;
Sekulic and Black, 2016a).
7. After 16 hr of dialysis, there should be ~500ml of Rb-Low still left. Move the
dialyzer into a fresh beaker containing the ~500ml of Rb-Low. If precipitate
is visible, take reaction out of the dialyzer and spin-clarify, then transfer to
fresh dialyzer. Dialyze for a few hours in Rb-Low.
8. Dialyze in TCS-0 buffer, 500ml each (x3, a few hours each, the last dialysis
usually goes overnight).
9. Check nucleosome quality with native PAGE.
a. Pour 5% native gel (with 1.5mm combs) with BioRad Mini protean
tetra cell casting module. Use ~10ml per gel:
10ml
20ml
40% acrylamide
1.25 ml
2.5 ml
2% Bis
0.416 ml
0.832 ml
5x TBE
0.8 ml
1.6 ml
H2O
7.87 ml
15.74 ml
TEMED
5 ul
10 ul
APS
50 ul
100 ul
b. Pre-run native gel at 150V for 1hr, at 4°C. Use 0.2X TBE as running
buffer.
c. Prepare gel samples. Each sample should contain no more than 1-3 µg
of nucleosomes (as measured by DNA concentration). Loading 1µg
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will result in a very crisp band. If planning to excise the band from the
native gel to resolve on denaturing SDS-PAGE, then load 3µg per lane,
to allow for more protein per band. Loading more than 3µg will more
easily result in smeary bands. Add equal volume 10% sucrose. Load
no more than 10µl of volume per lane, otherwise bands are likely to
be smeary (because the native gel has no stacking layer, unlike SDSPAGE gels). But loading less than ~5µl is also suboptimal since the
solution may not spread evenly within the well. So loading 5µl-10µl is
optimal.
d. After gel is finished running, stain with EtBr, then with Coomassie
Blue (see Figure 49 for example native gel).
10. If the nucleosome prep results in multiple bands (as is common for many αsatellite sequences), perform thermal shifting of nucleosomes, as described
(Dyer et al., 2004; Luger et al., 1999; Sekulic and Black, 2016a), to allow
histone octamer to slide along the DNA to the most favorable position on
DNA. Heat-shift nucleosomes by incubating them at 55°C f or 2hr, then
running a native PAGE to verify successful heat-shifting (Figure 49).

Figure 49. CENP-A nucleosomes
assembled 147bp Bunick DNA,
with and without thermal shifting.
The gel is stained with EtBr as
well as with Coomassie Blue.
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11. To determine protein components within a band on the native gel, it is
helpful to excise the band from the native gel and resolve its components on
denaturing SDS-PAGE gel (i.e., 2D gel):
a. It is imperative to run the denaturing gel (or, at least make the gel
samples) as soon as possible after the native gel has destained.
b. Place the native gel (Coomassie-stained and destained) on a piece of
Saran wrap. Use a clean razorblade to cut out the bands of interest.
c. If the native gel is 1.5mm (as opposed to 1.0mm), it is necessary to cut
the band further to fit it within the wells of the 1.5mm SDS-PAGE gel.
To do so, I find it easiest to bisect the band along its coronal axis, then
placing the two identical pieces vertically in the well of the SDS-PAGE
gel, then pipetting in ~20µl of SDS sample buffer into the lane.
For examples 2D gels, see
d. Figure 10 and Figure 31
12. To assemble complexes of CENP-A nucleosome with CENP-CCD and/or CENPNNT, incubate with 2.2 molecules of CENP-C for each molecule of CENP-A
nucleosome, and incubate with 4 molecules of CENP-N for each molecule of
CENP-A nucleosomes. See Figure 31 for example of these complexes run on
native gel. Complexes can be purified by preparative native PAGE as
described (Dyer et al., 2004; Luger et al., 1999; Sekulic and Black, 2016a).
13. For making HXMS reactions from these complexes (i.e., comparing
nucleosome alone vs. nucleosome bound to protein), it is imperative to add
equal volume of Blank buffer to the nucleosome-alone sample, so that the
final buffer content can be identical between the two samples to be
compared.

A5. HXMS OF NUCLEOSOME AND COMPLEXES
A5A. MAKING BUFFERS FOR HXMS REACTIONS
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Keep in mind that pD = pH + 0.4
Make stocks:
-

1M Tris in 10ml D2O
o (0.010mol)(121.14g/mol)=1.21g of Trizma Base
o pH to ~7.1 at room temp with NaOD (so that pD ~7.5)

-

0.25M EDTA in 10ml D2O
o (0.0025mol)(372.24g/mol)=0.93g of EDTA
o pH to ~7.6 at room temp with DCl (so that pD ~8). Note: EDTA will
not dissolve until pD approaches ~8.

On-exchange Buffer for timecourse (10mM Tris, pD ~7.5 at RT; 0.5mM EDTA, pD ~8
at RT):
-

In 10ml of D2O, add:
o 100ul of 1M Tris in D2O (pD ~7.5 at RT)
o 20ul of 0.25M EDTA in D2O (pD ~8 at RT)
o No need to further pH

On-exchange Buffer for Fully Deuterated (FD) samples (0.s5% formic acid in D2O):
-

In 10ml D2O, add 57ul of 88% formic acid

Quench Buffer for timecourse (2.5M GdHCl, 0.8% formic acid, 10% glycerol):
-

2.388g of GdHCl

-

91ul of 88% formic acid

-

1ml of 100% glycerol

-

Add to 10ml with autoclaved milliQ water

-

Sterile-filter through 0.22um filter.

-

Adjusting pH of this quench buffer is very important. See below for
instructions.

Quench Buffer for fully deuterated (FD) samples (2.5M GdHCl, 0.5% formic acid,
10% glycerol):
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-

2.388g of GdHCl

-

57ul of 88% formic acid

-

1ml of 100% glycerol

-

Add to 10ml with autoclaved milliQ water

-

Adjusting pH of this quench buffer is very important. See below for
instructions.

Steps for adjusting pH of Quench Buffers:
1. Objective is to make sure that the pH of our quench buffer + on exchange
buffer will be 2.4-2.5. This is the pH at which back-exchange will be
minimized).
2. Make all buffers.
3. Then, make separate “test reactions” of 600µl total (since that is the
minimum volume required by the pH meter):
-

60ul TCS buffer

-

180ul exchange buffer

-

360ul quench buffer

-

(Thus all components are proportional to each actual reaction, which
would contain 5ul TCS buffer with sample + 15ul on-exchange buffer +
30ul quench = 50µl total)

-

(Note: for the FD buffers, make sure to use the FD Quench Buffer + Onexchange buffer for FD samples)
a. Measure pH of the “test reaction”. Then adjust pH of Quench Buffer,
and make another 600µl of “test” reaction to measure pH, and
continue adjusting the pH of quench buffer until the “test” reaction
reaches pH 2.4-2.5.

Store all buffers at 4°C in the dark, and make sure to wrap any solutions with D2O
with parafilm.

A5B. SET UP HXMS REACTIONS
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Non-deuterated (ND) samples
-

These samples are used for collecting a peptide pool, and also for the allH control at the beginning of each data collection day.

-

For each reaction:
o 5µl of sample at ~1mg/ml (if samples are nucleosomes or
complex, use DNA concentration)
o 15µl of buffer (e.g., TCS-0 buffer)

-

For each reaction, pipet 20µl of this reaction into 30µl of cold Quench
Buffer, then flash freeze in liquid nitrogen.

-

Note: For nucleosome samples, it is OK to use a histone mix instead of
nucleosomes to make the non-deuterated samples (e.g., 1:1 mix of CENPA/H4 and H2A/H2B), if the peptides in the histone mix have the same
retention times as the peptides in nucleosomes (this can be verified
empirically).

-

In general, I make >20 ND samples for each timecourse.

Fully-deuterated (FD) samples
-

Set up a tube containing multiple reactions (I generally make >10 FD
samples for each timecourse) of 5µl of sample (at ~1mg/ml) with 15µl of
FD On-exchange Buffer. Wrap this in parafilm and foil during incubation.

-

When starting to work with a new protein, it is necessary to try various
temperatures and incubation times (e.g., 24hr at RT, 24hr at 37°C, 48hr at
RT…) and determine which condition allows for the fullest exchange. (See
section on “Quality checking FD sample”

On-exchange timecourse samples:
-

Prepare tubes by adding 30µl of cold Quench Buffer to each tube, and
labeling them exactly according to the planned timecourse (see example
timecourse in Table 5). Keep all tubes on ice.

-

Prepare samples for on-exchange:
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o As in example timecourse, prepare 6 tubes total, 3 of which will
contain CENP-A nucleosomes (CA-A, CA-B, and CA-C), and 3 of
which will contain CENP-A nucleosomes + CENP-C (CAC-A, CAC-B,
CAC-C).
o Add 27.5µl of sample (at ~1mg/ml) to each tube. (Since each
reaction will require 5µl of sample, this calculates for 5.5
reactions).
-

To begin the exchange:
o Pipet 82.5µl of On-Exchange Buffer to each tube (containing 27.5µl
of sample). Then immediately start the timer (counting up). At
each timepoint, pipet 20µl from the on-exchange reaction into the
appropriate tube containing 30µl of cold Quench Buffer. Pipet up
and down quickly (especially to mix the glycerol) and drop into
liquid nitrogen.
o Store all HXMS samples at -80°C until ready to run on mass spec.

Time

CENP-A nucs

CENP-A nucs + CENP-C

101s (10 sec)

CA-A1

CA-B1

CA-C1

CAC-A1

CAC-B1

CAC-C1

102s (1min 40s)

CA-A2

CA-B2

CA-C2

CAC-A2

CAC-B2

CAC-C2

103s (16min 40s)

CA-A3

CA-B3

CA-C3

CAC-A3

CAC-B3

CAC-C3

104 (2hr 46min 40s)

CA-A4

CA-B4

CA-C4

CAC-A4

CAC-B4

CAC-C4

105s (27hr 46min 40s)

CA-A5

CA-B5

CA-C5

CAC-A5

CAC-B5

CAC-C5

Table 5. Example of timecourse for HXMS, with two samples, 5 timepoints
performed in triplicate.

A5C. CROSSLINKING PEPSIN TO POROS RESIN
Make buffers
-

Buffer A (500ml): 50mM sodium citrate, pH 4.4. Filter.

-

Buffer B (25ml): 1.5M sodium sulphate, pH 4.4. Filter
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o Note: A previous protocol says: the sodium sulphate should be
dissolved in hot (>80C) water in a volume close to the final buffer
volume (~5.35g in 25ml). Allow solution to slowly cool at room
temperature. When temp is close to 30C, adjust pH to 4.4 (with
concentrated HCl) using as little volume as possible to prevent buffer
from cooling too rapidly. Allow buffer to cool to 25-30C before use.
However, we have found so far that the high temperature is not
necessary for dissolving sodium sulphate.
-

Buffer C (1ml)
o 100mM sodium phosphate
o 0.1M ethanolamine (6.26µl of 16.6M stock)
o 5µl of 1M sodium cyanoborohydride


This must be hydrated fresh with milliQ water and used
immediately. Beware that this reducing agents very toxic,
so wear mask, goggles, and lab coat when weighing
out. The dry powder should be kept on a desiccator.

o Note: the pH will be ~9 after ethanolamine addition. This is above
pH 4.4-4.5, But the volume added is small relative to the total
volume, so do not need to adjust pH.
-

Buffer D (50ml): 50mM sodium citrate, 1M NaCl, pH 4.4. Filter

-

Buffer E (500ml): 0.1% formic acid. Filter and de-gas.

Important note: Buffers A, B, D need to be at pH 4.4-4.5, where proteases have low
activity. At pH 6 and above the protease is irreversibly inactivated.

Day 1 (makes enough for 2-3 columns (UpChurch, C-130B)
1. Crack open a PD-10 column (GE, 8.3ml bed volume, 5cm bed length) and
pour out storage buffer. (Cut open the ridge with razorblade, place needle at
the end of column). Equilibrate with 25ml of Buffer A
2. Dissolve protease at 100mg/ml (50mg in 0.5ml of Buffer A)
-

Pepsin: Sigma P6887
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-

Fungal protease: Sigma P2143

3. Load protease onto column, and chase with 500µl of Buffer A, then 2ml of
Buffer A. Collect flowthrough in 500µl gractions (thus we have collected 5
flowthrough fractions).
4. Add 200µl of Buffer A at a time, collecting 200µl fractions. Repeat 15-20
times. Then plug the column and Ponceau-stain the fractions to see where
the protein is (using 2µl of sample per dot on membrane). Combine the
fractions that contain protease in a 15ml conical.
5. Calculate “x” which is just a scaling factor:
(total µl of eluted protease)/285=x
6. To the eluted protease, add:
50(x)µl of 1M sodium cyanoborohydride
For example, if x=5, then add 250µl
7. Slowly add 160(x)µl of Buffer B
8. Weigh out 100mg of POROS-20AL dry resin (Applied Biosystems #1-602802) into an Eppendorf tube. Add enough of the protease mixture to dissolve
the resin, and transfer the suspension to the 15ml conical. Gently agitate to
form a homogenous solution.
9. Add 330(x)µl of Buffer B over 2 hours (by adding the same amount every 5
minutes. Keep the solution homogenous by intermittent swirling.
-

For example, if the total volume is 1.62ml, we can add 67.5µl every 5
minutes, for 24 times total.

10. Tumble gently overnight at RT.
Day 2
1. Next morning, quench the reaction with 75µl of Buffer
2. Tumble gently for 5 more hours at room temperature
3. Using a fine sintered glass funnel, wash the resin with: 6ml Buffer A, then 5ml
Buffer D, then 6ml Buffer A
4. Gently use spatula to scrape resin from funnel and place in 15ml conical
5. Resuspend resin with Buffer A to make 50:50 solution
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6. Store in a 15ml conical at 4°C
Note: unused cross-linked proteases usually last several months. Can still be
used after 6 months, but may lose some efficiency.

A5D. SETTING UP AND CALIBRATING THE ORBITRAP
Preparing system to run samples
1. Prepare “Pre-injection Mix” of 3:2 Quench Buffer: milliQ water. This will be at
1M GdHCl, and is the solution to be used for all washes.
2. Turn on the power switch at the bottom of the cart.
3. Connect the HXMS Box to start cooling. Make sure the arrow points toward
the blue dot (otherwise the box will be heated instead). Place a temperature
probe inside the box, and monitor temperature of the box throughout the
day.
4. Turn on the Waters pump.
5. Take knobs off of the tubing in the Box.
6. Connect the tubing to the Waters pump, but do so under flow: set Waters
pump to 0.050ml/min and press “Run”.
7. Flip on the air switch for the Eksigent (on the wall), and turn on the Eksigent
(the switch is on the side of the box). The green light should come on on the
other side.
8. On the computer, open XCalibur software. Wait for “Eksigent LC Channel 1”
to say “Ready to Download”.
9. Open Eksigent software on computer. Go to “System”  “Direct Control”. Set
to 12%, at 6µl/min. Then click Start.
10. Now connect the tubing from the Eksigent to the HXMS Box.
11. Open ThermoTunePlus on the computer. Then open “LMtune.LTQtune.”
12. Begin calibration
a. Load the syringe attached to the Orbitrap with Calibration Mix
(CalMix). Press the Pump button on the Orbi and wait for masses to
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appear on the computer. Check to make sure they are relatively stable.
The NL should be in the 10^7 range.
b. In ThermoTunePlus, go to “Control”  “Calibrate”
c. First check to see if Orbi is already calibrated. Go to the “Check” tab,
and check “Mass Calibration” under “Positive Ion Mode”. Document
the Universal and Low RMSD values in the Excel spreadsheet on the
desktop. If values are >1.5, then calibrate. Otherwise, can proceed
without calibration.
d. To perform the actual calibration, go to the “Semi-Automatic” tab, and
check “Mass Calibration” under “Positive Ion Mode”.
e. After calibration, perform another check: Go to the “Check” tab, and
check “Mass Calibration” under “Positive Ion Mode”. Document the
Universal and Low RMSD values in the Excel spreadsheet on the
desktop.
13. After calibration, make sure to connect the tubing from the Orbi to the HXMS
Box (instead of to the syringe for CalMix).
14. Now ready to start the day of runs. Start with a pre-clean run.
a. Choose a name for the run. Specify Path and Inst Method in
XCaliber. For pre-clean and washes in between runs, Inst Meth should
be “C:\Xcalibur\methods\Lucie\3-29-11 yeast cleanup_tp”.
b. Check the method. Right click → “Open File” to make sure everything
is correct, especially the pre-flush times.
c. Click “Run Sample” (not Run Sequence), and do NOT click “OK” yet.
d. Make sure both valves are in P1.
e. Draw up 50ul of Pre-Injection Mix into the Hamilton
syringe. Inject. Then quickly change V1 to P2, and click “OK” on the
computer to start running the method. Prepare to change the water
pump from 0.050ml/min to 0.150ml/min, but do NOT click “Menu”
yet.
f. After 2min, click “Menu” to change the water pump to 0.150ml/min
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g. After another 2min (4 min total), flip V2 to P2. Then change water
pump back to 0.050ml/min.
h. Wait for 15min clean-up method to finish.
15. After the pre-clean run is finished:
a. Set both valves to P1
b. Make sure the water pump is on 0.050 ml/min
c. Check temperature probe in the box. Temperature should be close to
0C.
d. Wait for pressures stabilize.
e. Rinse the syringe and tubing:
1. Rinse the Hamilton syringe 3 times with 1% formic acid + TFA
pH 2.20 (the buffer for the waters pump).
2. Rinse the injection tubing: With V1 in P1, fill up the Hamilton
syringe with 1% formic acid + TFA pH 2.20 and inject into
V1. There should be liquid oozing out of the bypass
tubing. Catch with Kim wipes to prevent a puddle.

A5E. RUNNING ND SAMPLES FOR GENERATING PEPTIDE POOL
1. Keep all HXMS samples on dry ice before injecting into the system.
2. After the pre-clean (see previous section), start an ND run.
3. For ND runs, specify
“C:\Xcalibur\methods\Lucie\20111205_forNDs_4minpreflush” for Inst
Meth.
a. The method consists of a linear 12-55% buffer B gradient at 6 µl/min
(Buffer A: 0.1% formic acid; Buffer B: 0.1% formic acid, 99.9%
acetonitrile). The method for ND will collect MS/MS data.
4. Click “Run Sample” (not Run Sequence), and do NOT click “OK” yet.
5. Make sure both valves are in P1. Take sample out from dry ice and let thaw
slowly at 0°C. Draw sample (50ul) into the Hamilton syringe. Inject. Then
quickly change V1 to P2, and click “OK” on the computer to start running the
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method. Prepare to change the water pump from 0.050ml/min to
0.150ml/min, but do NOT click “Menu” yet.
6. After 2min, click “Menu” to change the water pump to 0.150ml/min
7. After another 2min (4 min total), Change V2 to P2. Then change water pump
back to 0.050ml/min. Then wait for the 25min run to finish.
8. In between each run, perform a wash step.
9. After the ND run (and after each subsequent run), do a wash run (same
method as the pre-clean).
10. To continue building the peptide pool:
a. Use SEQUEST to generate a list of peptides from this ND run. Then use
ExMS to generate an exclusion list with these peptides, and load this
exclusion list into the Method file of the next ND run. See section “A5g.
Generating exclusion list and final peptide pool” for more details.
b. For the 3rd ND run, generate an exclusion list containing peptides from
both of the first two runs, and load that into the Method file.
c. You should see that the number of peptides within the Ppep threshold
(e.g., <0.90) will decrease with every iterative ND run. Depending on
the length of your protein, usually after ~4 runs, we start getting
diminishing returns.

A5F. PROTEIN SEQUENCES
CENP-A/H4/H2A/H2B histone mix
Histone CENP-A (MS index 1-140):
MGPRRRSRKPEAPRRRSPSPTPTPGPSRRGPSLGASSHQHSRRRQGWLKE
IRKLQKSTHLLIRKLPFSRLAREICVKFTRGVDFNWQAQALLALQEAAEAF
LVHLFEDAYLLTLHAGRVTLFPKDVQLARRIRGLEEGLG
Histone H4 (MS index 141-243):
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MSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLI
YEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYG
FGG
Histone H2A (with N-terminal GPLG tag remnant) (MS index 244-377):
GPLGMSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVG
AGAPVYMAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELN
KLLGKVTIAQGGVLPNIQAVLLPKKTESHHKAKGK
Histone H2B (MS index 378-503):
MPEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSVYVYKVLKQV
HPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRL
LLPGELAKHAVSEGTKAVTKYTSSK
CENP-CCD
MAKPAEEQLDVGQSKDENIHTSHITQDEFQRNSDRNMEEHEEMGNDCVSKKQM
PPVGSKKSSTRKDKEESKKKRFSSESKNKLVPEEVTSTVTKSRRISRRPSDWWVV
KSEE
CENP-NNT-His
MDETVAEFIKRTILKIPMNELTTILKAWDFLSENQLQTVNFRQRKESVVQHLIHLC
EEKRASISDAALLDIIYMQFHQHQKVWDVFQMSKGPGEDVDLFDMKQFKNSFKK
ILQRALKNVTVSFRETEENAVWIRIAWGTQYTKPNQYKPTYVVYYSQTPYAFTSSS
MLRRNTPLLGQALTIASKHHQIVKMDLRSRYLDSLKAIVFKQYNQTFETHNSTTP
LQERSLGLDINMDSRIIHEGSSHHHHHHH

A5G. GENERATING EXCLUSION LIST AND FINAL PEPTIDE POOL
-

Summary: Depending on protein length, running ~4 NDs should provide a
complete peptide pool. Following the first run, use ExMS to generate an
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exclusion list from the SEQUEST results. For the next run, upload the
exclusion list into the Xcalibur method file.
-

To create FASTA database:
o The database should include the sequences of the proteins in the
sample (see protein sequences of my samples, in previous section).
o Also, make sure to include ALL the proteins used by the lab as well as
the protease (pepsin or fungal protease) used. Human keratins, MS
standards, and the proteome of the organism of expression are also
good ideas. You can also include the reverse protein sequences.

-

To generate Excel file of SEQUEST results from RAW file:
o Open Bioworks Browser software
o Drag the run (.RAW file) into the window
o Go to Actions → SEQUEST Search (to match against a database)
o Specify .params file (with appropriate FASTA database)
o Use peptide tolerance of 8 ppm (default is 4 ppm), fragment tolerance
of 0.1 (LM) AMU
o Right click → Display → Peptides → make sure Retention times is
checked (not Scan)
o Right click → Export → Excel
o This will generate an excel file containing all the peptides found in the
run, including their Ppep scores.

-

Generating an exclusion list in ExMS:
o Select 5: MS/MS related utilities
o Select 2: To make MS/MS exclusion (reject) list
o Select 1. Thermo Bioworks/SEQUEST (the result table saved as .xls
file)
o Designate P score (I use 0.90)
o Xcorr score: [1,1,1,1,1]
o Number of MS/MS experiments: 1 on first run, 2 on second, etc.
o RT range of MS/MS experiments: [0 25] for a 25 minute run
o RT window for exclusion list: 1 s
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o This should generate a .txt file. In the next run, import this exclusion
list into the Method file of the run.
-

To generate peptide pool in ExMS from several iterative ND runs:
o To begin analyzing ND sample (which will ask to generate a peptide
pool as the first step), start ExMS and choose 1: Start auto-processing
HX MS dataset


Alternatively, to just generate the pool without analyzing a run,
choose 5: MS/MS related utilities  1: To make
experimental/theory peptide pools

o Input name of protein and sequence. For my sequences, see “A5f.
Protein sequences”.
o Choose 1: Thermo Bioworks/SEQUEST (the result table saved as .xls
file)
o Input the score system to be used (1=XCorr; 2=Ppep): Ppep.
o Input Ppep score threshold for filtering peptides: 90
o How many MS/MS experiments (result tables of peptide search) to
establish the "peptidesPool"?: Enter how many ND runs from which to
build the peptide pool.
o Then, choose each .xls file to be analyzed.
o ExMS will then generate the peptide pool file (“ExMS_preload”) with
an accompanying .fig file (see examples in Figure 50 and Figure 51).
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Figure 50. Peptide pool showing CENP-A/H4/H2A/H2B from several iterative ND
runs.
See “A5f. Protein sequences” for how the residue number lines up with each protein.
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Figure 51. Peptide pool showing CENP-NNT, from several iterative ND runs.

A5H. RUNNING THE DEUTERATED TIMECOURSE SAMPLES
1. Keep all HXMS samples on dry ice before injecting into the system.
Remember to let each sample thaw slowly at 0°C on ice.
2. Start with a pre-clean,,then start the day with an All-H run (with an ND
sample). See “A5e. Running ND samples for generating peptide pool” for
protocol and method file. Then make sure that the retention times of the
peptides in this run align well (within ~half a minute) to those in the peptide
pool.
3. I usually run the FD sample as the second run of the day. For the FD run (and
for all deuterated runs), specify “Deuterium_run_MS1_12to55_tp” as the
Method file. Just like the file for the ND runs, this file consists of a linear 1255% buffer B gradient at 6 µl/min (Buffer A: 0.1% formic acid; Buffer B: 0.1%
formic acid, 99.9% acetonitrile). But it does not collect MS/MS data.
1. After the FD, start running timecourse samples, with a wash run between
each run. For my first dataset with CENP-A nucleosomes +/- CENP-C, I also
ran an empty gradient (a 25min run, but without injecting sample) after each
wash, to make sure that no peptides have been carried over from the
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previous run. I never saw any carryover of peptides, and when I repeated the
dataset, I saw no difference in the results. So for subsequent datasets, I no
longer did the empty gradients.
4. At the end of day, before disconnecting the system, remember to store the
analytical C18 HPLC column in 90% acetonitrile: bump up to 90% Buffer B
stepwise (e..g., start with 20%, then up to 30%, then up to 40%... to 90%).
Notes:
-

I usually run the same timepoint of two samples back-to-back, to minimize
the variability in data collection between the two samples (and randomly
select which one to run first). For example, for the timecourse shown in
Table 5, I can run CA-A1, then CAC-A1, then CAC-A3, then CA-A3).

-

I have found by experience that the data looks tighter if the entire timecourse
is run over a single day, or over two consecutive days. (Note: if doing runs
continuously, make sure to re-calibrate the Orbi every 12 hours).

-

Make sure that all plumbing is running well before starting the timecourse,
because changing any component of the plumbing (especially the C18
analytical column) can dramatically alter the retention times of peptides,
which will make analysis very problematic.

A5I. ANALYSIS OF DEUTERATED SAMPLES BY EXMS
1. Convert RAW files to mzXML files (to be used by ExMS)
a. Open TPP Web Tools (purple flower icon). Username: guest. Then
password should auto-fill (should also be guest)
b. On the desktop there is a link to “TPP data
directory”. (C:\Inetpub\wwwroot\ISB\data). Draw .RAW files into
this folder
c. Then on the web interface: Analysis Pipeline
i. Specify RAW Input File(s) to convert to mzXML (select our
files)
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ii. Conversion Options: check “Profile” (not Centroid)
iii. Convert
d. Now you should see .mzXML files appearing in the TPP data directory
folder. Remove them from this public folder immediately after
transferring the files.
2. Use ExMS to auto-process the mzXML files by selecting “1: Start autoprocessing HX MS dataset”, and following the steps as asked by the program.
After preprocessing, ExMS will generate an “ExMS_wholeResults” file.
a. We can perform auto-check of the results by selecting “2: Check autoprocessed results or re-check” and selecting “1: To just use this autodetermined good peptide set (Will need no manual check)”. This will
generate an “ExMS_wholeResults_afterCheck” file.
3. Quality check the fully deuterated (FD) sample
a. To check whether the FD sample will serve as an adequate control for
full deuteration, run the FracDeut script (written by J. DawickiMcKenna). The code requires the “ExMS_wholeResults_afterCheck”
files for both the ND and the FD. The code will calculate the theoretical
full deuteration of each peptide and compare it to the experimental
degree of deuteration, then plot a histogram of fractional deuteration
for all peptides (Figure 52). For my FD samples of histone mixes, I
usually get a median fractional deuteration of >85%.
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Figure 52. Example
FracDeut analysis of a
fully deuterated (FD)
histone mix sample.

4. Manually check peptides
a. After letting ExMS perform autocheck of the data, you can manually
check each peptide or selected peptides. To perform manual checking,
select “2: Check auto-processed results or re-check”. Then, you can
manually check every peptide by choosing “3: To check all peptides no
matter auto-determined good or not (Maximum manual check)”, or
just check the peptides that ExMS could not confidently identify by
choosing “2: To check those peptides outside the good set (Partial
manual check)”. For guidelines on how to perform manual checking,
see published literature (Kan et al., 2011).
5. Plotting data
a. Data can be plotted into figures by using Matlab scripts written by T.
Panchenko and M. Salman. This code first prompts the user for input,
then performs necessary calculations and creates HDX Ribbon plots,
Difference plots where applicable as well as XY plots for all data sets.
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APPENDIX B: PROTOCOLS FOR CHAPTER 4
B1. SILAC EXPERIMENTS
B1A. MAKING MEDIA FOR SILAC
Overview: this protocol makes 4L of SILAC media, which emulates the Joklik formula
(from Sigma). My SILAC experiments were always 2L light + 2L heavy, since this was
determined to be the minimum scale needed to detect the phosphosites of interest.
This media is made completely from scratch, by adding nutrient powder into milliQ
water. Lysine and Arginine are added later.
1. First measure out 3L milliQ water in a 4L flask, keep this stirring at room
temperature.
2. Weigh out each individual component in table below. Note that many of these
components require some time to dissolve, so for best results, keep the water
stirring as the components are added.
1. Note: for vitamins, since so little quantity is required, I found it
easiest to weigh out the smallest quantity that can be comfortably
measured and then dissolve that in 1ml ddH2O. Then, add the
volume that would correspond to the appropriate final quantity.
Component

mg/L

For 4L

Magnesium chloride x 6H2O (Sigma M9272)

200

800

Potassium chloride (Fisher BP366)

400

1600

Sodium chloride (Sigma S9888)

6500

26000

Sodium dihydrogen phosphate x H2O (Sigma S9638)

1327

5308

D(+)-Glucose anhydrous (Sigma D9434)

2000

8000

Salts and sugars
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Amino acids (NOT including Lys, Arg, and Pro, which are to be added later)
L-Cystine (Sigma C7352)

24

96

L-Histidine base (Sigma H6034)

31

124

L-Isoleucine (I7403)

52

208

L-Leucine (Sigma L8912)

52

208

L-Methionine (Sigma M5308)

15

60

L-Phenylalanine (Sigma P5482)

32

128

L-Threonine (Sigma T8441)

48

192

L-Tryptophan (Sigma T8941)

10

40

L-Tyrosine (Sigma T8566)

32.6

130.4

L-Valine (Sigma V0513)

46

184

D-Calcium pantothenate (Sigma P5155, stored at 4°C)

1

4

Choline chloride (Sigma C7527)

1

4

Folic acid (Sigma F8758)

1

4

Myo-inositol (Sigma I7508)

2

8

Nicotinamide (Sigma N0636)

1

4

Pyridoxal-HCl (Sigma P6155, stored at -20°C)

1

4

Riboflavin (Sigma R4500)

0.1

0.4

Thiamine-HCl (Sigma T1270)

1

4

Vitamins

3. After adding all components, wait to make sure there are no precipitates.
4. Then add phenol red to media (10mg/L, so add 40mg for 4L)
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5. At this point, the media will look yellow (acidic). Add NaOH until it looks
more red.
6. Measure pH, and add more NaOH until pH reaches ~7.
7. Add 8g of sodium bicarbonate (Sigma S9638)
8. Pour in water to ~3.6L.
9. Measure pH again. Adjust pH to ~7.2-7.3.
10. Sterile-filter into 1L bottles using 0.22µm filter, 900ml per bottle (thus
leaving 100ml for adding serum). This is now a master stock of Joklik media,
and can be stored at 4°C for several weeks. Note: the media should go
through the 0.22µm filter easily. If it is failing to go through easily, it might
indicate that there is precipitation in the media, and that it is unable to be
used since it could be missing key nutrients.
11. When beginning a SILAC experiment, make light and heavy media separately,
from this master stock.
12. Make separate stocks of lysine, arginine, and proline to be added individually.
Store these hydrated stocks at -20°C until ready to use. Can refreeze and
thaw as many times as needed.
a. For lysine (make 50mg/ml stock in ddH2O, which Is 1000x)
1. Light: L-Lysine (Sigma L5501)
2. Heavy: 13C15N labeled Lysine-HCl, 100mg (Silantes 211603902)
b. For arginine (make 50mg/ml stock in ddH2O, which Is 1000x)
1. Light: L-Arginine (Sigma L5006)
2. Heavy: 13C15N labeled Arginine-HCl, 100mg (Silantes
201603902)
c. For proline (Sigma P0380), make 120mg/ml stock in ddH2O, which is
1000x
13. To make 500ml of light (or heavy) media:
a. Add 450ml of Joklik media (from master stock)
b. 50ml of dialyzed FBS (Gemini # 100108). It is important to use
dialyzed FBS, since normal FBS contain trace amounts of lysine and
arginine.
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c. 5ml of GlutaMax (Gibco 35050-061, which is at 100X). I find this
easier to work with compared to L-Glutamine, especially since this
stock is stored at room temperature.
d. 5ml of Pen/Strep
e. 5ml of 1M HEPES
f. 5ml of 100X MEM Non-Essential Amino Acids Solution (Gibco 11140050, containing Gly, Ala, Asn, Asp, Glu, Pro, and Ser).
g. 500µl of 1000x Lysine (50mg/ml) – light or heavy
h. 500µl of 1000x Arginine (50mg/ml) – light or heavy
i.

500µl of 1000x Proline (120mg/ml)

B2B. GROWING HELAS3 SPINNER CELLS IN SILAC MEDIA
1. Make sure spinner flasks are autoclaved, once in ddH2O, and once dry.
2. HeLaS3 cells expressing CENP-A-LAP (Bailey et al., 2013) are frozen in liquid
nitrogen at 2 x 107 cells/vial.
3. Make sure to pre-warm media in 37°C water bath prior to use.
4. Combine two vials into some volume of normal media (e.g., 50ml), then split
into two equal 50ml conicals (e.g., 25ml each). Then spin down gently
(800rpm, 3min), and carefully remove the media. Then, to one cell pellet, add
50ml of Light media. To the other conical, add 50ml of Heavy media.
Carefully and thoroughly mix each tube of cells using a transfer pipet.
Monodispersing the cells is crucial for optimal growth, since clumped cells do
not grow as well.
a. Thus, both the Light and Heavy flasks are starting from equivalent
cells, and the starting concentration of cells in each flask is ~4x105
cells/ml.
5. Gently pour each conical of cells into a pre-warmed 100ml spinner flask.
Make sure to label which flask is Light, and which is Heavy.
6. Check cell density and viability daily. Do not let the cells overgrow (>1x106
cells/ml), and do not split them to lower than ~3x105 cells/ml. If cells are
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doubly daily, and percent of dead cells is <10%, then they are growing well.
Every day, add more pre-warmed media (light or heavy, according to which
flask).
7. Once the capacity of the flask is maxed out, transfer to the next biggest size of
spinner flask (and make sure it is autoclaved twice-- first in water and next in
dry-- and pre-warmed to 37C).
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APPENDIX C: LIST OF PLASMIDS
Plasmids containing guide RNAs (gRNA), for transfection in mammalian cells (for
CRISPR/Cas-mediated gene editing). [All are in the pX330 (BB901) backbone]
BB #

Description

Vector

Cloning notes

957

pX330 with gRNA to
CENP-A C-terminus
(LG-033 + LG-034)

pX330
(BB901)

Annealed oligos LG-035 and LG-036
and ligated with pX330 (BB901) that
had been digested with FastDigest
BpiI (Thermo).

958

pX330 with gRNA to
CENP-A C-terminus
(LG-035 + LG-036

pX330
(BB901)

Annealed oligos LG-035 and LG-036
and ligated with pX330 (BB901) that
had been digested with FastDigest
BpiI (Thermo).

963

pX330 with gRNA to
CENP-A C-terminus
(LG-045 + LG-046)

pX330
(BB901)

Annealed oligos LG-045 and LG-046
and ligated with pX330 (BB901) that
had been digested with FastDigest
BpiI (Thermo).

Plasmids containing repair templates, for transfection in mammalian cells (for
CRISPR/Cas-mediated gene editing):
BB #

Description

Vector

Notes on cloning, source, or usage

965

SNAP-P2A-NeoR

pUC19

Repair template for CENP-A-SNAP
CRISPR, containing ~800bp
homology arms on either end of the
exogenous gene

Plasmids for transfection in mammalian DLD-1 Flp-In T-Rex cells, to insert construct
into unique FRT site by Flp/FRT recombination:
BB #

Description

959

Flp recombinase

961

pcDNA5/FRT with
CENP-A-SNAP

Vector

Notes on cloning, source, or usage
This is a commercial plasmid from
Invitrogen (pOG44).

pcDNA/FR
T (BB955)
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PCR’ed up BB921 with LG-037 and
LG-038 (used KAPA HiFi with GCrich buffer!); inserted into BB955
backbone by KpnI and PspXI digest.

962

pcDNA5/FRT-CENPC (untagged, fulllength)

pcDNA/FR
T (BB955)

PCR’ed up BB891 with LG-039 and
LG-040; inserted into BB955
backbone by NheI and PspXI digest.

1007

pcDNA5-FRT-CENPC(∆426-537)

pcDNA/FR
T (BB955)

PCR BB892 with LG-039 and LG-040.
Ligation with BB962 after NheI +
PspXI digestion.

1008

pcDNA5-FRT-CENPC(∆736-758)

pcDNA/FR
T (BB955)

PCR BB903 with LG-039 and LG-040.
Ligation with BB962 after NheI +
PspXI digestion.

1009

pcDNA5-FRT-CENPC(∆426-537 + ∆736758)

pcDNA/FR
T (BB955)

PCR BB904 with LG-039 and LG-040.
Ligation with BB962 after NheI +
PspXI digestion.

1135

pcDNA5-FRT-CENPC(∆519-533)

pcDNA/FR
T (BB955)

Mutagenesis of BB962 with LG 104
and LG 105

1136

pcDNA-FRT-CENPC(R521A)

pcDNA/FR
T (BB955)

Mutagenesis of BB962 with LG 106
and LG 107

1137

pcDNA-FRT-CENPC(R522A)

pcDNA/FR
T (BB955)

Mutagenesis of BB962 with LG 108
and LG 109

Plasmids for expression in bacterial cells:
BB #

Description

Vector

Notes on cloning, source, or usage

675

pGEX-GST-CENPC(426-537)

pGEX

Gift from Aaron Straight (used in
Carroll et al., 2010, and Falk et al.,
2015)

1015

CENP-N(1-240)-HIS

His-tagged CENP-N(1-240). Made by
Kara McKinley (first used in
McKinley et al., 2015)

1072

CENP-N(1-205)-His

His-tagged CENP-N(1-205)

1145

GST-CENP-C(R521A)

pGEX

CENP-CCD, R521A

1086

GST-CENP-C(R522A)

pGEX

CENP-CCD, R522A
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APPENDIX D: LIST OF OLIGOS
LG#
LG-033
LG-034
LG-035
LG-036

Sequence
CACCGCAACTGGCCCGGAG
GATCCG
AAACCGGATCCTCCGGGCC
AGTTGC
CACCGCCGGAGGATCCGGG
GCCTTG
AAACCAAGGCCCCGGATCC
TCCGGC

Purpose

Notes

CENP-A-SNAP CRISPR: gRNA #1
CENP-A-SNAP CRISPR: gRNA #1
CENP-A-SNAP CRISPR: gRNA #2
CENP-A-SNAP CRISPR: gRNA #2
Tm=59C;
71% GC;
17bp
annealed
Tm=60C;
To insert CENP-A-SNAP from
43% GC;
BB921 into pcDNA/FRT (C28bp
terminal PspXI site)
annealed
Tm=6061C, 75%
To insert CENP-C from BB891 into GC; 16
pcDNA/FRT (N-terminal NheI site annealed
and ATG)
bases
To insert CENP-C from BB891 into Tm=59C;
pcDNA/FRT (already has C43% GC;
terminal PspXI; keeping the stop 30bp
codon)
annealed

GACTGGTACCGACGTCACC To insert CENP-A-SNAP from
GGTCCGGCCGGATCTATGG BB921 into pcDNA/FRT (NLG-037 G
terminal KpnI-AgeI sites)
GATCATGCTCGAGTCTCAA
GCGTAATCTGGAACGTCAT
LG-038 ATG

GACTGCTAGCATGGCTGCG
LG-039 TCCGGTCTG

CCCTCTAGACTCGAGTCAT
LG-040 CTTTTTATCTG
CACCGCTGACAGAAACACT
LG-045 GGGTGC
CENP-A-SNAP CRISPR: gRNA #3
AAACGCACCCAGTGTTTCT
LG-046 GTCAGC
CENP-A-SNAP CRISPR: gRNA #3
F mutagenesis primer for repair
CCGGGGCCTTGAAGAGGGA template for gRNA #035-036 (for
LG-049 CTCGGC
both BB956 and with NeoR)
R mutagenesis primer for repair
GCCGAGTCCCTCTTCAAGG template for gRNA #035-036 (for
LG-050 CCCCGG
both BB956 and with NeoR)
AGATTACGCTTGAGCTCTT F mutagenesis primer for repair
LG-051 GCACCCAGTGTTTCTG
template for gRNA #045-046 (for
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Tm=67C

Tm=67C
Tm=66C

BB956 ONLY)
R mutagenesis primer for repair
CAGAAACACTGGGTGCAAG template for gRNA #045-046 (for
LG-052 AGCTCAAGCGTAATCT
BB956 ONLY)
U6 F promoter (Recommended by
GAGGGCCTATTTCCCATGA Ran et al 2013) for sequencing
LG-053 TTCC
gRNAs in pX330
GTGAATTCGAGCTCGGTAC CENP-A-SNAP CRISPR (with
CCGGGGATCCTCTAGAGGA NeoR): F for 5' homology arm
LG-054 ACTCTCTCGTTTGTCCAC gPCR
CENP-A-SNAP CRISPR (with
CCTCGAGAAGGCCGAGTCC NeoR): R for 5' homology arm
LG-055 CTCCTCAAG
gPCR
CENP-A-SNAP CRISPR (with
LG-056 GCCTTGAGGAGGGACTCGG NeoR): F for gBlock
AAGACTGACAGAAACACTG CENP-A-SNAP CRISPR (with
LG-057 GGTG
NeoR): R for gBlock
CENP-A-SNAP CRISPR (with
ATGACTCGAGGCTCCTGCA NeoR): F for 3' homology arm
LG-058 CCCAGTGTT
gPCR
ACGCCAAGCTTGCATGCCT CENP-A-SNAP CRISPR (with
GCAGGTCGACTAGTGCCTT NeoR): R for 3' homology arm
LG-059 TTCTCCCATACCACAG
gPCR
GTGCAACTGGCCCGAAGAA F mutagenesis primer for repair
LG-060 TTCGCGGCCTTGAGGAGGG template for gRNA #033-034
CCCTCCTCAAGGCCGCGAA R mutagenesis primer for repair
LG-061 TTCTTCGGGCCAGTTGCAC template for gRNA #033-034
F mutagenesis primer for repair
GTTATGACTCGAGGCTCTT template for gRNA #045-046 (for
LG-076 GCACCCAGTGTTTCTG
the one with NeoR ONLY)

CAGAAACACTGGGTGCAAG
LG-077 AGCCTCGAGTCATAAC
GCTACCTGCCCATTCGACC
LG-080 ACCAAGCG
CGCTTGGTGGTCGAATGGG
LG-081 CAGGTAGC
GTGACTTCAACTGTCACGA
LG-104 AATCAGAGGAGAGTCCT

Tm=64C
Tm=58C,
52% GC
Tm=57C,
52% GC
Tm=58C,
67% GC
Tm=60C,
68% GC
Tm=58C,
48% GC
Tm=59C,
61% GC
Tm=57C,
52% GC
Tm=63C,
63% GC
Tm=67C,
63% GC
Tm=65C,
annealed
34bp (51%
GC)
Tm=64C,
annealed
34bp (51%
GC)

R mutagenesis primer for repair
template for gRNA #045-046 (for
the one with NeoR ONLY)
F mutagenesis for L-->F in CRISPR
repair template with SNAP-NeoR Tm-64C
R mutagenesis for L-->F in CRISPR
repair template with SNAP-NeoR Tm-64C
CENP-C CD mutagenesis: F d519533
Tm=52C
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AGGACTCTCCTCTGATTTC
LG-105 GTGACAGTTGAAGTCAC
AGAAGTGACTTCAACTGTC
ACGAAAAGTGCCAGAATTT
LG-106 CCAGGCGT
ACGCCTGGAAATTCTGGCA
CTTTTCGTGACAGTTGAAG
LG-107 TCACTTCT
TCAACTGTCACGAAAAGTC
GAGCCATTTCCAGGCGTCC
LG-108 ATCTGAT
ATCAGATGGACGCCTGGAA
ATGGCTCGACTTTTCGTGA
LG-109 CAGTTGA

CENP-C CD mutagenesis: R d519533

Tm=55C

CENP-C CD mutagenesis: F R521A Tm=63C

CENP-C CD mutagenesis: R R521A Tm=63C

CENP-C CD mutagenesis: F R522A Tm=63C

CENP-C CD mutagenesis: R R522A
For sequencing (this is the
LG-116 CGAGGTCGACGGTATCG
common "KS primer")
GCGTAATCTGGAACGTCAT For sequencing (R primer that
LG-117 ATGG
anneals to "HA")

GGAGATATACATATGGATG F primer for CENP-N(205)-His
LG-191 AGACTGTTG
gBlock

CCAAGCTTAGATCTGGATC R primer for CENP-N(205)-His
LG-192 CTC
gBlock
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Tm=63C
Tm=55C,
65% GC
Tm=57C,
48% GC
Tm=55C, 28
annealed
bases, 39%
GC
Tm=55C, 22
annealed
bases, 50%
GC
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